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Enterococci are opportunistic pathogens that are frequently a source of nosocomial 
infections and it is their resistance to antibiotics and their ability to form biofilms that 
represent important virulence traits. Normally, in healthy individuals it is a harmless 
commensal that is usually found in the intestine. This thesis firstly studies signal 
peptidases (SPases), which play an essential role in protein translocation. Interestingly, 
E. faecium was found to contain three type I SPases. Many proteins that are secreted are 
virulence factors, and the aim was to delete one or more of the SPases and study the 
effect of its removal on virulence. Unfortunately no mutants were obtained suggesting 
that the genes were essential. To establish if the genes were essential an inducible 
integration vector was constructed, but due to time constraints this could not be tested 
further. 
 
Biofilm formation was studied in both E. faecium and E. faecalis. The presence of the 
Enterococcal Surface Protein (Esp) in E. faecium was shown to increase hydrophobicity, 
and therefore also increase biofilm formation. Similarly, E. faecalis isolates that were 
good biofilm formers were also more hydrophobic in nature. The expression of Esp in E. 
faecium was studied under different conditions; these studies indicated that the highest 
level of Esp expression was found in biofilms cells. This growth-dependent manner Esp 
expression was not observed in E. faecalis BS12297. Surprisingly, Esp in E. faecium 
was also shown to have a role in ampicillin resistance, which was identified using 
calorimetry. This method proved to be a sensitive and rapid method to analyse antibiotic 
resistance.  
 
In the gut, bacteria encounter various adverse conditions, such as low pH and the 
presence of bile salts. Here we investigated the effects of bile salts on biofilm formation 
in E. faecium and E. faecalis and demonstrated that biofilm formation is induced at 
physiological concentrations of bile salts. In E. faecium the presence of bile salts caused 
an increase in initial attachment, microcolony formation and EPS production. Various 
factors were investigated, including hydrophobicity, cell growth, cell morphology, Esp 
expression and the production of extracellular polymeric substance (EPS). In E. faecium, 
only EPS production appeared to play a role, but the stimulation of biofilm formation 
due to bile salts is still to be fully explained. 









Chapter 1: Introduction 
 
Biofilm formation and 























Enterococci are Gram-positive, facultative anaerobic bacteria; they are oval cocci 
that form chains of different lengths and belong to the lactic acid bacteria of the 
firmicutes phylum. They were first classified as streptococci, but with the 
introduction of Lancefield serological typing system in 1930 and, in addition, their 
ability to grow at a wide range of temperatures (10-45oC), in 6.5% sodium salt 
(NaCl), in pH 9.6, in 40% bile and ability to survive 30 minutes at 60oC, they were 
separated from other streptococci and given the genus name enterococci (Cetinkaya 
et al., 2000). The natural habitat of enterococci is in the intestine and oral cavity of 
humans and animals where they are usually harmless commensals, but they have 
also been found in water, soil, plants and birds (Gelsomino et al., 2002, Franz et al., 
1999). They can, however, become opportunistic pathogens in humans when the host 
resistance is lowered i.e. by other diseases or drugs. The diseases they can cause 
include endocarditis, urinary tract infections, bacteraemia, and intra-abdominal and 
pelvic infections. There are two clinically relevant enterococcal species, 
Enterococcus faecalis and Enterococcus faecium. Importantly, enterococci are 
becoming an increasing problem in hospitals due to their resistance to many 
antibiotics (Mohamed and Huang, 2007). 
 
1.2. Biofilm formation. 
 
Not only are enterococci resistant to many antibiotics, they are also able to produce 
biofilms. Biofilms are communities of organisms that are attached to a range of 
biotic and abiotic surfaces and are encased in exopolymeric substances (Mohamed 
and Huang, 2007). Such a community can contain single species or multiple species 









1.2.1 Initial attachment 
 
Bacteria, when they are not attached to a surface, are planktonic, free-floating 
bacteria (Hall-Stoodley et al., 2004). These planktonic cells may attach to a surface, 
but that is dependent on several key elements, such as the properties of the cell, the 
properties of the substratum and the environment. Initial attachment of bacterial cells 
requires electrostatic, Lewis acid-base interactions, Lifshitz-van der Waals and 
hydrophobic forces to overcome the repulsion of the usually net negative charge 
surfaces, and some of the above interactions are helped by the cell surface proteins 
(van Merode et al., 2006a).  This attachment is initially reversible but eventually it 
becomes irreversible. There are also genetic changes occurring, due to possibly the 
sensing of a change in environment, which triggers a shift in expression of genes the 
products of which further stimulate attachment (Beloin and Ghigo, 2005, Monds and 
O'Toole, 2009). An example of this is the shift seen in Escherichia coli in which 
genes encoding flagella components are repressed as these are not needed anymore 
after attachment (Ren et al., 2004). Bacteria also have other surface structures that 
are important to initial attachment, which include fimbriae, lipoproteins, 
lipopolysaccharides, enzymes, and adhesins (such as Bap in S. aureus (Latasa et al., 
2006)) (Lejeune, 2003). The properties of the substratum also has a role, as bacteria 
have been shown to attach better to rougher surfaces as well as those that are more 
hydrophobic (Donlan, 2002). The presence of a conditioning film on the surface can 
also effect initial attachment; the film can contain different organic and inorganic 
materials depending on the environment and can therefore effect attachment by 
altering the surface characteristics leading to better attachments (Palmer et al., 2007). 
The effect of conditioning films seen in industry has been shown to reduce and 
increase bacterial attachment to surfaces (Palmer et al., 2007). It has also been shown 
to increase bacterial attachment to tooth enamel and medical devices inserted into the 
body (Donlan, 2002, Habash and Reid, 1999). The environmental factors that can 
effects initial attachment include flow velocity, pH, temperature, cations and the 
presence of antimicrobials agents. All of these may affect attachment, which in some 
cases coincides with changes in gene expression as mentioned above (Beloin and 
Ghigo, 2005, Donlan, 2002). 
 





1.2.2 Microcolony formation 
 
Once attached, more bacteria add to the monolayer and bacteria already present 
divide forming a microcolony which contains approximately 100 cells in a cluster 
(Costerton, 1995, Hall-Stoodley and Stoodley, 2002, Monds and O'Toole, 2009). 
When microcolonies form on the surface there is also an increase in the production 
of extracellular polymeric substances (EPS; Hall-Stoodley and Stoodley, 2002), 
which is essential for the production of a biofilm as it holds cells closely together 
and further helps attachment to the surface. Components of EPS include 
polysaccharides, proteins (enzymes and structural proteins), extracellular DNA 
(eDNA), lipids, and biopolymers. The amount of EPS varies between biofilms, due 
to temperature, shear force, nutrients available and the organisms within the biofilm 
having the ability to form components of the EPS. These combined factors mean that 
even the composition of EPS produced by identical bacteria may vary considerably 
(Sutherland, 2001, Allison, 2003, Flemming and Wingender, 2010).  
 
Biofilms tend to have a high cell density and this allows for quorum sensing (cell-
cell communication) to occur. Quorum sensing is a cell-population density 
dependent gene regulation system that is controlled by the concentration of chemical 
signal molecules, autoinducers, which are released into the environment by the 
bacteria. Once these autoinducers reach a critical concentration, which only occurs at 
high cell densities, the bacteria collectively are able to switch on genes. Genes 
regulated through quorum sensing often includes those involved in symbiosis, 
virulence, biofilm formation, conjugation, motility, sporulation and antibiotic 
production (Miller and Bassler, 2001, Li and Tian, 2012). 
 
1.2.3 Mature biofilm 
 
In well-established mature biofilms, the microcolonies and EPS have developed into 
large 3-dimensional structure (macrocolony). Usually at this stage the amount of 
microorganisms are only 10% of the dry mass, with 90% of the dry mass represented 





by the EPS matrix (Flemming and Wingender, 2010). At this stage the biofilms will 
have dense areas with many bacteria present and also some sparse areas which act as 
channels that transport of water, nutrients and oxygen (Donlan, 2002). The biofilm 
environment also allows for recycling of components, which includes the EPS 
matrix that can be degraded if required, and components from dead bacteria can be 
reabsorbed by other cells in the biofilm (Flemming and Wingender, 2010).  
 
Biofilms also enable the transfer of DNA between bacteria, either through eDNA 
released by cells, conjugation or horizontal transfer (Montanaro et al., 2011, Donlan, 
2002). Within the biofilm structure conditions can vary, for instance some areas with 
less oxygen or nutrients than in others. These differences in local conditions will not 
be advantageous for all the cells (Flemming and Wingender, 2010). 
 
1.2.4 Dispersal  
 
Particularly in older biofilms, dispersal of cells also starts to play a role. These 
dispersed cells can then, for instance, colonise or infect other sites of the body. 
Dispersal can be active being caused by cell signals or environmental changes, or 
physical dispersal in which flow forces cause shearing (Donlan, 2002, McDougald et 
al., 2012). Active dispersal is usually first noticed by the death of cells leaving voids 
in the biofilm; the dead cells then provide the nutrients for the other cells to detach 
and move to other areas. Inducers that cause active dispersal include nutrient levels 
(Carbon/oxygen limitation or iron availability), quorum sensing signals, c-di-GMP 
levels, D-amino acids, nitric oxide and EPS-degrading enzymes (McDougald et al., 
2012). Physical dispersal has been studied mainly in biofilm reactors and it has been 
established that biofilms can be dispersed due to abrasion, which is when particles 
from detached biofilm already in the fluid collide into the biofilm causing parts to 
become detached. This type of removal is more likely to occur with the backwashing 
biofilters, these filters contain microorganisms which degrade and therefore clear 
pollutants from water systems and air systems (Morganroth and Wilderer, 2000). 
Biofilm removal can also occur by erosion or shearing, which happens over time 





removing small sections of biofilm by the shear stress on the surface caused by the 
fluid flow (Derlon et al., 2008). Physical dispersal of biofilms in nutrient rich 
environments can also occur with sloughing; this removes the biggest amount of 




Figure 1.1. Simplified schematic of the steps involved in biofilm formation. See 
text for details. 
 
1.2.5 Biofilms in nature 
 
It has been found that bacteria are more often found in a biofilm as compared to the 
planktonic state (Davey and O'Toole G, 2000). Biofilms are found on most surfaces 
of the planet, such as on living tissues (e.g. mouth and gut), sea beds, hot springs,  
rock surfaces, soil, in sediments, industrial water systems and natural aquatic 
systems (Donlan, 2002, Davey and O'Toole G, 2000, Hall-Stoodley et al., 2004). 
Usually biofilms will have multiple species within it (Moons et al., 2009), although 
some clinically found biofilms can have a single species (Hall-Stoodley et al., 2004). 
The disadvantages to living in biofilms is similar to living in any environment with 





many bacteria present, which include competition for nutrients, toxins produced by 
other bacteria and a lack of space (Moons et al., 2009). There are however many 
advantages to growing in biofilms. Firstly, biofilms provide protection from the 
harsh environments, such as UV exposure, host defence systems, antimicrobial 
agents and dehydration (Hall-Stoodley et al., 2004). Secondly, having a place to 
attach gives the cells a stable place to grow and by keeping cells close together it 
also enables cross-feeding of nutrients (Costerton, 1995, Moons et al., 2009, Hall-
Stoodley et al., 2004). 
 
1.2.6 Clinical relevance 
  
It is now widely known that more than 60% of infections caused by micro 
organisms are in biofilms (Lewis, 2001). Human infections caused by biofilms 
can be divided in two groups: general infections i.e. periodontitis, otitis media, 
biliary tract infections and osteomyelitis, and infections involving a foreign body 
such as ventilation-associated pneumonia, cerebral spinal fluid-shunts, urinary 
catheter infections and orthopaedic prosthesis (Fux et al., 2005). One of the main 
clinical problems with biofilms in the clinical setting is that the bacteria in 
biofilms are 10-1000 times more resistant to antibiotics. They are also more 
resistant to the immune system and other stressful conditions (Hoiby et al., 
2010). Resistance to antimicrobials is caused by several factors. Firstly, biofilm 
cells probably have features similar to cells grown to stationary phase in which 
the metabolic rate is strongly decreased. Many antibiotics block processes that 
are most active in rapidly growing cells, and these compounds are therefore not 
very active on cells that are in a near-dormant state (Fux et al., 2005, Lewis, 
2001). Secondly, penetration through the biofilms (and EPS) is likely to play a 
role, although the evidence for this is conflicting. Some studies have shown that 
EPS does not inhibit penetration of antibiotics, but there are suggestions that the 
biofilm may bind or deactivate the antibiotics, creating an antibiotic gradient 
within the biofilm that could induce resistance genes (Hall-Stoodley and 
Stoodley, 2009). In contrast, other studies have shown that penetration of EPS of 





antibiotics can occur, but also that penetration can depend on the antibiotic used 
(Zahller and Stewart, 2002, Singh et al., 2010b).  
 
Cells in biofilms are also resistant to several host defence systems. Studies have 
shown that phagocytes are unable to attack bacteria in biofilms due to the 
protective layer of the EPS, which also prevents proper interaction of antibodies 
with cells as they can interact with the biofilm surface only. Furthermore, 
bacteria within the biofilms have been shown to produce toxins that kill 
polymorphic neutrophils, preventing biofilm clearance (Hall-Stoodley and 
Stoodley, 2009). It is not only toxins that help bacteria during colonisation or 
infection. Several other aforementioned factors may also help in this, including 
the production of adhesins and secretory proteins that enable attachment and 
invasion of host tissues. Finally, as mentioned before, some of the cells in 
biofilms grow very slowly (e.g. due to low levels of nutrients or oxygen) and 
behave like persister cells that are very tolerant to antibiotics. These type of cells 
lie dormant until a more favourable environment occurs, after which they then 
can reform the previously antibiotic-treated biofilm, causing a relapse in 
infection (Lewis, 2001). 
 
1.2.7 Industrial relevance 
 
Biofilm formation and other types of biofouling is a large problem in industry 
causing reduced levels of production, a decrease in product quality and instrument 
damage, all of which cost the industry a considerable amount of money. Areas 
affected include water treatment systems and food/beverage industries (Bixler and 
Bhushan, 2012). In the case of water-treatment systems, biofouling can cause 
damage leading to problems such as an increase in friction, an increase in power 
requirements, corrosion of stainless steel, reduced efficiency in heat exchangers, 
premature destruction of mineral materials, pipe-pressure drops and contamination of 
pharmaceutical products. This all leads to the quality of water decreasing as it allows 
re-growth of bacteria in the water (Coetser and Cloete, 2005, Bixler and Bhushan, 
2012). Such problems can be prevented (partially) by using low adhesion materials, 





by decreasing the amount of drag on the flow, and by using chemical methods 
(Bixler and Bhushan, 2012). 
 
Food spoilage and disease transmission are also worries for the food industry. To 
prevent biofilm formation and microbial contamination, specific cleaning procedures 
are in place to ensure that attached bacteria are removed before they are able to 
produce biofilms. These procedures include the use of chemical agents and/or a high 
temperature (Chmielewski and Frank, 2003). Surfaces in the food industry are often 
made of stainless steel, which is resistant to damage caused by cleaning procedures 
and this helps to prevent bacterial attachment (Chmielewski and Frank, 2003, Kumar 
and Anand, 1998). Equipment design is also important, as a good design allows for 
good cleaning methods and prevents for instance dead ends for bacteria to attach and 
multiply (Kumar and Anand, 1998, Chmielewski and Frank, 2003). Routine testing 
of processing surfaces is important also to monitor microbial attachment, which is 
performed by swabbing, contact plates or ATP bioluminescence testing 
(Chmielewski and Frank, 2003). 
 
It is also important to point out that biofilms can also be helpful in industry, with an 
example being their use in bioremediation. Biofilms can degrade toxic compounds 
and help reduce pollutants. They are also used in waste sewage management and 
water purification management, where they can be used for organic nutrient-trapping 
(Kumar and Anand, 1998). 
 
1.3. Antimicrobial resistance in Enterococci 
 
Enterococci are becoming an increasing problem in hospitals due to their resistance 
to many antibiotics such as penicillins, glycopeptides (e.g. vancomycin) and 
aminoglycosides (Sood et al., 2008). The European Antimicrobial Resistance 
Surveillance system (EARSS) has been monitoring resistance in this organism across 
Europe and they have seen over the past 9 years that vancomycin resistance has been 





increasing in many countries.  Vancomycin resistant enterococci (VRE) pose a 
problem clinically, as 10-25% (Figure 1.2) of E. faecium clinical isolates were 
vancomycin resistant in the UK in 2010 (EARRS, 2010), and patients that acquire 
VRE are harder to treat. Another cause for concern is the transfer of this resistance to 
other bacteria such as meticillin-resistant Staphylococcus aureus (MRSA; Sood et 
al., 2008).  
 
 
Figure 1.2.  Distribution of vancomycin-resistant E. faecium in EARS-Net 
countries in 2010. (EARRS, 2010) 
 
1.3.1 Intrinsic resistance 
 
There are two forms of antimicrobial resistance: intrinsic resistance and acquired 
resistance. Intrinsic resistance is when the bacteria lack the target site for the 
antimicrobial or that the antimicrobial cannot penetrate the cell to reach the target 
site. All enterococci have up to nine different penicillin-binding proteins (PBP; 
Williamson et al., 1986) which   have   low   affinity   and   therefore   resistance   to   β-
lactams such as penicillins, carbapenems and cephalosporins. The amount of 





resistance   varies   between   the   β-lactams, with resistance the lowest for penicillins 
such as ampicillin (Top et al., 2008).  
 
Enterococci also show resistance to aminoglycosides due to poor permeability of the 
cell wall to highly polar molecules (Arias and Murray, 2012). Aminoglycosides can 
be   used   in   conjunction   with   β-lactams and glycopeptides (cell wall synthesis 
inhibitors), which can work together synergistically, allowing increased efficacy of 
the aminoglycosides to kill (Top et al., 2008). Unfortunately, E. faecium has a 
chromosomally encoded enzyme, aminoglycoside acetyltransferase AAC(6’)Ii,   that  
can stop the above synergism occurring, leading to resistance to tobramycin and 
kanamycin, but enterococci remain sensitive to gentamicin (Top et al., 2008, Chow, 
2000). 
 
1.3.2 Acquired resistance 
 
Acquired resistance is accompanied by a change in the genetic material of the 
bacteria, either through mutation or by acquiring genetic material via plasmids, 
transposons or other mobile genetic elements. It is this type of resistance that has 
enabled enterococci to become highly resistance to ampicillin. E. faecium has 
mutations that cause the overproduction of PBP5 or decreased affinity for ampicillin, 
the decrease affinity is due to amino acid changes in the active site (Arias and 
Murray, 2012). Hospital-associated isolates of E. faecium are 90% likely to be 
resistant to ampicillin while, in contrast, it is rare to find E. faecalis isolates that are 
resistant to ampicillin. When ampicillin resistance is identified in hospital isolates of 
E. faecalis it   has   occurred   due   to   the   production   of   β-lactamases (Murray, 1992). 
Due to the increase in high level ampicillin resistance and vancomycin resistance 
(see below), E. faecium now causes between 38% and 75% of enterococcal 
infections, with the remainder caused by E. faecalis. This ratio has gradually 
changed from the early 1990s when E. faecalis (with only low level ampicillin and 
vancomycin resistance) caused 90% of infections and the remainder was caused by 
E. faecium (Willems et al., 2011).   





Enterococci can also acquire high level resistance of aminoglycosides, which 
prevents the synergistic effects they have with cell wall synthesis inhibitors such as 
ampicillin and vancomycin. This resistance is caused by aminoglycosides-modifying 
enzymes, which stop the antibiotic interfering with the recognition site of tRNA by 
rRNA. The most clinically important enzyme found in enterococci is Aac(6’)-Ie-
Aph(2’’)-Ia, which cause the bacteria to be resistant to most of the aminoglycosides 
available (Denyer et al., 2004, Chow, 2000). 
Other acquired resistances found in enterococci include resistance to macrolides by 
ribosomal methylation, resistance to chloramphenicol by CAT encoding enzymes, 
and resistance to quinolones by modification to DNA gyrase and Topoisomerase IV 
(Top et al., 2008). 
 
1.3.3 Vancomycin resistance 
 
As mentioned in the beginning of this section, vancomycin resistance is increasing 
causing clinical problems. Vancomycin resistance in enterococci was first identified 
in 1986 in Europe. Since being identified, its dissemination in European hospitals 
has been slow, whereas in the USA vancomycin resistance in hospitals is extremely 
high and dissemination was fast (Willems et al., 2011, Arias and Murray, 2012). 
Vancomycin resistance in Europe was initially more widespread in the community in 
meat products and animals; this was due to the use of avoparcin (which gives cross 
resistance to vancomycin) as a growth promoter in animal feed. However, the use of 
avoparcin was banned in 1996, which helped decrease this reservoir of VRE. In 
contrast to Europe, the USA has low vancomycin resistance in the community (Top 
et al., 2008, Arias and Murray, 2012). 
 
Vancomycin acts by binding to the D-alanyl-D-alanine (D-ala-D-ala) portion of the 
peptidoglycan precursor, which stops the enzyme transglycosylase from attaching 
the peptidoglycan precursor to the cell wall (Denyer et al., 2004). There have been 
six types of resistance described in vancomycin, VanA, VanB, VanC, VanD, VanE 
and VanG (Top et al., 2008). Resistance occurs due to two different methods: 





replacement of the terminal residue of the peptidoglycan precursor, or removal of 
target precursors with D,D-dipeptidases and carboxypeptidases (Werner et al., 2008). 
The peptidoglycan  precursor, D-alanine is replaced with D-lactate (D-Lac), which is 
what is found in resistance types VanA, VanB and VanD, or with D-serine (D-Ser) 
in resistance types VanE (in E. faecalis only), VanG (in E. faecalis only) and VanC. 
The resistance types above are all acquired, except for VanC which occurs 
intrinsically and can be found in E. gallinarum, E. casseliflavus and E. flavescens, 
but not E. faecium or E. faecalis. VanA and VanB resistance are the most likely to 
be found in hospital isolates (Rice, 2006), and both are problematic clinically 
because of patient treatment. An additional problem is that their genes are found on 
mobile genetic elements, enabling the spread of resistance to other bacteria. Such 
horizontal gene transfer has already been shown to occur in group A and viridans 
streptococci, Listeria monocytogenes and most importantly S. aureus (Cetinkaya et 
al., 2000, Noble et al., 1992). The latter is critical as vancomycin is an important 
drug for the treatment of infections with MRSA, and therefore gaining this 
vancomycin resistance would be a significant clinical problem. There have already 
been 12 MRSA isolates identified in the USA that are also vancomycin resistant 
(VRSA), and all of these have gained vancomycin resistance from enterococci 
(Kobayashi et al., 2012). 
 
1.3.4 Epidemiology of the highly resistant E. faecium and E. faecalis clones 
 
As resistance to vancomycin is on the increase in E. faecium, it is clear that 
molecular techniques are required to study genetic changes and the epidemiology of 
the outbreaks. Initially the main molecular method of studying the genetics and 
epidemiology of E. faecium and E. faecalis was by using pulsed-field gel 
electrophoresis (PFGE), the gold standard method used by many laboratories (Arias 
and Murray, 2012, Top et al., 2008). It was found however that this method could be 
too discriminatory for epidemiological studies due to enterococci rapidly 
recombining, leading to a single strain having variations in the pattern of banding 
which caused misleading results (Morrison et al., 1999, Willems et al., 2011).  





Various other techniques were tested to look at epidemiology and to see if there were 
differences between isolates from differing backgrounds, they included amplified-
fragment length polymorphism (AFLP) analysis, which identified isolates from 
different hosts, such as human, pigs or calves (Top et al., 2008, Jureen et al., 2004)  
and comparative genomic hybridization (CGH). The latter showed that isolates 
causing hospital outbreaks and clinical isolates were placed in the same cluster, and 
therefore there appears to be a single hospital clade (Leavis et al., 2007). Both CGH 
and AFLP showed that the genetics of hospital and non-hospital isolates differed, 
and that it was likely that hospital isolates have evolved from a recent common 
ancestor (Leavis et al., 2007, Willems et al., 2011).  
 
To give more evolutionary detail on the genotypes multilocus sequence typing 
(MLST) was performed on E. faecium. This method studies the differences in seven 
housekeeping genes giving them a numeric allelic profile which is assigned a 
sequence type (ST). This method identified that hospital isolates clustered in groups 
called clonal complexes (Top et al., 2008, Arias and Murray, 2012). It also showed 
that the hospital-outbreak isolates clustered in one clonal complex group 17 (CC17) 
and this cluster contained many polyclonal subpopulations (ST17, ST18, ST78 and 
ST192; Willems et al., 2011, Arias and Murray, 2012). 
 
Using MLST and CGH while analysing E. faecalis isolates, it was noticed that 
hospital-associated isolates (including the most common clones, ST6, ST9, ST16, 
ST21, ST28, ST40 and ST87) are also found in the community, in animals and food 
products. There are therefore no distinct hospital clonal complexes, but some clones 
are more enriched for the hospital environment (ST6, ST9, ST28 and ST40). 
Virulence factors found in E. faecalis have also been shown to be present in non-
hospital associated isolates (Willems et al., 2011). 
 
The main reasons for the emergence of hospital-associated enterococci is due to their 
ability to gain new DNA readily and this means that their genomes are enriched with 





insertion sequence (IS) elements, some of which are involved in antibiotic resistance 
and virulence. An example is E. faecalis V583, a strain in which a quarter of its 
genome contains mobile genetic elements such as plasmids, prophages, and 
pathogenicity islands (Paulsen et al., 2003, Shankar et al., 2002). Similarly, the E. 
faecium hospital-adapted clonal complex 17 isolates also contains many acquired 
genes and seem to be able to take up any amount of exogenous DNA (van Schaik et 
al., 2010, Leavis et al., 2007).  It has also been observed that multidrug-resistant 
enterococci lack the clustered, regularly interspaced short palindromic repeats, 
CRISPR-cas loci, which are part of a genetic interference pathway that limits 
conjugation and transduction, and is therefore said to encode an adaptive immunity 
against incoming DNA. Due to the lack of these loci, it enables hospital-associated 
isolates to easily pick up antibiotic resistance and other virulence genes (Palmer and 
Gilmore, 2010, Marraffini and Sontheimer, 2010). 
 
1.3. Biofilm formation and pathogenicity in Enterococci 
 
1.3.1 Enterococcal infections 
 
As mentioned at the start of this chapter, enterococci are usual found in the GI tract 
were they are commensals and cause no harm to the host. Enterococci can become 
opportunistic pathogens and cause many nosocomial infections (Jett et al., 1994). 
Usually enterococcal colonisation of the GI tract increases due to use of antibiotics, 
which causes changes in the gut microbiota and then enables pathogenic enterococci 
such as VRE to colonise the GI tract (Ubeda et al., 2010, Donskey et al., 2000).  One 
study showed that a decrease in Gram-negative bacteria caused by antibiotics lowers 
the stimulation of surface proteins on the epithelium cells of the small intestine. This 
decrease   in   stimulation   in   turn   reduced   production   of   REGIIIγ,  which   is   a   C-type 
lectin with activity against Gram-positive bacteria, and therefore allowing those 
bacteria to proliferate in the gut (Brandl et al., 2008, Kinnebrew et al., 2010). 
Enterococci have been shown to translocate from the lumen of intestine to the 
mesenteric lymph nodes, liver and spleen, and then this allows them to enter the 
bloodstream and cause infections such as endocarditis (Arias and Murray, 2012, Jett 





et al., 1994). Enterococci can also infect other patients and spreads around the 
hospital by faecal contamination, which can cause UTIs and intravenous catheter 
infections (Arias and Murray, 2012). 
 
1.3.2 Environmental factors effecting enterococcal biofilm formation 
 
Enterococci live in the intestine, which is a hostile environment; they have to 
withstand varying conditions (nutrients, pH, oxygen levels), bile acids, digestive 
enzymes, and toxins from other bacteria (Wilson et al., 2002). Any number of these 
factors could affect biofilm formation.  
 
One example that has been shown already is glucose, which has been shown to 
stimulate biofilm formation in many E. faecalis and E. faecium isolates (Tendolkar et 
al., 2004).  In a separate study a sugar-binding transcriptional regulator, BopD, 
which is part of the bop operon (biofilm on plastic), was shown to be involved in 
biofilm formation in E. faecalis. It was suggested that the presence of 
oligosaccharides in food influences this operon and therefore biofilm formation 
(Hufnagel et al., 2004, Creti et al., 2006). Thus, sugars have an important effect on 
biofilm formation and so it is likely that, more generally, the composition of growth 
media have an effect. Indeed, a study by Kristch et al showed that some media 
promoted biofilm formation and maturation (M17, TSB and M9YE) and others (BHI 
and THYE) only promoted the initial stages of biofilm formation, after which 
dispersal of the cells occurred. They suggested that this was due to an unknown 
signal triggered by components in different media that caused biofilm maturation or 
dispersal (Kristich et al., 2004).  
 
Biofilm formation in E. faecalis has also been shown to decrease with increasing 
osmolarity (Kristich et al., 2004). This has also been shown to occur in other 
bacteria, showing environmental control of biofilm formation (Loo et al., 2000). 
Another factor effecting biofilm formation is the presence of serum, which increases 





E. faecalis’s ability to adhere to glass and silicone by increasing its hydrophobicity 
(Gallardo-Moreno et al., 2002).  This was not found in all bacteria, and in for 
instance Burkholderia cepacia attachment varied in the presence of serum and 
depended on the type of conditioning film and the ionic strength (Hwang et al., 
2012). Such variation was also seen in organisms found in the oral cavity, with for 
instance the presence of serum, decreasing Fusobacterium nucleatum attachment, 
but increasing Phorphyromonas gingivalis attachment. When inflammation occurs 
gavial margin there is an increased production of gingival crevicular fluid (GCF), 
which is type of serum based exudates, therefore in this study serum is used as a 
substitute for GCF (Biyikoglu et al., 2012). These factors suggest that serum affects 
the surface with conditioning films and changes in physiochemisty and these 
changes are not always advantageous for biofilm formation. 
 
 1.3.3 Role of Esp and other biofilm associated surface proteins 
 
The Sec-dependent pathway is a system which contains many components that work 
together to transport proteins that contain a signal peptide out of the cell (Mori and 
Ito, 2001). Many of the virulence factors mentioned here are transported via this 
pathway. Once transported through the membrane, lipoproteins are retained at the 
membrane through a lipo-modified N-terminal cysteine residue (Kovacs-Simon et 
al., 2011, Hutchings et al., 2009). Several other cell wall proteins contain a C-
terminal LPxTG motif and these proteins are attached to the cell wall by a sortase 
(Hendrickx et al., 2009b). This enzyme cleaves between the threonine and glycine 
residues in this motif and the protein is then covalently immobilized to 
peptidoglycan in the cell wall (Hendrickx et al., 2009b). Many of the virulence 
factors mentioned below, and are shown in figure 1.3, contain this motif and require 
attachment to the cell wall by sortase. There is also a summary table of virulence 
factors found in both E. faecium and E. faecalis at the end of this section (Table 1.1) 
 
 






Figure 1.3.  Surface attached proteins involved in virulence for E. faecalis and 
E. faecium, more details in text (Hendrickx et al., 2009b). 
 
Enterococcal surface protein (Esp) is an approximately 202 kDa large cell wall 
protein found in both E. faecium and E. faecalis strains (Figure 1.3). The proteins in 
both strains are very similar and have a sequence identity of around 90% (Heikens et 
al., 2007). Esp has three regions (Figure 1.4): the N-terminal domain, which alone is 
sufficient to mediate biofilm formation (Tendolkar et al., 2005), a repeat domain, 
which contains repeat units, and the C-terminus which contains the cell wall anchor. 
Further details on structure of Esp are in chapter 6 (Shankar et al., 1999). Esp also 
shows similarities to other biofilm-associated proteins in other species, which 
include Bap from S. aureus, LapA from Pseudomonas fluorescens and BapA from 
Salmonella enteritidis (Lasa and Penades, 2006, Latasa et al., 2006). 
 
 






Figure 1.4. E. faecium E1162 Esp structure. The signal peptide is represented 
by purple and also contains the YSIRK motif. A, B and C repeats are 
represented by blue, pink and green, respectively. FPxTG is the sortase-
dependent cell wall-anchoring sequence. See text and chapter 6 for further 
details. 
 
In E. faecalis Esp is found on a pathogenicity island along with other virulence 
factors such as cytolysin (Shankar et al., 2002). The pathogenicity island has recently 
been identified as an integrative conjugative element (ICE) and is therefore self-
transmissible, and enables transfer between its own species and other species 
(Laverde Gomez et al., 2011). E. faecium Esp is also found on pathogenicity island, 
ICEEfm1, which also been shown to be transmissible (Top et al., 2011).  
 
E. faecalis biofilm formation has been shown to occur both dependent and 
independent of the presence of Esp, showing that there are also other biofilm-
formation determinants involved (Kristich et al., 2004, Toledo-Arana et al., 2001, 
Tendolkar et al., 2004). Esp has also been shown to have a role in biofilm formation 
in E. faecium (Heikens et al., 2007), and isolates from hospitals are frequently found 
to have Esp. Importantly, although some strains can develop biofilms without the 
presence of Esp (usually non-clinical strains), strains with Esp have much thicker 
biofilms (Di Rosa et al., 2006). This study also observed that more E. faecalis 
isolates are able to produce biofilms compared to E. faecium isolates, and that E. 
faecalis is more likely to have Esp and gelatinase present compared to E. faecium 
isolates (Di Rosa et al., 2006). 
 
The role of Esp in biofilm and virulence is still unclear. Research has shown that Esp 
is involved in initial attachment, colonisation and persistence (Heikens et al., 2007, 





Shankar et al., 2001, Toledo-Arana et al., 2001, Van Wamel et al., 2007). The role of 
Esp in pathogenesis has been studied using human cell lines and in mammalian 
infection models. Studies in human bladder carcinoma T24 cells, Madin-Darby 
canine kidney (MDCK) epithelial cells and mice models have demonstrated that E. 
faecium Esp plays a role in urinary tract infections but not peritonitis by increasing 
attachment (Leendertse et al., 2009). Another study also showed Esp to be involved 
in renal parenchyma and persistence in the kidney (Sava et al., 2010). E. faecalis 
studies have been contradictory when it comes to a role for Esp in UTIs, with one 
study showing no role (Leendertse et al., 2009) and another study showing a role for 
Esp (Shankar et al., 2001). It has also been observed by one study that E. faecalis is 
involved   in   UTI’s   using   mouse   models   (Kau et al., 2005). E. faecium isolates 
containing Esp were also shown to be recovered at higher levels than non-Esp 
producing isolates when studying endocarditis-induced vegetations from rat infection 
models (Heikens et al., 2011). Studies to see if Esp is essential to intestinal 
colonisation, showed in fact that there is no difference in adherence to human 
colorectal adenocarcinoma cells (Caco-2-cells) and that both E. faecium E1162 and 
an esp mutant strain were able to translocate to the mesenteric lymph nodes in mouse 
models (Heikens et al., 2009). 
 
It has been observed that E. faecium and E. faecalis esp mutants are able to be 
complemented with plasmid-borne esp, thus restoring full biofilm formation 
(Tendolkar et al., 2005, Heikens et al., 2007). Interestingly, a study in which an E. 
faecalis esp was introduced in esp negative E. faecium or L. lactis strains did not 
show an increase in biofilm formation in these strains, even though expression levels 
of the protein on the cell surface were the same as observed for E. faecalis. Thus, it 
appears that E. faecalis Esp requires one or more additional factors, which are absent 
in E. faecium and L. lactis, to stimulate biofilm formation (Tendolkar et al., 2005). 
 
Expression of Esp in E. faecium was shown to be dependent on growth conditions, 
as experiments showed increased expression at higher temperatures (37oC compared 
to 21oC),  and under anaerobic conditions compared to aerobic. It was found that the 





increase in Esp expression due to the temperature shift from 21oC to 37oC showed a 
correlation with increase initial attachment (Van Wamel et al., 2007). Similar to 
several other organisms, another growth condition that influences biofilm formation 
in E. faecalis was the presence of glucose in the media. This was, however, not due 
to Esp as its expression was not affected by the presence or absence of glucose 
(Tendolkar et al., 2004). 
 
Aggregation substance (AS) was one of the first surface proteins to be discovered in 
E. faecalis and have not as yet been found in E. faecium (Figure 1.3; Hendrickx et 
al., 2009b, Hallgren et al., 2009). The genes for AS are found on pheromone-induced 
conjugative plasmids, and AS acts by allowing close contact between donor and 
recipient cells so virulence plasmids can be transferred (Hendrickx et al., 2009b). 
Several other roles for this protein have also been identified, including roles in 
adhesion and invasion of intestinal cells (Waters et al., 2004, Sartingen et al., 2000), 
binding to lipoteichoic acid (LTA; Waters et al., 2004), binding to the extracellular 
matrix (ECM; Rozdzinski et al., 2001), and stimulation of biofilm formation through 
cell aggregation (Chuang-Smith et al., 2010). 
 
Pili are also found protruding outwards on the surface of the cell; they are made of 
major and minor pilin subunits. The genes for the production of pili are found on 
specific pilin gene clusters (PGCs) and include their own specific class C sortase that 
connects the subunits together. Once the structure is complete the housekeeping class 
A sortase attaches the pilus to the cell wall (Hendrickx et al., 2009b). E. faecalis has 
two PGCs, the biofilm enhancer in enterococci (bee) locus and the endocarditis and 
biofilm-associated pili (ebp) locus. The bee locus contains three bee genes (bee-1 to -
3) and two sortase genes, and this locus was identified to effect biofilm formation by 
inserting a transposon (Tn917) into the genes of the locus. The locus was also shown 
to be carried on a large extrachromosomal element, likely a conjugative plasmid, but 
it is not widely distributed among the isolates (Tendolkar et al., 2006).   
 





The ebp locus has been studied in more detail (Figure 1.3). This locus has been 
identified in many clinical and environmental isolates and is thus widely spread in 
the E. faecalis population (Cobo Molinos et al., 2008). As the name suggests it has 
been linked with a role in endocarditis and biofilm formation (Nallapareddy et al., 
2006b). It contains the genes ebpA, ebpB, ebpC, srtC and is regulated by ebpR. It is 
unknown what exactly the regulator responds to, but studies have shown increase 
expression in the presence of bicarbonate and/or carbon dioxide (Bourgogne et al., 
2010, Bourgogne et al., 2007).  
 
There have been found four PGCs in E. faecium that are similar to the ebp locus in 
E. faecalis. The two PGCs that have been studied the most are named PilA and PilB 
(Figure 1.3; Hendrickx et al., 2009b). Interestingly, expression of these genes is 
reduced at lower temperatures such as 21oC, and pili are only observed on the 
surface when at 37oC, and so the pili are controlled in a temperature dependent 
manner which allows them to take advantage if they are present in the body. 
Hospital-associated E. faecium isolates have been shown to be enriched in these 
pilus genes, again suggesting their role in pathogenesis. Research has also shown 
that cells can have both PilA and PilB present on the surface at any one time 
(Hendrickx et al., 2008) and PilB has also been associated with biofilm formation 
and virulence in UTI in mouse models (Sillanpaa et al., 2010).  
 
Hendrix et al found five surface proteins that were found frequently in E. faecium 
Clonal complex 17 isolates. Some of these showed similarities with E. faecalis 
proteins involved in the aforementioned pili production, and some were of unknown 
functions (Hendrickx et al., 2007). One of the proteins was given the name SgrA 
(serine-glutamate repeat containing protein A). This protein consists of a non-
repetitive region A, which may bind ligands, and it also contains a C-terminus with a 
repeating B-domain and a cell-wall anchor sequence. Similar B-domain repeats are 
also found in a S. aureus collagen binding protein, a protein belonging to the family 
of Microbial Surface Components Recognising Adhesive Matrix Molecules 
(MSCRAMM). However, SgrA is not an MSCRAMM as it does not contain 





characteristic IgG-like folds. It was shown that this protein can bind to fibrinogen 
and human nidogens (glycoproteins associated to laminin) and also has a role in 
biofilm formation on abiotic surfaces (Hendrickx et al., 2009a). 
 
As more enterococcal genomes become available, more genomic studies for 
virulence factors are being performed. In one such study on E. faecalis V583, a 
surface protein, EF3314, was identified. The gene encoding this protein was shown 
to have an above average GC content, suggesting that is was acquired through 
horizontal gene transfer. EF3314 has similarities to alpha-like proteins of group B 
streptococci as well as Esp. It too has been shown to effect biofilm formation and is 
involved in the early steps in attachment to epithelial cells. Also in a Caenorhabditis 
elegans infection model it was shown that the protein was a possible virulence 
factor, as there was attenuated killing with a deletion mutant (Creti et al., 2009). 
 
1.3.4 Role of fsr two-component system and secreted proteins 
 
E. faecalis has an fsr locus which consists of four genes, fsrA, fsrB fsrC and fsrD, 
and these genes are part of a quorum sensing two-component pathway. It involves an 
autoinducing peptide that increases in concentration outside of the cell. When the 
extracellular concentration of this peptide is high enough the expression of a number 
of other genes is up- or down-regulated (Hancock and Perego, 2004). The 
autoinducing peptide is a cyclic peptide called gelatinase biosynthesis-activating 
pheromone (GBAP), which is encoded by fsrD. Maturation of GBAP requires FsrB, 
which cyclises the peptide (Nakayama et al., 2006). Once GBAP accumulates, it is 
sensed by FsrC, a histidine kinase, and this leads to activation of the response 
regulator and transcription factor FsrA. The above process leads to the production of 
gelatinase (GelE) and serine protease (SprE; Qin et al., 2001, Hancock and Perego, 
2004), the role of which in biofilm formation is outlined below. The fsr system has 
also been observed to affect other genes using both negative and positive regulation; 
genes included are involved in virulence and metabolism (Bourgogne et al., 2006). 
 





GelE and SprE are encoded on the same operon; GelE is an extracellular zinc 
metalloprotease and SprE is a serine protease (Qin et al., 2001). Several studies have 
shown that mutants lacking gelE produce less biofilm (Mohamed et al., 2004, 
Hancock and Perego, 2004, Thomas et al., 2008). GelE has also been shown to effect 
virulence in mouse model peritonitis and endocarditis, endophthalmitis (Singh et al., 
2005, Singh et al., 1998, Engelbert et al., 2004) and Caenorhabditis elegans models 
(Sifri et al., 2002). Gelatinase is able to degrade many proteins such as casein, 
gelatin, collagen fibrin, haemoglobin, plasmid conjugation factors and autolysins 
(Carniol and Gilmore, 2004). There have been many theories of how GelE is 
involved in biofilm formation, one being that that it is able to cleave at hydrophobic 
residues and therefore could cleave surface proteins on the cell, thereby allowing 
hydrophobicity to increase and stimulate attachment to surfaces (Carniol and 
Gilmore, 2004). However, the main theory now which has experimental evidence is 
that GelE-SprE locus is involved in fratricide, which is also known as allolysis 
(“sibling-killing-sibling”  mechanism).  This  fratricidal  mechanism  allows  the  release  
of eDNA, which then contributes to the biofilm development. Thomas et al (2009) 
suggest that in biofilm cells, GBAP will switch on the frs system allowing the 
production of GelE and SprE. If a sibling cell (prey cell) has not as yet switched on 
their frs system, GelE from the producing cell (predator cell) will release an 
autolysin (AltA) from their membranes (it has a C-terminal cell wall anchor (Eckert 
et al., 2006)), leading to cell lysis and release of eDNA for biofilm formation. GelE 
from the predator cell is unable to act on its own AltA as SprE is also being 
produced; the latter acts as an immunity factor by stopping GelE attachment and 
therefore activation of AltA (Thomas et al., 2008, Thomas et al., 2009).  
 
Initially it was suggested that SprE does not influence biofilm formation (Mohamed 
et al., 2004), but newer studies (mentioned above), showed that SprE does effect 
biofilm formation by modulating  GelE’s   effect   on   fratricide   (Thomas et al., 2009, 
Thomas et al., 2008). SprE has also been shown to effect virulence in a mouse 
peritonitis model (Qin et al., 2000), a rabbit endophthalmitis model (Engelbert et al., 
2004) and in a C. elegans model (Sifri et al., 2002).  
 





E. faecalis has several autolysins one of which, AltA (also mentioned above) if 
disrupted showed a decrease in biofilm formation, initial attachment and increased 
chaining (Kristich et al., 2008, Mohamed et al., 2004, Qin et al., 1998, Guiton et al., 
2009). The role of autolysin in biofilm formation is to release eDNA into the 
environment (Thomas et al., 2009). eDNA has been shown to have a structural 
stabilising role in biofilms, and DNase I treatment has been shown to disrupt the 
biofilms of many bacteria (Montanaro et al., 2011). Experiments with DNaseI have 
also shown this to be the case in enterococcal biofilms; experiments showed that 
cells grown in the presence of DNaseI were able to attach to surfaces but were 
unable to form mature structured biofilms (Guiton et al., 2009). Barnes et al showed 
that eDNA also has a role in early biofilm formation, this study found that E. faecalis 
cells had thread like structures between them which were co localised with eDNA 
and suggested that the cells are able to secrete the eDNA (Barnes et al., 2012). 
 
A major secreted antigen, SagA, was identified in E. faecium isolates from 
endocarditis patients. It was shown to be able to bind to many ECM components 
including fibrinogen, collagen I and IV and fibronectin, but it was also suggested 
that it has a role in cell metabolism (Teng et al., 2003). Homologues of sagA were 
identified in E. faecalis, salA and salB; these were shown when deleted to have 
reduced amounts of biofilm formation. SalB was shown to bind collagen I and 
fibronectin but SalA did not bind any of the ECM proteins tested (Mohamed et al., 
2006). Interestingly, even though biofilm formation was decreased in a salB mutant 
under standard conditions, when the mutant was grown in presence of horse serum 
and fibronectin its biofilm formation was actually more than the wild type strain 
(Mohamed et al., 2006). SalB has also been shown to be involved in cell shape 
(Breton et al., 2002), and it was therefore suggested that perhaps the lack of SalB 
allows easier binding of other proteins, in the presence of ECM proteins, due to the 
change in cell shape, therefore increasing biofilm formation under these conditions 
(Mohamed et al., 2006). 
 
 





1.3.5 Role of other virulence factors  
 
MSCRAMMs are types of surface associated adhesions that are involved in the 
attachment to components within the ECM of the host. These proteins can attach to 
fibrinogen, fibronectin and collagen (Vengadesan and Narayana, 2011). One well 
studied MSCRAMM is Cna in S. aureus, which contains an A domain that consists 
of single and multiple sequences of an immunoglobulin (IgG)-like fold, an N-
terminal signal peptide, a B-repeat domain and a C-terminal contain the LPxTG cell 
wall anchor sequence (Hendrickx et al., 2009b, Vengadesan and Narayana, 2011). 
Seven MSCRAMMs have been identified in E. faecalis (Sillanpaa et al., 2004) with 
similar structure to Cna. The main one studied is denoted Ace (Figure 1.3), a protein 
that has the ability to bind collagen type I and VI as well as laminin (Rich et al., 
1999, Nallapareddy et al., 2000a). Ace has been shown to be expressed during 
human infection (Nallapareddy et al., 2000b) and has a role in urinary tract 
infections (Nallapareddy et al., 2011b) and endocarditis (Singh et al., 2010a).  
Recently there has been evidence to suggest that the E. faecalis MSCRAMMs 
expression on the surface is regulated by the Frs system and GelE (Pinkston et al., 
2011). 
 
Several E. faecium strains, and in particular clinical isolates, also encode 
MSCRAMMS, all of which share homology with Ace (Nallapareddy et al., 2008b). 
There have been three studied so far: Acm (Figure 1.3; adhesion of collagen form E. 
faecium), which interacts with collagen type I and has been shown to be involved in 
the pathogenesis of endocarditis (Nallapareddy et al., 2008a, Nallapareddy et al., 
2003); Scm (Figure 1.3; second collagen adhesion of E. faecium) which interacts 
with collagen type V and fibrinogen (Sillanpaa et al., 2008); and EcbA (E. faecium 
collagen binding protein A) that binds to collagen types I to V, fibrinogen and 
laminin, and is detected in exponential and late exponential phase of growth 
(Hendrickx et al., 2009a).  
 





A gene cluster called epa (Enterococcal polysaccharide antigen) has also been linked 
to E. faecalis biofilm formation. This cluster of genes has been shown to be involved 
in polysaccharide biosynthesis, and it contains many genes including glycosyl 
transferases, dTDP-4-dehydrorhamnose 3,5-epimerase, ABC transporter permease 
protein and hypothetical membrane proteins (Teng et al., 2009). A disruption mutant 
strain at the glycosyl transferase EpaB showed a 73% decrease in biofilm formation 
(Mohamed et al., 2004). Similarly, deletions in other genes in the locus have also 
been shown to decrease in biofilm formation (Teng et al., 2009). There has also been 
evidence that the locus is involved in UTIs and peritonitis pathogenesis (Teng et al., 
2009, Singh et al., 2009). However, the mechanisms in virulence is unclear as these 
protein have not been identified on the surface, but there is a suggestion that they 
may be buried in the cell wall (Hancock and Gilmore, 2002). 
 
As mentioned earlier many of the virulence factors mentioned contain the cell wall 
anchor motif and therefore require attachment to the cell wall by sortase. Therefore it 
is unsurprising that sortase A (srtA) has been implicated in biofilm formation. 
Deletion of srtA has indeed been shown to cause a decrease of 30% and 60% 
respectively in biofilm formation in two separate studies (Guiton et al., 2009, 
Kristich et al., 2008), but further studies into which SrtA-dependent proteins are 
involved in biofilm formation is required (Guiton et al., 2009). Similarly, deletions 
in srtC (encoding sortase C) also result in a decrease in biofilm formation. This 
sortase is part of the ebp locus, which is involved in attachment and cross-linking 












Table 1.1 Virulence factor summaries for E. faecium and E. faecalis 
Protein Role in virulence 
Surface associated proteins: 
Esp  (E. faecium and E. faecalis)  Biofilm formation 
 Experimental UTI/endocarditis 
AS (E. faecalis)  Role in plasmid conjugation 
 Biofilm formation 
 Adhesion & invasion of intestinal cells 
 ECM attachment 
Pilus production: bee locus (E. faecalis)  Biofilm formation 
Pilus production: ebp locus (E. faecalis)  Biofilm formation 
 Endocarditis 
Pilus production: PilA and PilB (E. faecium)  Biofilm formation 
 Experimental UTI 
EF3314 (E. faecalis)  Biofilm formation 
 Attachment to epithelial cells 
 Virulence in C. elegans 
MSCRAMMS: Ace (E. faecalis) 
 
 ECM attachment 
 Experimental UTI and endocarditis 
MSCRAMMS: Acm, Scm & EcbA (E. 
faecium) 
 ECM attachment 
 Experimental UTI 
Secreted proteins: 
GelE and SprE (E. faecalis)  Biofilm formation 
 Experimental models: peritonitis, 
endocarditis, endophthalmitis 
 Virulence in C. elegans 
Autolysin (E. faecalis and E. faecium)  Biofilm formation 
SagA (E. faecium) 
SalA and SalB (E. faecalis) 
 ECM attachment 
 Biofilm formation 
Other factors: 
epa locus  Biofilm formation 
 Experimental UTI and peritonitis 
SrtA  Biofilm formation 
bop locus  Biofilm formation 





1.4. The aims of the thesis 
 
Enterococci are increasingly becoming a problem clinically with their increase in 
antibiotic resistance and ability to form biofilms. Initially the thesis will consider a 
possible antimicrobial target, the signal peptidase; this enzyme is a component of the 
Sec-dependent pathway. This pathway is responsible for exporting many 
enterococcal virulence factors, and so by interfering with this pathway there is a 
possibility that it would make enterococci less virulent. There has already been an 
inhibitor for signal peptidases identified, Penem (Harris et al., 2009), and so if signal 
peptidases are found to be a good target here it would allow further investigation into 
this inhibitor. The above will be performed by producing a signal peptidase mutant 
which can then be studied for virulence differences. 
The next section of the thesis will study antimicrobial resistance in E. faecium E1162 
using the method of calorimetry to establish the merits of the method. This method 
has been shown to identify between meticillin sensitive and resistant S. aureus 
isolates in hours compared to traditional antimicrobial methods that can take days 
(von Ah et al., 2008). Here we address whether this is also the case for enterococci.  
Further experiments will include studies on the effect of bile salts on biofilm 
formation in both E. faecium and E. faecalis isolates. A particular focus is on the role 
of Esp in these organisms. Its function is still not fully understood, and the role of 
Esp in relation to the effect of bile on biofilm formation will be analysed further.  
Research has shown that E. faecalis shows pathogenicity in a C. elegans infection 
model (Garsin et al., 2001), whereas the E.  faecium strains that have been tested are 
not (Moy et al., 2006, Moy et al., 2004, Garsin et al., 2001). However, only a limited 
number of E. faecium strains have been tested, and for that reason several clinical 
isolates will be analysed to establish if a lack of pathogenicity to C. elegans applies 










Chapter 2:  
Materials and Methods. 




2.1. Bacterial strains. 
 
All bacterial strains used in this thesis are listed in Table 2.1. 
 







Strain Information Reference 
E. coli: 
E. coli JM109 F´ traD36 proA+B+ lacIq 
Δ(lacZ)M15/  Δ(lac-proAB) glnV44 
e14- gyrA96 recA1 relA1 endA1 thi 
hsdR17 
Yanisch-Perron et al. 1985 
(Yanisch-Perron et al., 
1985) 
E. coli C41 (DE3)  F– ompT hsdSB (rB- mB-) gal dcm 
(DE3) 
Miroux and Walker 1996 
(Miroux and Walker, 1996) 
E. coli NovaBlue  Used for routine cloning, K-12  









E. coli HB101 F-, hsdS20( rB- mB ), xyl5, l-, 
recA13, galK2, ara14, 
supE44, lacY1, rpsL20(strpR), 
leuB6, mtl-1, thi-1 
Lacks and Greenberg 1977 
(Lacks and Greenberg, 
1977) 
E. coli OP50 Uracil requiring mutant Brenner 1974 (Brenner, 
1974) 
L. lactis: 
L. lactis NZ9700 Progeny of the conjugation 
between nisin producer strain 
NIZO B8 with MG1614 (RifR, 
StrpR derivative of MG1363) 
Kuipers et al. 1998 (Kuipers 
et al., 1998) 




Table 2.1. Bacterial strains continued... 
 
*Source  of  sample.  ‡Sample type.
Strain Information Reference 
E. faecium: 
E1162 Clinical blood isolate. AmpR, Esp+ Heikens et al. 2007 (Heikens et 
al., 2007) 
E1162∆esp E1162 strain with esp gene deleted Heikens et al. 2007 (Heikens et 
al., 2007) 
TX1330 Healthy volunteer faecal isolate.  AmpS, 
Esp- 
Nallapareddy et al. 2003 
(Nallapareddy et al., 2003) 
E1162∆ebrB E1162 strain with ebrB gene deleted. Not Published 
E. faecium clinical 
isolate 1 
Intensive  care  unit*.  Asctric  fluid‡.  
VanR, PenR, EryR, ChlR, TetR, AmpR 
Health protection agency. 
Southampton general hospital 
E. faecium clinical 
isolate 2 
Surgical ward*. Intra-abdominal drain 
swab‡.    VanR, PenR, EryR, ChlR,  AmpR 
As above 
E. faecium clinical 
isolate 3 
Leukaemic  ward*.  Blood  culture‡.  
VanR, PenR, EryR, ChlR, TetR, AmpR 
As above 
E. faecium clinical 
isolate 4 
Neonatal  unit*.Gastric  aspirate‡.  VanR, 
PenR, EryR, ChlR, TetR, AmpR 
As above 
E. faecium clinical 
isolate 5 
Intensive care unit*. Central venous 




ATCC19433 Reference strain- Esp+ ATCC 
BS12297 Isolate from clogged biliary stents. Esp+, 
GelE- 
van Merode et al. 2006 (van 
Merode et al., 2006b) 
BS11297 Isolate from clogged biliary stents. Esp+, 
GelE+ 
van Merode et al. 2006 (van 
Merode et al., 2006b) 
BS385 Isolate from clogged biliary stents. Esp-, 
GelE- 
van Merode et al. 2006 (van 
Merode et al., 2006b) 






All plasmids used and constructed are listed in Table 2.2. 
Table 2.2. Plasmids used during this thesis. 
Plasmid Details Reference 
Plasmids involved in making the signal peptidase mutant: 
pTEX5500ts Shuttle plasmid, temperature 
sensitive in Gram-positive hosts; 
ChlR, GenR 
Nallapareddy et al. 
2003. (Nallapareddy et 
al., 2006a) 
pSP1 pTEX5500ts with TX1330/E1162 
S0713 upstream fragment 
This thesis 
pSP2 pS0713U with TX1330/E1162 
S0713 downstream fragment 
This thesis 
pSP3 pTEX5500ts with TX1330 S1233 
upstream fragment 
This thesis 
pSP4 pTXS1233U with TX1330 S1233 
downstream fragment 
This thesis 
pSP5 pTEX5500ts with E1162 S0133 
upstream fragment 
This thesis 
pSP6 pE1162S0133U with E1162 
S0133 downstream fragment 
This thesis 
pSP7 pTEX5500ts with E1162 S1233 
upstream fragment 
This thesis 
pSP8 pE1162S1233U with E1162 
S01233 downstream fragment 
This thesis 
Plasmids involved in making the integration: 
pNZ8148 Broad host range vector with 
nisA-promoter and multiple 
cloning site and a NcoI site used 
for translational fusions, standard 
vector; ChlR 
Kuipers et al. 1998 
(Kuipers et al., 1998) 
pMUTIN4 pBR322-based vector containing 
lacZ, lacI, and Pspac inducible 
promoter; AmpR, EmR. 
Vagner et al 1998. 
(Vagner et al., 1998) 




pINT1 pMUTIN4 with no lacZ, lacI and 
an inserted NcoI site. 
This thesis 
pINT2 Combination of pNZ8148 and 
pMutin4. ColE1 replication 
sequence, nisA-promoter, AmpR, 
EmR and ChlR 
This thesis 
pINT3 pNZpMUT with nisRK This thesis 




pN-tEsp pCRT7/CT-TOPO TA expression 
vector encoding the Esp N-
terminal domain 
Van Wamel et al. 
2007. (Van Wamel et 
al., 2007)  
 
2.3. Chemicals and bacterial culture media. 
 
All chemicals were purchased from Fisher Scientific or Sigma unless stated 
otherwise. All culture media were purchased from Oxoid. 
 
2.4. Cell culture methods. 
 
2.4.1 E. coli growth conditions 
 
E. coli was grown at 37oC in Luria-Bertani (LB) broth, unless by otherwise stated. 
Antibiotics were added at the following concentrations: chloramphenicol 10 µg/ml 
(Fisher Scientific), gentamicin 25 µg/ml (Sigma), or ampicillin 100 µg/ml (Sigma).  
 
2.4.2 Enterococcal growth conditions 
 
E. faecalis and E. faecium strains were cultured in Tryptone soya broth (TSB), TSB 
containing 0.25% glucose (TSB-G), Brain heart infusion (BHI) broth or LB broth at 




37oC unless stated differently. Antibiotics were added at the following 
concentrations: chloramphenicol 10 µg/ml, gentamicin sulfate 200 µg/ml (Fisher 
Scientific) or gentamicin 125 µg/ml. 
 
2.4.3 Viable counts 
 
To establish the number of viable bacteria inoculated or present, the optical density 
at 600 nm (OD600) was determined of exponentially growing cultures using an 
Eppendorf Bio-Photometer. The number of colony forming units (CFU) were 
determined by serial dilution and plating on TSB agar (TSA) plates.    
 
2.4.4 Growth rate of E. faecium in the presence of bile salts 
 
E. faecium strains were cultured overnight at 37oC in TSB. Next, cultures were 
diluted in fresh TSB-G containing 0%, 0.5%, 1.5% or 5% bile salts, and the OD600 
was determined at regular intervals for 8 hours. 
 
2.5. Nucleic Acid techniques 
 
2.5.1 Small scale plasmid purification. 
 
All plasmids were isolated using the Nucleospin Plasmid Kit (Macherey-Nagel) 
following manufacturer’s  instructions. 
 
2.5.2 Chromosomal extraction of DNA 
 
Chromosomal DNA extraction from E. faecium strain E1162 was performed as 









2.5.3 Agarose gel electrophoresis and gel purification 
 
Agarose gel electrophoresis was performed using standard methods (Sambrook and 
Russel, 2001).  0.8%  agarose  gels  containing  0.5  μg/ml  ethidium  bromide  were  run  at  
120V and were visualised under UV light. Purification of DNA from agarose gels 
was performed using the Nucleospin Extract II Kit (Macherey-Nagel) following the 
manufacturer’s  instructions. 
 
2.5.4 DNA quantification 
 
DNA was quantified at 260 nm using an Eppendorf Bio-Photometer, or by 
comparison with standard amounts of DNA on agarose gels.  
 
2.5.5 DNA sequencing 
 
Sequencing was performed by Eurofins MWG Operon, UK. Samples were prepared 
by following Eurofins instructions. 
 
2.6. Cloning techniques. 
 
2.6.1 Polymerase chain reaction (PCR) 
 
PCR was performed with a Mastercycler gradient machine (Eppendorf). The 
KAPA2G robust or KAPA Hifi PCR kit was used (KAPA biosystems), following the 
manufacturer’s   instructions. All primers were synthesised by Invitrogen or Sigma 
and are noted in the relevant chapters. PCR products were purified using the 
NucleoSpin Extract II kit (Macherey-Nagel). 
 




2.6.2 Restriction enzyme digestion 
 
Restriction enzyme digests were performed as recommended by the manufacturer, 
New England BioLabs. DNA for ligations or other cloning steps was always 
digested overnight unless stated otherwise. After digestion, DNA was purified using 
PCR clean-up gel extraction kit, NucleoSpin Extract II (Macherey-Nagel). 
 
2.6.3 Ligation of DNA. 
 
Two methods were used for ligation of DNA. These were either using T4 DNA 
ligase (New England Biolabs) as described (Sambrook and Russel, 2001), or using 
the In-fusion advantage PCR cloning kit (Clontech),   following   the  manufacturer’s  
instructions. Primers for the latter were designed as recommended by Clontech; these 
were designed as normal with an additional 15 nucleotides that share sequence 
homology with the linearized vector. Primers used are stated in the relevant chapter.  
 
2.7. Transformation of competent cells with plasmid DNA 
2.7.1 Transformation of E. coli 
 
E. coli strain JM109 and C41 (DE3) were made competent for DNA uptake by 
treatment with CaCl2 (Sambrook and Russel, 2001), following this cells were used 
for transformations.  Commercial E. coli NovaBlue GigaSingles competent cells 
were  used  for  some  transformations,  following  the  manufacturer’s  guidelines.  After 
transformation bacteria were plated out on LB plates with the relevant antibiotic.  
 
2.7.2 Transformation of electro competent Enterococci cells. 
 
Electrocompetent enterococcal cells were prepared and transformed as previously 
stated (Heikens et al., 2007). In brief, 5 µl of plasmid was added to 100 µl of electro 




competent enterococcal cells in a 1mm cuvette (Invitrogen). Cells were 
electroporated at 1.25kV, 25µF and 200Ω,   using   a   BioRad   Gene   Pulser,   giving   a  
time constant of 4-6 msec. Cells were allowed to recover at 28oC for 4 hours for the 
SPase mutant protocol (Chapter 3, Section 3.3) or at 37oC for 2 hours for the 
integration plasmid protocol (Chapter 3, Section 3.4), before being plated onto Todd-
Hewit broth (THB) containing 20% sucrose and the relevant antibiotics.  
 
2.8. Protein gel techniques 
 
2.8.1 SDS-Polyacrylamide gel electrophoresis (PAGE) and Western blotting 
 
Western blotting was performed using a semi-dry western blotting system. Proteins 
were firstly resolved by SDS-PAGE (Laemmli, 1970). Samples were prepared by 
adding a 1:1 volume Laemmli loading dye and boiling for 3 minutes. For full length 
Esp a 7.5% gel was used, while for the analysis of the N-terminal domain of Esp a 
12.5% gel was used. For all gels the EZrun Pre-stained Rec protein ladder (Fisher) 
was used to establish size of bands. The gel and polyvinylidene difluoride membrane 
(PVDF; Immobilon-P; Millipore) were sandwiched in between several layers of 
Whatman 3MM chromatography paper (Schleicher & Schuell). The buffers used for 
transfer were Towbin transfer buffer (25mM Tris, 192 mM glycine, 20% Methanol) 
or a buffer with SDS for the transfer of large proteins such as Esp (48mM Tris, 
39mM glycine, 0.1% ml SDS and 10% methanol). The membrane and gel were 
blotted for 2-3 hours at 20V and 150mA. 
Following blotting membranes were blocked with Tris-buffered saline containing 
Tween 20 (TBST; 150 mM NaCl, 20mM KCl, 25mM Tris pH 7.4 and 0.05% 
Tween-20/litre) and 5% skimmed milk (Marvel) for 2 hours. Next, the membrane 
was incubated at 4oC overnight with the primary antibody or pre-immune sera at the 
appropriate concentration (as stated in the chapter). The membrane was washed and 
the secondary antibody, horseradish peroxidase- conjugated to goat anti-rabbit 
(Promega), added in all cases at concentration of 1 in 5000. Blots were washed with 
TSBT prior to performing signal detection with the Supersignal West Pico-
chemiluminescent Substrate Kit (Pierce), following  the  manufacturer’s  guidelines. 




2.8.3 Coomassie staining 
 
Proteins were separated by SDS-PAGE, and the gel was fixed (40% methanol and 
10% acetic acid) for 25-20 minutes on a rocker at room temperature. Next, the gel 
was stained for 1 hour (in 0.025% Coomassie brilliant blue G250 in 10% acetic 
acid), and then destained (20% methanol and 10% acetic acid) until the bands were 
clearly visible. For long-term storage gels were dried in cellophane wrap (BioDesign 
GelWrap). 
 
2.9. Antibiotic sensitivity. 
 
2.9.1 Isothermal Calorimetry. 
 
Cultures for calorimetry were grown overnight at 37oC in TSB. 15% glycerol was 
added and aliquots of 1 ml were dispensed and frozen at -80oC. Viable counts were 
performed to establish the numbers of cells after freezing. These were then used for 
continuous culture calorimetry, using a Thermometric 2277 Thermal activity 
Monitor (TAM-Therometric AB, Jarfalla, Sweden) that was calibrated between 0-
1000µW (the experiment range) at 37oC.  
The strain of choice was thawed and diluted to give approximately 1 x 104 CFU/ml 
of TSB. This was then incubated in an external water bath at 37oC. Tubing from the 
calorimeter ampoule was placed in the culture and a peristaltic pump (flow-rate: 
1ml/minute) was used to pump the growing culture through the calorimetry cell and 
the power-heat out-put was measured over time by the thermopile arrays. 
Cells were grown in the absence or presence of ampicillin. Ampicillin (64µg/ml, 
twice the MIC of E. faecium E1162) was added when the output of the culture had 
reached 10 µW (corresponding to approximately 1.2 x 105 cfu/ml).  
Before and after use of the calorimeter the tubing and ampoule was washed by firstly 
by turning the peristaltic pump to 90% speed and washing through a one molar 




solution of sodium hydroxide for 5 minutes. Sterile distilled water was then washed 
through at the same speed for 20 minutes. 
 
2.9.2 Minimum inhibitory concentration (MIC) tests and Minimum 
bactericidal concentration (MBC) tests. 
 
MIC tests using a microdilution protocol were performed as described (Andrews, 
2001). Tests were performed in TSB-G, 200 µl cultures were grown for 18 hours at 
37oC in 96-well plates, with ampicillin ranging in concentration from 1-256 µg/ml, 
and an inoculum of 105 cells/ml. MIC determinations for each strain were performed 
in triplicate test. The MIC is defined as the lowest concentration without visible 
growth.  
Following the above MBC for the strains were determined. From the MIC 96-well 
plate 10µl was taken from each of the wells with concentrations of ampicillin that 
were higher than the MIC. The 10µl sample was added to 90µl TSB and this was 
then plated onto a TSA plate. The plates were incubated for 24 hours at 37oC. The 
MBC was taken as the lowest concentration where no colonies grew. 
 
2.9.3 M.I.C.Evaluator strip test and Antimicrobial susceptibility discs test. 
 
The M.I.C.Evaluator strip (Oxoid) or discs (10 µg; Oxoid) with ampicillin were 
used. Tests were performed in triplicate on Mueller Hinton agar (Lab M) as 
recommended by the manufacturer. The plates were incubated at 37oC for 24 hours. 
 
2.10. Crystal violet biofilm assay 
 
2.10.1 Biofilm growth 
 
Strains were grown overnight in TSB-G. The following day they were diluted in 
TSB-G to 108 cfu/ml suspension, and 100  μl   of   the   suspension  was   then   added   to  




wells of a 96-well  microtitre  plate  (Costar).  100  μl  of  the  relevant  concentration  of  
the compound (diluted in TSB-G) being assayed was added to the well, or in the case 
of the controls, TSB-G. Compounds included Bile salts (0-5%), Sodium taurocholate 
(0-2%), Sodium glycocholate (0-2%; Calbiochem), Sodium taurocholate plus 
Sodium glycocholate (0-2%), Sodium dodecyl sulphate (SDS; 0.00975-0.03%), 
Triton X100 (0.01-1%). The microtitre plates were incubated for 24 at 37oC on a 3D 
plate rotator (Grant-Bio; 30 rpm). If 48 hour biofilms were being studied, after 24 
hours planktonic cells were removed and replaced with fresh media containing the 
compound being assayed. 
 
2.10.2 Crystal violet assay 
 
After incubation the cell suspension was removed, the plate was washed twice with 
0.9% NaCl, and then inverted to dry for 1 hour at room temperature. Following this 
150  μl   of Crystal violet solution (CV; PROLAB Diagnostics) was added and was 
allowed to stain the biofilm for 15 minutes. Next, CV was removed and the wells 
were   washed   3   times   with   0.9%   NaCl.   The   CV   was   solubilised   with   200   μl   of  
ethanol-acetone (80:20 v/v). The CV absorbance of the wells was read at 595 nm on 
a Versa max Tunable microplate reader. Each condition was tested at least three 
times in three independent tests.  
 
2.11. Initial polystyrene adherence assay. 
 
The initial adherence was performed as described previously (Baldassarri et al., 
2001). Briefly, bacterial strains were grown overnight at 37oC on Tryptone soya agar 
(TSA). The following day they were diluted in TSB-G to an OD600 of 0.5 (5 x 108 
CFU/ml). 50µl of the suspension was added in triplicate to the wells of a 96 well 
plate. 50 µl of TSB-G containing the relevant amount of bile salts (double the 
required amount) was added to the wells. The plate was then placed on the 3D 
rotator (Grant-Bio; 30 rpm) and incubated for 2, 4 and 6 hours at 37oC. Following 
incubation, wells were washed twice with 200µl of 0.9% NaCl and then allowed to 
dry for 15 minutes at 60oC. 50 µl Crystal violet solution was added to the wells and 
was allowed to stain for 15 minutes. The stain was washed three times with 0.9% 




NaCl, plates were allowed to dry for 15 minutes at room temperature, and then 
absorbance was read at 595nm on the plate reader (Versa max Tunable microplate 
reader). Each condition was tested three times in three independent tests. 
 
2.12. Cell surface hydrophobicity determination 
 
Bacterial cell surface hydrophobicity was performed using MATHS, as previously 
described (Rosenberg et al., 1981). Briefly, bacterial cultures were grown in TSB-G 
overnight at 37oC. Next, the culture was diluted 50-fold in TSB-G or TSB-G 
containing the compound being assayed. Each culture was incubated for 4 hours at 
37oC, and the log-phase cells were harvested by centrifugation and washed 3 times 
with PUM Buffer (0.15M potassium phosphate, 0.3M Urea, 6.7mM MgSO4, pH 
7.1). Cell pellets were resuspended in PUM buffer to an optical density at 400 nm 
(OD400) of 1. To 1 ml of the cell suspension, 200µl of n-hexadecane was added this 
was incubated for 10 min at 30oC. Following this, the mixture was mixed thoroughly 
by vortexing for 2 min. Next, the mixture was allowed to stand for 15 min at room 
temperature to ensure complete separation of the organic and aqueous phases. The 
absorbance of the aqueous layer was measured at 400nm. The percentage of cell 
surface hydrophobicity, which is a measure of the percentage of bacterial cells 
partitioning into the organic phase, was calculated by using the following formula: 
[1-(final OD400/initialOD400) x100]. At least three independent tests were 
performed. 
 
2.13. Confocal Laser Scanning Microscope (CLSM). 
 
2.13.1 Biofilm preparation 
 
Cells were cultured overnight in TSB-G. The following day they were diluted in 
TSB-G to 108 cfu/ml suspension and 2 ml of the suspension was added to wells of a 
6-well microtitre plate (Costar). 2 ml of TBS-G containing different concentrations 
of bile salts was added to each well. Vinyl coverslips (Electron Microscopy 
Sciences, EMS, UK) were added to each well so that the biofilm could form on these 




and used for visualisation. Every 24 hours medium was replaced with fresh medium 
(containing the relevant concentration of bile salts). Biofilms were grown for 72 
hours.  
 
If early attachment was being studied biofilms were only allowed to grow for 6 hours 
prior to staining.  
 
2.13.2 Coverslip preparation and staining 
 
After incubation the coverslips were removed and washed twice with 0.9% NaCl on 
a horizontal plate shaker (Heidolph). 1 ml of BacLight (Invitrogen) or acridine 
orange (Sigma) was added to each coverslip, and these were then placed in darkness 
for 10 minutes. Following staining the coverslips were rinsed twice with 0.9% NaCl. 
If EPS was also being studied then calcofluor white stain (600 µl) was added for 10 
minutes (in darkness), followed by two wash steps. Coverslips were then mounted 
onto glass slides with nail varnish.   
 
2.13.3 Confocal Laser Scanning Microscope  
 
Images were collected using a LSM510META Zeiss Confocal laser scanning 
microscope, lasers included the argon laser (488nm) and the helium/neon laser (543 
nm). A Plan-Apochromat 63x/1.4 oil objective was used. Images were prepared 
using Zeiss LSM software (release 4.0).  Quantitative analysis of maximum 
thickness and bio volume of the CLSM biofilm images was measured using Comstat 
2 software (Heydorn et al., 2000).  At least three independent tests were performed. 
 
 
2.14 Cell chain length determination. 
 
E. faecium strains were grown overnight in TSB broth and diluted 100 fold in fresh 
medium in the presence or absence of 0.5% bile salts. Cells were then cultured until 
mid-exponential growth phase (OD600 ~0.5-0.6) and examined by light microscopy. 
The number of cells in each chain observed was counted in at least 4 fields of view. 




2.15 Protein expression and purification of the N-terminal Esp.  
 
2.15.1 Induction of E. coli C41 (DE3) cells. 
 
E. coli C41 (DE3) cells were used to express the N-terminal domain of Esp. A 
culture was grown in LB broth until an OD600 of 0.6, at which point the cells were 
induced with 1 mM isopropyl-β-thiogalactopyranoside (IPTG). Cells were then 
grown for 16 hours before harvesting 
 
2.15.2 E.coli cell lysis 
 
Cells were collected by centrifugation and resuspended in a 1/20th volume of buffer 
A (50mM sodium phosphate pH 7.5, 300mM NaCl) containing 0.2 mg/ml lysozyme 
(Sigma). Cells were incubated for 10 minutes on ice and then lysed by sonication 
(Branson; model 250/450). Cell debris was removed by centrifugation (8000 g, 10 
minutes). A protease inhibitor cocktail (complete- EDTA free, Roche Molecular 
Biochemicals) was added to prevent protein degradation. 
 
2.15.3 His-tagged protein purification 
 
A HisPur Cobalt Resin (Pierce) was used for purification, following the 
manufacturer’s  instructions.  
 
2.15.4 Fast performance liquid chromatography (FPLC) 
 
FPLC Akta Prime system (GE Healthcare) was used to further purification using a 5 








2.15.5 Protein dialysis 
 
Fractions containing N-terminal Esp protein (as judged by analysis with SDS-Page) 
were pooled and dialysed using Snakeskin dialysis membrane (10kDa MWCO, 
Pierce) overnight in 50mM Tris, pH 8. 
 
2.15.6 Protein concentration 
 
Purified protein was concentrated using Viva spin filters 15R (Sartorius; 10,000 
MWCO),  following  the  manufacturer’s  instructions. 
2.15.7 Determining protein concentration 
 
Protein concentration was determined using the BCA assay (Pierce), following the 
manufactures guidelines. 
 
2.15.8 Raising polyclonal antibodies  
 
Polyclonal antibodies were raised by immunizing two rabbits with slices of SDS-
PAGE gel containing 200 µg of the purified Esp protein per injection (Eurogentec, 
Belgium). A 3 month programme was used, with rabbits being injected at day 0, 14, 
28 and 56 days, with a final bleed on day 87. This was all performed according to 
regulations on animal experiments. The antiserum was purified using protein A 
Sepharose (GE Healthcare).  
 
2.15.9 Esp Expression using flow cytometry 
 
2.15.9.1 Bacterial growth 
 
Bacteria were grown in various conditions: on TSA plates, in broth till stationary 
phase (aerobically (with shaking) and anaerobically (no shaking)) or grown in broth 
until log phase. In all cases cells were resuspended in phosphate buffered saline 




(PBS) containing 0.05% Bovine Serum Albumin (PBS-BSA; Sigma) to an OD600 of 
1. 
 
Biofilm formation and biofilm planktonic cells were prepared differently; bacteria 
were grown for 24 hours in 6 well microtitre plates (Costar). Planktonic bacteria 
were removed, washed and resuspended in PBS-BSA to an OD600 of 1 for testing. 
Cells in the biofilm were washed twice with 0.9% NaCl, and following this PBS-
BSA was added to wells and cells were removed by scraping the surface and 
resuspended to a final OD at 600 nm of 1. 
 
2.15.9.2 Flow cytometry 
 
The expression of Esp on enterococcal cells were determined by flow cytometry with 
FACSCantoTM (B-D Biosciences, San jose. Calif.), equipped with an argon ion laser 
(488nm). Samples were prepared as stated above and then 300μl   of   each   sample  
were pelleted by centrifugation (6,500g,  1  min)  and  resuspended  in  50μl  PBS-BSA 
containing 20-fold diluted anti-Esp serum. E1162Δesp was used as the main negative 
control for the E. faecium experiments, but the pre-immune serum was used as an 
additional control. For E. faecalis Esp experiments the pre-immune serum was used 
as the main negative control. Samples were incubated at 4oC for 16 hours, washed 
once in PBS-BSA, resuspended in PBS-BSA containing a 1/50 dilution of goat anti-
rabbit antibody labelled with Alexa Fluor 488nm (Invitrogen) and incubated on ice 
for 1 hour. Finally, samples  were  washed   twice  and  resuspended   in  500μl  of  PBS-
BSA for flow cytometry measurements. 10,000 cells were counted in each 
experiment. BD FACSDiva software version 5.0.3 was used to determine the 
number of esp expressing cells, using EfmE1162Δesp (for E. faecium) or the pre-
immune sera (for E. faecalis) as non-expressing negative control cells. Tests were 









2.16.9 Esp Expression using SDS-PAGE 
 
2.16.9.1 Bacterial growth 
 
Bacteria were grown under aerobic and anaerobic conditions (using an anaerobic jar 
with carbon dioxide generators and indictors (Becton, Dickinson (BD)) on TSA-G or 
TSB-G containing 5% sheep blood agar plate (TSA-G-B, TSB-G-B). Samples were 
incubated at 37oC overnight. Next, bacteria were washed with PBS and made to an 
OD600 of 1. Mutanolysin (50U) and lysozyme (5mg/ml) was added to the bacteria 
and incubated at 37oC for 1 hour. Samples were prepared for SDS-PAGE as stated in 
section 2.8. 
 
2.16. C. elegans 
 
2.16.1 C. elegans maintenance 
 
NGM plates (Brenner, 1974) were prepared and overnight culture of the E. coli 
HB101 strain was added to the centre of the plate and allowed to grow overnight at 
37oC. The C. elegans strain AU37 (glp-4(bn2), sek-1 (km4)) used was obtained from 
the Caenorhabditis Genetics Centre (CGC) (Moy et al., 2006); this strain has 
mutations making the worms unable to produce progeny at 25oC and, in addition, is 
more sensitive to pathogens. This strain was maintained on NGM plates with an E. 
coli lawn at 15oC, as described previously (Brenner, 1974). NGM plates usually 
contained nystatin (Fisher; 125 U/ml) to inhibit fungal contaminations. 
 
2.16.2 Synchronising C. elegans 
 
Worms were transferred to fresh NGM plates containing E. coli HB101. Plates were 
then incubated for 7-8 days (depending on seeding) at 15oC until the presence of 
many adults were observed and most of the E. coli was consumed. Worms were 
removed from the plates and washed 3 times with M9 (3 g/L KH2PO4, 6 g/L 
Na2HPO4, 5 g/L NaCl, 0.25 g/L MgSO4.7H2O). Eggs were released from the adult 




worms using an alkaline bleach solution (2 ml 10% NaOCl, 5 ml 1M NaOH and 2 
ml water) as described (Burns et al., 2006) then washed 4 times with M9. 200-500 
eggs were seeded on agar plates with lawns of E. coli HB101 and incubated at 25oC 
for 72 hours to allow the eggs to hatch and mature to L4/young adult stage. Worms 
were collected from the plates and washed 3-4 times in cold M9 to remove E. coli. 
 
2.16.3 C. elegans Infection  
 
BHI agar plates containing 80 µg/ml kanamycin (Sigma) and a lawn of the relevant 
pathogen to be tested were prepared prior to requirement. For anaerobic killing 
assays bacteria were grown on plates in an anerobic GasPak jar (Becton Dickinson) 
prior to requirement. NGM agar plates containing spectinomycin (50 µg/ml; Sigma) 
were made for the E. coli HB101 controls. Antibiotics and nystatin were added to 
stop contamination but also in the case of the pathogen plates stop E. coli HB101 
growing. A ring of palmitic acid (10 mg/ml in ethanol) was also added around the 
edge of the plates; the palmitic acid is not soluble and forms crystals that prevent 
worms escaping from the plates. 30-50 synchronised L4/young adult worms were 
placed on a least 3 plates. These were incubated at 25oC and worm survival was 
scored daily. Worms that lost their characteristic sigmoidal shape and were 
insensitive to mild agitation by tapping the plate or gentle touch with a platinum wire 
were considered dead. 
 
2.17. Statistical analysis 
 
Differences between conditions were analysed using Students T-test. Significance 
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Chapter 3: Results section I 
 
3.1. Background and objectives  
 
Bacteria transport proteins across the cytoplasmic membrane using a number of 
distinct processes. Two of these are general secretion pathways, being able to 
translocate a wide variety of proteins. These are the Sec-dependent pathway, in 
which proteins are transported unfolded across the membrane, and the Tat pathway, 
in which proteins fold in the cytoplasm prior to translocation (Palmer and Berks, 
2012). In addition Gram-positive bacteria also have a number of more specialist 
pathways that are involved in the translocation of only a very limited number of 
substrates.  Two   examples   include   the   ‘Accessory   Sec   system’   which   is   found   in  
staphylococci and streptococci. This pathway can contain an additional SecA2 and 
SecY2 which are able to transport proteins, usually virulence factors, across the cell 
membrane independently of the Sec-dependent pathway. The second example is the 
Type VII/WXG100 system, which is the most recent secretion pathway discovered. 
It has most widely been studied in Mycobacterium tuberculosis and other high-GC 
diderm (two membranes) Gram-positive bacteria (Freudl, 2013). This chapter deals 
with the Sec pathway only as enterococci do not have the Tat pathway. 
 
Enterococci transport the majority of their proteins across the cell membrane using 
the Sec-dependent pathway (Figure 3.1). In this, secretory proteins are synthesised as 
pre-proteins with a signal peptide at the amino terminus. This signal peptide is an 
indicator to the Sec machinery that this protein has to be transported across the 
cytoplasmic membrane. The pre-protein is targeted by chaperones to a membrane-
bound translocase which contains several components that recognise the pre-protein 
and transports it through the cytoplasmic membrane. At the trans side of the 
membrane the signal peptide is cleaved off by a signal peptidase, and the protein 
folds into its active configuration. Many of the components for protein transport are 











Figure 3.1. Sec-dependent pathway. See text for details. 
 
 
There are four types of bacterial signal peptides: archetypal Sec-type, lipoprotein, 
Tat and prepillin (Paetzel et al., 2002), and only the first two will be discussed here. 
Signal peptides are divided into three regions: the N-terminal, H - region and C- 
region (Figure 3.2). The N-terminal consists of positively charged amino acid 
residues; these help orientate the signal peptide in the membrane. The H-region 
consists of hydrophobic amino acid residues, usually 10-15,  which  form  a  α-helix in 
the membrane. The C- region  contains  the  signal  peptidase  recognition  site,  ‘Ala-X-
Ala’,  at  -1 and -3 relative to the cleavage site in the pre-protein (van Roosmalen et 
al., 2004). The signal peptides for lipoproteins vary from the above; they too contain 
the three regions, but their H-domain is shorter and their signal peptidase recognition 












Figure 3.2. Types of bacterial signal peptides. A. Bacterial signal peptide (Sec-
type). B. Tat signal peptide. C. Lipoproteins signal peptide. D. Prepillin signal 
peptide. Black arrow indicates cleavage site. Bold letters that are not X 
represent conserved amino acid residue. Bold letter X represents non-conserved 
amino acid residues (Paetzel et al., 2002). 
 
There are two types of signal peptidases (SPase), being type I and type II, both of 
which have their active site at the trans side of the membrane (Paetzel et al., 2002). 
Type II SPases, also called prolipoprotein signal peptidases (Lsp), cleave glyceride-
modified prolipoproteins that contain the Lipobox. Those lipoproteins are retained at 
the membrane after processing (Pragai et al., 1997). This chapter will focus on type I 
signal peptidase, of which there are two subtypes: the prokaryotic (P)-type and the 
endoplasmic reticulum (ER)-type. P-type SPases are found in bacteria and organelles 
of eukaryotes (mitochondria and chloroplasts), while ER-type SPases are found in all 
the three domains of life (van Roosmalen et al., 2004).  
 
Using bioinformatics to study the genomes of enterococci (Qin et al., 2009, van 
Schaik et al., 2010, Qin et al., 2012), some of which are not fully annotated, it was 




observed that E. faecium has three putative type I signal peptidases  Interestingly, 
many bacteria (including Escherichia coli) have only one type I SPase (Dalbey and 
Wickner, 1985), but amongst the Gram positive bacteria there are a number of 
examples of organisms with several SPases, such as Bacillus subtilis, Clostridium 
perfringens, S. aureus and Staphylococcus epidermidis (van Roosmalen et al., 2004). 
Studies in B. subtilis have shown that the type I SPases may have different 
specificities, albeit that there is some overlap in activity as the deletion of one signal 
peptidase is not lethal to the bacteria (Tjalsma et al., 1997). Research has not clearly 
established why there are more type I SPases in these bacteria; it has been suggested 
that they may be used for increased cell-processing capacity, as a back-up signal 
peptidase activity if one is lost, or as a way to adapt to changing environments by 
regulating which signal peptidase is expressed and, therefore, which pre-proteins are 
being processed (van Roosmalen et al., 2004) 
 
Several proteins involved in biofilm formation and virulence in enterococci are 
predicted to be Sec-dependent substrates. One such protein, the Enterococcal surface 
protein (Esp) has been shown to enhance biofilm formation in some clinical isolates 
(Heikens et al., 2007, Tendolkar et al., 2004). Another example is Gelatinase E 
(GelE), an extracellular zinc metalloprotease that is able to hydrolyse gelatine, 
collagen and casein; research has shown that it is also involved in biofilm formation 
(Thomas et al., 2008). Other examples are SalA and SalB, which are believed to be 
major secreted antigens. SalA is likely to be involved in binding to the extracellular 
matrix and whereas SalB plays a role in the resistance to stressful conditions 
(Nallapareddy et al., 2006a, Mohamed et al., 2006). 
 
Although there are many components of the Sec-dependent pathway, the intention of 
the work here was to produce knockouts of the signal peptidases found in E.  faecium 
to analyse possible substrate specificities and, in addition, whether any of the signal 
peptidases has a specific role in virulence. This is important as there are signal 
peptidase inhibitors available (Harris et al., 2009) and further research on these could 
be encouraged with more information if the importance of signal peptidases in 
pathogens such as enterococci is clearly demonstrated.  




3.2.1 Identification of the signal peptidase genes of E. faecium 
 
Type I SPases can be split into two groups: the P-type, and ER-type. All type I 
SPases contains 5 conserved regions (boxes A-E; Tjalsma et al., 1997). Region A 
(not illustrated in the alignments shown in figure 3.4) represents the anchor region 
that inserts into the membrane.  Region B contains a serine and region D contains a 
lysine residue, both of which form an essential catalytic dyad. The first serine 
residue in region E helps to position these two residues. Residues in region C and the 
arginine residue in region D have been suggest to be involved in structural roles 
involved in substrate attachment (Paetzel et al., 2002). 
 
ER-type SPases have the same conserved serine but have a histidine residue instead 
of the lysine residue for catalytic activity. ER-type and P type SPases also differ in 
the sequences between the conserved domains. In ER type SPases, regions B and C 
are only separated by one residue, whereas P-type SPases can be separated by 19-42 
residues. In addition, regions D and E are separated by 2-11 residues in ER-type 
SPases, whereas P-type SPases are separated by 23-118 residues. There is also an 
additional  domain  C’  in  ER-type SPases (van Roosmalen et al., 2004). 
 
The typical P-type SPase 1 SipS of the Gram-positive bacterium B. subtilis was used 
in a Blast search to find SPase sequences in the E. faecium DO genome. Three 
SPases were identified, denoted: S0133DO (ZP_00605020.1), S0713DO 
(ZP_00604101.1) and S1233DO (ZP_00603941.1). Further Blast searches found 
similar genes in the E. faecium E1162 genome: S0133E, S0713E and S1233E 
(ZP_06677521.1, ZP_06677866.1 and ZP_06676098.1) and TX1330 genome: 
S0133TX, S0713TX and S1233TX (ZP_03982526.1, ZP_07860942.1 and 
ZP_03980473.1).    
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To study the relationships between the enterococcal SPases, multiple sequence 
alignments were made using the protein sequences encoded by the genes mentioned 
above as well as B. subilis SPases SipS (Figure 3.3). Alignment percentages for 
identical and similar residues are stated in Table 3.1. All alignments except S1233 
show moderate similarity between the proteins and SipS of B.subtilis. Alignment 
analysis of the amino acids shows that SPases S0713 and S0133 from all E. faecium 
strains (Figure 3.3A) contain the essential residues for activity. All the alignment 
percentages were low for S1233 to SipS for all E. faecium strains (alignments not 
shown), with identities between 11-16% (Table 3.1). It was observed that the S1233 
sequence for E. faecium E1162 starts short of the other S1233 sequences. This could 
be due to incorrect annotation, and could indicate that there is a start codon further 
upstream that can be used instead. However, no other potential start codon with a 
ribosomal binding site could be found upstream.  
 
A phylogenetic tree was constructed (Tamura et al., 2011) with the sequences used 
for the alignments but also an additional B. subtilis SPase SipW, which is an ER-
type SPase (Figure 3.4). It can be seen that each of the three enterococcal strains 
contains three different types of SPases that cluster together. Two of those clusters 
(containing the SPases S0713 and S0133) are similar to B. subtilis SipS, while those 
in the third cluster (SPases S1233) are closely related to SipW. Therefore multiple 
sequence alignments were performed comparing the SPases S1233 with SipW. The 
percentage identity of the E. faecium S1233 SPases to SipW were higher than when 
compared to SipS (Table 3.1), although the percentage was still relatively low (16-
24% identity). Alignments for SPases S1233DO and S1233TX, but not S1233E (due 
to residues missing at the beginning) with B. subtilis SipW are shown in Figure 3.2B. 
The transmembrane helices spanning domains were also analysed using the software 
TMHMM 2.0 (Krogh et al., 2001). These results showed that there are two 
membrane spanning domains, with one N-terminal anchor and one C-terminal 
anchor. In contrast, type 1 SPases usually only have one N-terminal anchor (van 
Roosmalen et al., 2004), again showing that the SPases S1233 are more alike to 
SipW than SipS B. subilis (Figure 3.4B). All the E. faecium SPases S1233 show 
some   consensus   in  Regions  C,   C’   and  E   between   each   other.   It   is   also   noted   that  
there is one residue between regions B and C and 20 residues between regions C and 




D, which is similar to what has been found for SipW. The consensus sequence in 
region B for ER-type SPases is usually vlsgSMePxf (Capital letters being highly 
conserved) (Tjalsma et al., 2000b). Surprisingly, none of the E. faecium SPases 
S1233 contains the serine residue in domain B required for activity. In S1233E and 
S1233DO (but not S1233TX) there is a serine residue, but it is not in the usual place. 
Instead, it is located between the conserved residues methionine and proline, not 
prior to the methionine. The other essential active residue, a histidine which is 
usually found in Region D is also not present in the E. faecium SPases S1233; 
together with the lack of serine it suggests that the SP1233 SPases are not active.  
Table 3.1. Alignment percentage identity and similarity comparing the E. faecium 
SPases to two B. subtilis SPases. 
 B.subtilis SPase genes 
SipS SipW 








S0133 DO 30.9 9 - - 
 TX1330 39.6 4.0 - - 
 E1162 39.6 19.6 - - 
S0713 DO 36.4 20.6 - - 
 TX1330 36.4 20.1 - - 
 E1162 39.7 26.1 - - 
S1233 DO 16.3 23.9 23.7 22.1 
 TX1330 14.7 23.4 23.2 21.0 
 E1162 11.4 15.8 16.3 17.4 
  










 Figure 3.3. Signal peptidase alignments. SPases S0713 compared with B. subtilis SipS (A) and SPases S1233 compared with SipW (B). 
Box B-E show conserved areas of the signal peptidases in B. subtilis. The symbols at the bottom of the line indicate regions of perfect (*), 
good (:), and moderate (.) conservation. Residues highlighted in green for A are essential for stability/activity in SipS of B. Subtilis (van 
Dijl et al., 1995). Residues highlighted in green for B are conserved in ER-type SPases (Tjalsma et al., 2000b). Colour lines indicate 
transmembrane helices spanning domains. More details in the text. 







Figure 3.4.  Phylogenetic tree for the E. faecium SPases S0713, S0133 and 
S1233. They are also compared to B. subtilis SPases SipS (SipS BACSU) and 
SipW (SipW BACSU). E- E. faecium E1162, DO- E. faecium DO and TX-E. 
faecium TX1330. The scale bar represents the number of substitutions per 
position. The tree was constructed with Mega5.10 software using maximum 
likelihood method (Tamura et al., 2011). 
 
3.2.2 Identification of proteins secreted via the Sec-dependent pathway. 
 
As mentioned before, Sec-dependent proteins contain a signal peptide that is 
essential for translocation. Using SignalP (V.4.0) software (Petersen et al., 2011) and 
LipoP (V.1.0) software (Juncker et al., 2003) we firstly identified proteins that 
contained possible signal peptides. To ensure that only secreted proteins were to be 
studied the proteins were analysed for transmembrane helices spanning domains 
using software TMHMM Server, v 2.0 (Krogh et al., 2001); any protein with 3 or 
more transmembrane domains was disregarded, even though there was still a 




possibility they contain a cleavable signal peptide.  Table 3.2 shows the possible 
secreted proteins and lipoproteins identified.  
 
The proteins encoded by the E. faecium E1162 genome were analysed with the 
above software to establish if they are secreted. There are in total 2964 proteins 
encoded by the E. faecium E1162 genome; of these proteins 2.3% (69) have a Sec-
type signal peptide and are therefore putatively secreted (Table 3.2). This is slightly 
lower compared to another Gram-positive bacteria; for instance, 4% of B. subtillis 
proteins contains Sec-type signal peptides (Tjalsma et al., 2000a). In E. faecium, 
there is an array of proteins secreted: hydrolases, various enzymes, extracellular 
binding proteins and many cell wall surface proteins. There are also many virulence 
factors, which is important for the aim of this chapter, these include: Esp, autolysins, 
pili B subunit protein, two bee3 genes and a collagen adhesion proteins. There are 
also 16 hypothetical secreted proteins with no known function (23% of the total 
number of secretory proteins). 
 
Lipoproteins are a group of membrane proteins that have many roles in virulence, 
signal transduction, adherence and conjugation (Kovacs-Simon et al., 2011). Whilst 
analysing the genome for proteins with signal peptides, 55 lipoproteins (1.8%) were 
identified with LipoP, but the percentage found compares well with other research 
which suggests lipoproteins usually represent 2-3% of the genome (Reffuveille et al., 
2011, Babu et al., 2006). The lipoproteins identified include: three PrsA foldase 
proteins, a lactose transport system, zinc binding, ABC transporters, thiamine 
biosynthesis and a pheromone. In addition, there are 12 lipoproteins with unknown 
functions (20% of the total lipoproteins).  




Table 3.2. Predicted Sec-type signal peptides and lipoprotein signal peptides of E. faecium E1162.* 
 

































* SPase cleave recognition site is illustrate by underling. Positivity charged residues are indicated in bold letter and the H-region is indicated in 
grey shading.




3.3. Construction of type I SPase mutants. 
 
3.3.1 Summary of the method 
 
Using methodology previously developed (Nallapareddy et al., 2006a); the objective 
was to make SPase mutants as shown in Figure 3.5. Fragments upstream and 
downstream of the signal peptidase gene of choice (in blue) were introduced into the 
pTEX5500ts vector (A). The vector was then used to transform E. faecium E1162 or 
TX1330 (B). Colonies obtained with the vector were screened for single-crossover 
occurrences. Integration can occur through either the upstream or downstream 
fragment (C). A second step in which single crossover integrants will undergo a 
double crossover via homologous recombination leads then to the deletion of the 
gentamicin and signal peptidase gene (D-E). The correct mutants are thus gentamicin 
sensitive and chloramphenicol resistant. 
 
3.3.2 Making the vector constructs (A) 
 
Using the In-fusion advanced PCR cloning kit, upstream and downstream fragments 
were inserted into the plasmid. Primers used to amplify the fragments are listed in 
Table 3.3. Upstream fragments were inserted in the NheI and HindIII sites of 
pTEX5500ts, while downstream fragments were inserted into PvuI and PstI sites 
following  the  manufacturer’s  guidelines for the infusion method. 
Constructs were made for all three E. faecium E1162 SPases (E0133, E0713 and 
E1233), producing the three SPase mutant constructs (pSP2, pSP8, pSP6). 
Constructs for E. faecium TX1330 were only produced for only two of the SPases, 
TX0713 and TX1233 (pSP2 and pSP4, respectively). All constructs were verified 
with PCR, restriction digests, and sequencing (see methods and materials section). 
The vector construct for E. faecium TX0133 was not made as this gene appeared to 
contain some of the restriction sites used for cloning, even though these were absent 
from the sequence in the database.  
 














Table 3.3. Primers used for producing vector constructs. 
Name Type Sequence  (5’  to  3’)* Reference 
E. faecium TX1330- to make the pTEX5500ts constructs 
TX713UpFW Forward TTGTACAATTGCTAGCGCTTGCGGAAAGATTCAAAG This thesis 
TX713UpRev Reverse AACGAAAATCAAGCTTCTGCTTTTGGAACACCGTTT This thesis 
TX713DwnFw Forward GCGCGCCATGGGCCCTGCAGCAATAAAGCGTGCAGTCTGTT This thesis 
TX713DwnRev Reverse CGGGTACCGAATTCGATCGGCCCGAAATGAATGCAAGAT This thesis 
TX1333UpFw Forward TTGTACAATTGCTAGCTGGATGGATTTCTGGTCGAT This thesis 
TX1333UpRev Reverse AACGAAAATCAAGCTTCCTCCTACTTGTATTTTCCTCGTT This thesis 
TX1333DwnFw Forward GCGCGCCATGGGCCCTGCAGAGCGAAGCGTTTTTGTTCAT This thesis 
TX1333DwnRev Reverse CGGGTACCGAATTCGATCGACAGCCACCAAAAAGTCCTG This thesis 
TX1233UpFw Forward TTGTACAATTGCTAGCCGTCCCAATAGCAATGAAAA This thesis 
TX1233UpRev Reverse AACGAAAATCAAGCTTTGCGCATAAAATGGAGCATA This thesis 
TX1233DwnFw Forward GCGCGCCATGGGCCCTGCAGAGGTGGCGTTTTGATGGTAG This thesis 
TX1233DwnRev Reverse CGGGTACCGAATTCGATCGCAAGAATCAGCGGAACATCA This thesis 
E. faecium E1162- to make the pTEX5500ts constructs 
E713UpFw Forward TTGTACAATTGCTAGCGCTTGCGGAAAGATTCAAAG This thesis 
E713UpRev Reverse AACGAAAATCAAGCTTCTGCTTTTGGAACACCGTTT This thesis 
E713DwnFw Forward GCGCGCCATGGGCCCTGCAGCAATAAAGCGTGCAGTCTGTT This thesis 
E713DwnRev Reverse CGGGTACCGAATTCGATCGGCCCGAAATGAATGCAAGAT This thesis 
E1333UpFw Forward TTGTACAATTGCTAGCTGGATGGATTTCTGGTCGAT This thesis 
E1333UpRev Reverse AACGAAAATCAAGCTTCCTCCTACTTGTATTTTCCTCGTT This thesis 
E1333DwnFw Forward GCGCGCCATGGGCCCTGCAGAGCGAAGCGTTTTTGTTCAT This thesis 
E1333DwnRev Reverse CGGGTACCGAATTCGATCGACAGCCACCAAAAAGTCCTG This thesis 
E1233UpFw Forward TTGTACAATTGCTAGCGGATGATCCATCACAACACG This thesis 
E1233UpRev Reverse AACGAAAATCAAGCTTGGTGAGCTAGGCAAACTGGA This thesis 
E1233DwnFw Forward GCGCGCCATGGGCCCTGCAGAGGTGGCGTTTTGATGGTAG This thesis 
E1233DwnRev Reverse CGGGTACCGAATTCGATCGCAAGAATCAGCGGAACATCA This thesis 
 
* Primers synthesised by Invitrogen 




3.3.3 Production of the single crossover integrants (B-C). 
 
Vector constructs were introduced into the relevant strain of E. faecium (TX1330 or 
E1162) by electroporation. The presence of plasmids in E. faecium was confirmed by 
re-isolating the plasmid followed by the relevant restriction enzyme digests (used 
above), or by PCR using a primer located in the chloramphenicol resistant gene on 
the vector, CmR or CmF (Table 3.4) and a primer used to amplify one of the SPase 
fragments (Table 3.3). 
After incubation at 42oC to force integration of the plasmids, confirmation of single 
crossover integration was performed by PCR with primers listed in Table 3.4. PCR 
reactions performed included primer CmR or CmF paired with primers that are 
located on chromosome upstream (FurUp) or downstream (FurDwn) the cloned 
fragments (Figure 3.3). Results for the positive PCR reactions are shown in Figure 
3.6; if a single cross over integration has occurred only one of the above PCRs will 
work (the negative control PCR is not shown), and this is the case for these. 
 
 





Figure 3.6.  PCR reactions to test for positive single cross over integrants to 
created mutations in the following genes: A. TX1233. B. TX1713. C. E713. D. 
E1333 and E. E1233. Primers used are stated at the top of the image and 
expected band size is indicated by the black arrow. Numbers in circles 
represent the different annealing temperature gradient for the PCR reactions 









Table 3.4. Primers for electroporation confirmation and crossover confirmation 
Name Description Sequence  (5’  to  3’) Reference 
pTEX5500ts 
CmF Forward primer found in the Chl 
gene 
GAATGACTTCAAAGAGTTTTATG (Nallapareddy et 
al., 2006a) 
CmR Reverse primer found in the Chl 
gene 
AAAGCATTTTCAGGTATAGGT (Nallapareddy et 
al., 2006a) 
Used for identifying the integrants: 
E. faecium TX1330 
TX713Fwd Primer upstream of the 
upstream fragment 
TACTGAAAGCAAGACAAAAG This thesis 
TX713Rev Primer downstream of the 
downstream fragment 
AAGTGAAAGTGAACCAGTCCT This thesis 
TX1233Fwd Primer upstream of the 
upstream fragment 
GCTGTCGCAGTTGCTCATAA This thesis 
TX1233Rev Primer downstream of the 
downstream fragment 
TAGCGTCACAGGAGGGATTC This thesis 
E. faecium E1162 
E713Fwd Primer upstream of the 
upstream fragment 
GTTGGATCAATTCCGAATGC This thesis 
E713Rev Primer downstream of the 
downstream fragment 
ATTCCCCGGCTTTACTTGTT This thesis 
E1333Fwd Primer upstream of the 
upstream fragment 
GCGTTCAACATCCAGACAGA This thesis 
E1333Rev Primer downstream of the 
downstream fragment 
TTGATTCAGGAAGCCCAAAC This thesis 
E1233Fwd Primer upstream of the 
upstream fragment 
CAAGAATCAGCGGAACATCA This thesis 
E1233Rev Primer downstream of the 
downstream fragment 
AATGCCAAAGCAAAGCAACT This thesis 
Primers for identifying possible mutant in the TX1330 SPase0713 
TXseqfwd Designed outside the area that 
has been manipulated 
ACGACTGGACATACGGAAGC This thesis 








3.3.4 Production of a mutant (D-E). 
 
After the single crossover integrants were produced, eight rounds of passage at 42oC, 
under chloramphenicol selective pressure was performed to allow the double 
crossover step to occur. If a double crossover event did occur, then colonies would 
be gentamicin sensitive and chloramphenicol resistant. For all the single crossover 
integrants 1000 colonies or more were screened. Although all single crossover 
integrants were passaged and screened for the double crossover occurrence only one 
colony was obtained (for E. faecium TX1330 SPase713) that was gentamicin 
sensitive and chloramphenicol resistant. PCR using primers TXseqfwd and 
TXseqRev (Table 3.4) were used to check whether the mutant was correct. The 
expected band size for the TX1330 control is 1980bp and for the SPase713 mutant 
2484bp; the obtained image showed both bands to be at approximately 2000bp 
(Figure 3.7) and a SPase713 mutant was thus unfortunately not obtained. Further 
PCR reactions were performed using the above primers in combination with primers 
CmR and CmF, and again these showed that no mutant had been obtained. 
 
Figure 3.7. PCR results for the possible TX713 mutant. L. DNA ladder. A. 
TX1330 control and B. Possible TX713 mutant. 








The results above suggested that the SPases of E. faecium might be essential for 
viability, and a different strategy to analyse the role of the signal peptidases was thus 
required. A potential route is to control the expression of genes of interest with an 
inducible promoter. However, such a system does not exist for use in enterococci 
and a new vector had to be constructed for that purpose.  
 
The vector would need (a) the ability to replicate in E. coli but not in E. faecium; (b) 
suitable antibiotic resistance markers; and (c) an inducible promoter. It was decided 
to base the construct on pMutin4, a commonly-used integration vector for B. subtilis, 
and combine this with a nisin-inducible system.   
 
pMutin vectors are used in B. subtilis as an integration plasmid controlled by a Pspac 
promoter, which is tightly controlled by levels of IPTG in the media. The vector is 
introduced into the genome thereby placing the target gene under control of the 
Pspac promoter (Vagner et al., 1998). A similar system is required for enterococci, 
but a drawback is that the Pspac promoter does not work in these organisms (Bryan 
et al., 2000).  
 
An alternative to the Pspac promoter is the nisin-controlled gene expression system 
(NICE). It has primarily been developed for Lactococcus lactis, but can also be used 
in other Gram-positive bacteria including enterococci (Zhou et al., 2006). Nisin is a 
lantibiotic which acts by causing cytoplasmic membrane leakage, and it controls its 
own expression via a quorum sensing system. This involves a two-component signal 
transduction system which is used here as the mechanism to control gene expression. 
To generate a nisin-inducible system the vector needs to contain the nisA promoter 
(PnisA) for control of the expression of the gene interest, and the nisRK regulatory 




genes. Variable (sub-inhibitory) amounts of nisin to the culture medium will then 
determine the level of expression of the gene of interest, as the histidine kinase 
(NisK) senses the nisin, resulting in autophosphorylation. The phosphate group from 
NisK is then transferred to the response regulator NisR, which in turn results in 
translational activation of the PnisA promoter (Mierau and Kleerebezem, 2005, Zhou 
et al., 2006).  
 
3.4.2. Construction of the nisin-inducible integration vector. 
 
Firstly, using PCR (KAPA HiFi PCR kit), the section of pMutin4 vector containing 
the ori and antibiotic resistance genes (but not the region containing the lacZ and lacI 
genes) was amplified, with the primers being used (pMUT4NCOfwd and 
pMUTNCO1rev) also introducing an NcoI site into the vector. The PCR product was 
then digested with NcoI and ligated, resulting in pINT1.  
 
Plasmid pNZ8048 was digested with NcoI and SalI and the fragment containing the 
chloramphenicol gene and PnisA was ligated into the NcoI and SalI sites of pINT1. 
The resulting plasmid was denoted pINT2. This plasmid was checked by sequencing 
using primers VecCombiP1 and VecCombiP4 (Table 3.5). 
 
The nisRK region was amplified using the L. lactis NZ9700 genome as a template 
(Table 3.5; primers: NisRKHindIIIfwd and NisRKBamHIrev). The amplified 
product was then cloned into the BamHI and HindIII sites of pINT2 using the 
infusion method, resulting in pINT3.  
 
Next, using the Infusion system, the region encoding the N-terminal domain of 
SPase713 was amplified from the E. faecium E1162 genome (Table 3.5; primers: 
Sig713fwd and Sig713rev) and then was cloned into the vector pINT3, resulting in 
pINT4. The SPase713 gene is small, being only 551bp and therefore the fragment 
required for the vector is even smaller. Studies with pMUTIN have shown that 150 




bp can be enough for homologous recombination and therefore the insertion of the 
vector into the genome (Vagner et al., 1998). To aid optimal insertion, primers were 
designed, one located 100bp upstream of the start codon of the gene and a second 
primer between the active sites of the spase713 gene, resulting in a 280 bp product. 
The construct made was verified by restriction digests (with NarI and NcoI) and 
sequencing (Table 3.5; primers: SPinsfwd and SPinsrev). Primers used here are 
listed in Table 3.5. The final plasmid is shown in Figure 3.8. 
Figure 3.8. Final integration vector containing the SPase 713 fragment (pINT4). 
ColE1 origin- E. coli origin of replication. AmpR- ampicillin resistance gene. 
Amp prom- ampicillin resistance promoter. nisRK- nisRK genes. CAT- 
chloramphenicol resistance gene. PnisA- nisA promoter. Spase frag- SPase713 
fragment. Restriction sites used are also shown. The map was made with Serial 
cloner 2.1 software. 
 




Table 3.5. Primers used to make the integration plasmid. 
Name Sequence  (5’  to  3’) Reference 
pMUT4NCO1fwd AAAACCATGGTGTGAGTTAGGCATCGCATC This thesis 
pMUT4NCO1rev AAAACCATGGGTGCTGCAAGGCGATTAAGT This thesis 
NisRKHindIIIfwd AAAAAAGCTTTGACTTCTCAGCAGGAGCAA This thesis 
NisRKBamHIrev AAAAGGATCCAACTGCCTTCAATGGCAAAC This thesis 
Sig713fwd GAGGCACTCACCATGGTGTCCAATAGCCTAATTGAAAGAA This thesis 
Sig713rev CTTGCAGCACCCATGGCCATCACAACCATATCACCTTG This thesis 
Sequencing primers: 
VecCombiP1 AATGGTTCGGGGAAATTGTT This thesis 
VecCombiP2 AACAATTTCCCCGAACCATT This thesis 
VecCombiP3 GGATCCCCAGCTTGTTGATA This thesis 
VecCombiP4 AACCGTATTACCGCCTTTGA This thesis 
SPinsfwd TGCCCCGTTAGTTGAAGAAG This thesis 
SPinsrev TTCTACCATCGACACCACCA This thesis 
 
3.4.3 Introduction of pINT4 to E. faecium 
 
Vector pINT4 was used to transform both E. faecium E1162 and TX1330; the latter 
was included as it is easier to transform. As the vector does not contain a Gram-
positive origin of replication, the vector will integrate into the genome by a single 
crossover (Campbell-type integration), in this case at the SPase713 gene. Insertion of 
this vector results in the spase713 promoter being followed by an incomplete copy of 
the spase713 gene (leading to an inactive protein), and a complete copy of the 
spase713 gene that is under control of the PnisA promoter (Figure 3.9).  
 
Before transforming the strains with pINT4, the tolerance of E. faecium E1162 and 
TX1330 to nisin was determined. In both cases they were able to grow in the 




presence of at least 40 µg/ml nisin (maximum concentration tested), which should be 
sufficient to achieve good expression levels. One study suggested that 20 µg/ml was 
the optimal concentration for induction in E. faecalis (Eichenbaum et al., 1998). 
Therefore, following transformation with pINT4, E. faecium cells were grown on 
agar plates with a range of nisin concentrations (0, 1, 2, and 20 µg/ml), and 10 µg/ml 
chloramphenicol for selection of the plasmid. The expectation was that, if the 
SPase713 gene is indeed essential, cells would only be able to grow in the presence 
of nisin.  
 
 
Figure 3.9. Schematic of the genome once the integration has occurred. 
SPase713- Genomic SPase713. SPase- SPase713 fragment. Chl- 
chloramphenicol resistance gene. Em-erythromycin resistance gene. Amp- 
ampicillin resistance gene. Ori- E. coli origin of replication. PnisA- nisA 
promoter. nisRK- nisRK genes. See text for further detail. 
 
Plates were incubated for 48 hours at 37oC and very few colonies (of varying sizes) 
of E. faecium TX1330 were observed both on plates with and without nisin. 
Transformed E. faecium E1162 cells did not result in any colonies. All colonies were 
tested by PCR to establish if the vector had integrated (data not shown). Primers 
used included CmF (found in the chloramphenicol gene) with either TXseqRev 
(Table 3.3) or TX713DwnRev (Table 3.2), found on in or outside of the SPase713 
gene. Both negative controls (using E. faecium TX1330 and the above primers) and 
positive controls (using primers used to amplify the SPase713 fragment) were 
included, and PCR reactions were performed at different temperatures to establish 
the best annealing temperature. Unfortunately, a correct integrant was not identified. 
Due to time constraints, it was also not possible to repeat this experiment.  
 






Using bioinformatics, three possible SPases were found in the genome of E. faecium 
and alignments were performed against B. subtilis SPases. Interestingly it was 
observed that S0713 is likely to be the main SPase for E. faecium, as all the strains 
were highly conserved for this gene. S0133 was also likely to be active for all E. 
faecium strains. Based upon multiple sequence alignments, membrane topology, and 
a phylogenetic tree it also seems likely that SPase1233 is possibly a SipW-type (ER-
type) SPase, although due to the lack of active residues they are likely to inactive. 
Alternatively, these SPases could represent a novel class of enzymes with a different 
catalytic mechanism. SipW is relatively uncommon in other bacteria except Bacillus 
spp. where it has been shown to have differing substrate specificity to the other 
SPases found. It has been linked to involvement in processing spore-associated 
proteins (van Roosmalen et al., 2004, Tjalsma et al., 2000b), but it should be noted 
that enterococci do not produce spores. SipW in B. subtilis has also been shown to be 
required for biofilm formation (Hamon et al., 2004) and it is part of an operon (tapA-
SipW-tasA). Both TasA and TapA are processed by SipW, after which they are 
transported to the extracellular matrix of the biofilm. TasA is major protein 
component in the EPS and it is attached and assembled at the cell wall with the help 
of TapA (Terra et al., 2012). SipW not only functions in the above mechanism but it 
also appears to have a regulatory role in biofilm formation as well (Terra et al., 
2012). Further research is required to establish if this is also the case in enterococci 
and therefore it could be a possible antimicrobial target.  
 
This chapter has illustrated that many proteins (2.3%) and lipoproteins (1.8%) are 
secreted via the Sec-dependent pathway, some of which have already been shown to 
be involved in virulence, but there are also many hypothetical proteins with 
unknown functions. Further studies, both bioinformatics and wet-lab experiments are 
needed to analyse the functions of these proteins. Analysis of E. faecalis V385 
showed that its genome contained 2.7% liproproteins; this is much more than seen 
here for E. faecium (Reffuveille et al., 2011). It is conceivable that it is these extra 
lipoproteins that make E. faecalis more prevalent in hospitals. It was interesting to 




observe that some virulence related genes had paralogues in the genome, which 
included bee-3, a gene that is usually found as a part of a locus in E. faecalis 
responsible for the production of a pilus (see introduction). However, this locus has 
only been identified in 1% of E. faecalis clinical isolates. Although the bee-3 gene is 
present in the E. faecium E1162 genome, the remainder of the locus is absent. The 
function of bee-3 has not as yet been studied in E. faecium (Nallapareddy et al., 
2011a). As mentioned in the introduction E. faecium have a large capacity to gain 
new genetic material. Perhaps in the case of the bee locus most of the locus was lost 
again, due to the fact that E. faecium already has four pilus clusters.  
 
Following a previous study method, which used pTEX5500ts to produce a deletion 
of particular gene (Nallapareddy et al., 2006a); we attempted to produce the SPase 
mutants for all three SPases in E. faecium E1162 and TX1330 (except for S0133TX). 
Other researchers have used this method successfully deleting their required gene 
(Nallapareddy et al., 2006a, Heikens et al., 2007, Hendrickx et al., 2010). In this 
study no mutants were found and there could be two reasons for this. Firstly, it could 
suggest that the genes were all essential for the bacteria and, secondly, some mutants 
are difficult to obtain for various reasons. For example, Nallapareddy et al 
(Nallapareddy et al., 2006a) found only 4 colonies in 5000 containing the correct 
mutation in the gene of interest, and perhaps with analysing more colonies a mutant 
could still be identified.  
 
The inducible integration plasmid was designed as the next logical step, to establish 
whether the genes were essential. Although the integration vector was successfully 
made and a SPase713 fragment inserted into it, time restrictions meant that 
successfully integrating the vector into E. faecium strains were not met and therefore 
studying the control of SPase713 expression was not achieved, this also meant that 
the  vector’s  ability  to  work  was  not  tested. 
Further research work on this section would include continuing to look for mutants 
with insertional inactivation mutagenesis and to test the integration vector. 
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4.1. Background and objectives 
 
Enterococci are emerging pathogens, with many clinical isolates developing 
resistance to antibiotics such as penicillins, glycopeptides (e.g. vancomycin) and 
aminoglycosides. This can make the treatment of enterococcal infections with 
antimicrobials very difficult (Sood et al., 2008). Resistance to antimicrobials can be 
split into intrinsic and acquired resistance. Intrinsic resistance occurs when bacteria 
are inherently resistant to a particular compound, for example because of structural 
features that prevent uptake of the compound, or lack of a target of the compound. In 
contrast, acquired resistance is created by mutations or gain of exogenous DNA, with 
the latter most frequently through genetic mobile elements such as transposons or 
plasmids from  other  bacteria.   In   the  case  of   the  β-lactam ampicillin, both intrinsic 
and acquired resistance has been found in enterococci. The former may due to low 
affinity of enterococcal penicillin-binding   proteins   (PBP)   to   β-lactams, whereas 
acquired (high level) ampicillin resistance is usually due to overproduction of PBP5 
or   mutations   in   this   protein,   or   β-lactamases that are encoded by transferable 
plasmids.  However,   β-lactamases producing enterococci are not often isolated and 
are usually in E. faecalis hospital isolates (Top et al., 2008, Sood et al., 2008).  
In the pharmaceutical industry calorimetry is frequently used to study purity, 
decomposition and also to study the types of interactions that occur between drugs 
i.e. synergic or antagonistic interactions, which can then lead on to being able to 
develop combination therapies for clinical use (Giron, 1986, Vine and Bishop, 
2005). In brief, a calorimeter (Figure 4.1) works by detecting heat flow from the 
sample being tested (within the ampoule) via thermopile arrays on the outside of the 
ampoule. The arrays are kept at a constant temperature as they are in a thermostatic 
water bath that serves as a heat sink. The energy required to keep the temperature 
constant is converted into a voltage signal (Power, µW; von Rege and Sand, 1998).  
Cultures of bacteria produce heat as they metabolise nutrients, and this heat can be 
monitored by calorimetry and provide real-time data on the growth. Thus, 
calorimetry could be used as a tool in the pharmaceutical industry to identify 
bacterial contamination of products, identifying the ideal growth conditions for the 
production of genetically engineered therapeutics, and as a high-throughput 
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screening method to identify effective antimicrobials (Vine and Bishop, 2005). 
Calorimetry has also been used in a clinical setting with a number of studies 
evaluating bacterial growth, such as the analysis of meticillin resistance in 
Staphylococcus aureus (Baldoni et al., 2009, von Ah et al., 2008). Calorimetry can 
also be used to identify bacteria, as each bacterium has a characteristic output signal 
(Beezer, 1980). 
There are two types of calorimetric techniques: batch and continuous flow 
calorimetry (Vine and Bishop, 2005). Batch calorimetry is when the media and 
bacteria to be tested are placed in an enclosed ampoule and measurements of 
temperature change are then recorded. Flow calorimetry is when the bacteria being 
tested are cultured outside the calorimeter, in a water bath kept a constant 
temperature, which is pumped at a continuous flow   rate   through   the   calorimeter’s  
ampoule. This has many advantages over batch calorimetry as the sample is 
continuously stirred reducing sedimentation, also aerobic bacteria can be tested 
(batch calorimetry is a closed system and the environment becomes anaerobic) and, 
more importantly, flow calorimetry allows the addition of  nutrients or antimicrobial 
compounds to the media during testing (Vine and Bishop, 2005). These advantages 
make flow calorimetry the ideal method for these trials. 
 
Figure 4.1. Schematic of the 2277 Thermal activity monitor (TAM; 
Thermometric AB; O'Neill et al., 2003). 




In this chapter the antibiotic resistance of E. faecium strain E1162 was analysed. 
This is a single clonal lineage of the Complex 17 (CC17), a clinical blood isolate that 
causes many hospital outbreaks (Heikens et al., 2007). The strain is resistant to 
ampicillin and contains the gene encoding the enterococcal surface protein Esp. The 
resistance of this strain was compared to that of E. faecium E1162Δesp, an esp 
deletion mutant of E1162 (Heikens et al., 2007), and E. faecium TX1330, an 
ampicillin sensitive and esp negative strain that was isolated from a healthy 
individual (Nallapareddy et al., 2003). The initial objective of this study was to test 
the use of isothermal calorimetry as a tool to measure antibiotic resistance, and to 
compare this with traditional methods such as the disc susceptibility and minimal 
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4.2. Traditional antimicrobial susceptibility tests. 
 
Disc susceptibility tests with ampicillin showed small clearing zones with E. faecium 
E1162 and E1162esp, demonstrating its resistance to ampicillin, while a larger 
zone of inhibition was observed around the disc on E. faecium TX1330 cells (Table 
4.1).  
 
As determined by microbroth dilution, both E. faecium E1162 and E1162esp have 
an MIC of 32 µg/ml, while MIC Evaluator strips showed a lower MIC at 16 µg/ml. 
Corroborating the disk tests, the control strain E. faecium TX1330 showed a higher 
sensitivity to ampicillin with an MIC of 4 µg/ml as determined by microbroth 
dilution or 0.75 µg/ml as determined by the MIC Evaluator strip (Figure 4.2). Using 
the standard antimicrobial susceptibility tests, it is therefore clear that the different 
methods (broth dilution, disc susceptibility, and MIC Evaluator strips; Table 4.1) do 
not show a difference between E. faecium E1162 and E1162esp strains. 
 
Figure 4.2. Representative images of the MIC Evalulator strip results. A. 










4.3.1. Optimisation of the method 
 
Initial tests showed that calorimetry is a very sensitive method that led to variation in 
curves obtained. Effects could be observed, for instance, from using different batches 
of media preparations or the length of time ampicillin was stored (data not shown). 
For consistency, one large batch of culture medium was prepared that was frozen and 
defrosted one day before use, while ampicillin was prepared fresh every week.  
 
4.3.2 Control curves 
 
As bacteria grow and metabolise nutrients in the broth, more heat is produced, which 
was recorded by the calorimeter as power-time (P-t) curves. P-t curves in the absence 
of antibiotics for E. faecium E1162, E. faecium E1162Δesp and E. faecium TX1330 
are shown in Figure 4.3A. As the bacteria metabolise nutrients in the media and 
multiply, the amount of heat (measured in µWatt) increases. The peaks and troughs 
observed are probably due to the sequential use of nutrient sources in the complex 
culture medium (O'Neill et al., 2003), which emphasises the importance of keeping 
the media contents consistent. With all three strains, three distinct peaks were 
observed at similar times and with similar heat outputs, implying that they 
metabolise the medium in a similar way. E. faecium strain TX1330 has a slightly 
different growth curve, probably due to it being a different isolate of E. faecium than 
the other two strains. The fact that E. faecium E1162  and  E1162Δesp display nearly 
identical P-t curves suggests that Esp does not have an effect on metabolism. 
 
4.3.3 Effect of ampicillin on P-t curves 
 
To test the effect of ampicillin on the three strains, a final concentration of 64 µg/ml 
was added when the cultures reached 10 µW (Figure 4.3B), which was equivalent to 
approximately 1.2 x 105 cfu/ml. The concentration chosen was double the MIC of the 
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E. faecium E1162  and  E1162Δesp strains, but still half the value MBC, thus ensuring 
a strong response without killing all the cells immediately. As expected, E. faecium 
E1162 responded differently to the addition of ampicillin compared to the control 
strain E. faecium TX1330. Whereas the maximum output of the E1162 strain reached 
36 µW, the heat output from the TX1330 strain, which has an MBC of only 8 µg/ml, 
almost immediately stopped after addition of ampicillin, reaching a maximum of 
only 12 µW.  
 
Unexpectedly, the addition of ampicillin to E. faecium E1162Δesp resulted in a 
consistently lower heat output than E1162, with an average peak value of 24 µW 
(Figure 4.3B; Table 4.1). Consequently the output of the strain lacking Esp was only 
64% of that of its parental strain, this was an unexpected result as the traditional 
antimicrobial susceptibility tests showed no difference in MIC between E. faecium 
E1162 and its esp mutant. 
 
Similar results were obtained when a lower ampicillin concentration of 32 µg/ml was 
added during testing (data not shown). Under those conditions, the maximum output 
of the E. faecium E1162 strain was considerably higher (maximal peak value around 
90 µW). However, these data were less reproducible, probably because the 
concentration of ampicillin was close to the MIC. However, a significant difference 
between E. faecium E1162  and  E1162Δesp was still observed, with the output of the 
latter being, on average, 50-60% lower (data not shown).  
 




Figure 4.3. Response of E. faecium cultures to addition of ampicillin. 
Representative Power-time   curves   for  E1162   (blue   line),   E1162∆esp (red line) 
and TX1330 (green line). A. Control conditions in the absence of ampicillin. B. 
64µg/ml ampicillin was added when cultures reached an output of 10µW 
(shown by the black arrow). 
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Table 4.1. Response of E. faecium strains to ampicillin using different test 
methods. 
 MIC  MBC  Isothermal 
Calorimetry  












height (µW)1,2  
E1162  32  1.5  16  128  36 ± 4.4 
E1162Δesp   32  1.5  16  128  23 ± 1.5 
TX1130  4  10  0.75  8  12  
 
1 From an average of three measurements, with the exception of E. faecium TX1330 
(n=1). 
2 Standard deviation stated 
 
 
4.4. MIC, broth dilution method using stepwise concentrations for 
ampicillin. 
 
Although there was no difference in ampicillin resistance using the standard broth 
dilution method (which uses doubling concentrations), it was decided to determine 
the MIC using a narrower range of concentrations, which in this case was between 
16 and 32 µg/ml. This method is somewhat more laborious and would not be 
realistic to be performed in a clinical setting, but was performed to see if a difference 
between E. faecium E1162   and   E1162∆esp could be observed. This method was 
indeed sensitive enough to observe a difference: E. faecium E1162 gave an MIC 
value of 22 µg/ml, while the MIC for E. faecium E1162∆esp was 18 µg/ml (Table 
4.2).  
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Adjacent to the esp gene is a gene encoding EbrB, which has recently been shown to 
be a regulator that controls expression of esp (see chapter 5 for more details; 
personal communication, Dr Janetta Top). It was therefore of interest to test whether 
an EbrB mutant was also more sensitive to ampicillin as shown above for the esp 
mutant. To this end we compared sensitivity of E. faecium E1162, with E. faecium 
E1162ebrB (kindly provided by J Top) containing either pAT18 (empty vector) or 
pAT18ebrB (expressing ebrB). In the E. faecium E1162 ebrB mutant, ebrB is 
disrupted by a chloramphenicol gene leading to a lack of expression of Esp (J. Top, 
unpublished data). Strikingly, it was also shown that EbrB does not only affect Esp 
but also a number of other genes including the NADH oxidase Nox, a putative 
muramidase, a hypothetical protein, and a drug resistance transporter (EmrB/QacA). 
Ampicillin sensitivity was tested using the stepwise method and, similar to the E. 
faecium E1162 esp mutant, inactivation of ebrB lead to an increased sensitivity (MIC 
18 µg/ml; Table 4.2). Presence of pAT18ebrB, but not the empty vector, partially 
restored ampicillin resistance (Table 4.2).  
 
4.5. Minimum inhibitory concentrations (MICs) for SDS 
 
Esp is a protein anchored to the cell wall, and the difference in ampicillin sensitivity 
could be due to a difference in cell wall integrity in the strains with and without Esp. 
If   so,   E1162Δesp cells would be expected to be more sensitive to cell lysis. To 
establish this hypothesis, sensitivity to the detergent SDS was determined using a 
standard broth dilution method. For both strains the MIC for SDS was however the 
same (0.0156%), suggesting that there was no difference in cell wall integrity. Other 
detergents were also tested, i.e. Triton X100 and bile salts. However, MIC values 
were not determined for these as E. faecium appeared to be very resistant to these 
(MIC for bile salts >50%, MIC for Triton X100 >1%).    
 
As a difference was seen for ampicillin using the stepwise broth dilution method it 
was decided to test this for SDS as well using a range between 0.0156% and 
0.0078%.  No  difference  was   seen  between  E1162  and  E1162∆esp, with their MIC 
value being 0.0137%. 




4.6. MIC, broth dilution and broth dilution using stepwise 
concentrations for Vancomycin. 
 
Ampicillin is an antibiotic that inhibits transpeptidase, which is involved in synthesis 
of the cell wall, and it was decided to test another antibiotic that also acts on the cell 
wall. Vancomycin was chosen, which is an antibiotic that binds to the terminal D-
Ala-D-Ala residues in the cell wall peptide chains (Gholizadeh and Courvalin, 
2000). A normal MIC using broth dilution was performed using vancomycin on the 
E. faecium strains, which gave an MIC value of 2 µg/ml (standard method) or 1.2 
µg/ml (stepwise method) for both strains (Table 4.2).  
 
Table 4.2. MIC values of E. faecium strains to ampicillin, SDS and vancomycin. 
 MIC: Broth dilution  






22  18  18  20  18  
SDS (%)  0.0137  0.0137  -  -  -  
Vancomycin 
(µg/ml)  














Initially when testing calorimetry as a method to monitor bacterial growth, it was 
surprising to discover how sensitive this was to small differences in culture 
conditions. Calorimetry has been used previously to differentiate between growing 
cultures of meticillin-susceptible and meticillin-resistant S. aureus; it was able to do 
this in 4-5 hours while standard methods take 24 hours, showing it to be a rapid 
method (von Ah et al., 2008, Baldoni et al., 2009). Calorimetry tests using E. 
faecium E1162 (ampicillin resistant) and TX1330 (ampicillin sensitive) have 
illustrated that differentiation and resistance to ampicillin can be shown in hours by 
calorimeter, which is a significant improvement over traditional methods used here, 
some that can take days. Calorimetry also showed the unexpected difference between 
the resistance of E. faecium E1162   and  E1162Δesp, which was not observed with 
traditional antimicrobial resistance tests. This illustrates that calorimetry is a 
sensitive and fast method. When the MIC value was studied more closely using the 
broth dilution method in a stepwise manner, a difference could be observed, but this 
method is more laborious than the standard method. Calorimetry in the setup used 
here is also rather laborious and limited by the number of samples that can be tested 
at once, but this could be improved by automation. Chip calorimeters are now widely 
used, with samples set up in 96 well plates that only require small quantities and 
enable the testing of many samples at once (Braissant et al., 2010). There are some 
automated antimicrobial susceptibility testing systems on the market such as Vitek2, 
MicroScan Walk-away and Phoenix. These systems work on a broth based methods 
i.e. the isolate is diluted to a specific optical density; it is then used to inoculate cards 
or 96 well plates containing various antibiotics at different concentrations. The result 
times once tests are setup are 9, 20 and 12 hours respectively, illustrating again the 
speed of calorimetry (Sellenriek et al., 2005). There are also genotypic methods, 
using PCR and DNA hybridization as a bases, which can be used to identify 
resistance genes in isolates (Fluit et al., 2001), but these methods do involve more 
preparation (DNA isolation) and can be time consuming. One other big advantage 
that calorimetry has over these other methods is that it is being adapted for use into 
studying biofilms. Biofilms are grown within the ampoule and then treatments 
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against the biofilms can be tested to establish efficient removal, this can be used for 
industrial problems or clinical problems by testing antibiotics (Buchholz et al., 
2010b). 
 
It was interesting to note that the difference in sensitivity between E1162 and 
E1162Δesp was only observed with ampicillin, but not with another antibiotic that 
acts   on   the   cell   wall   (vancomycin),   or   a   detergent   (SDS).   β-lactams (such as 
ampicillin) act by inhibiting the carboxy/transpeptidase or penicillin-binding 
proteins, which are involved in the late stages of peptidoglycan biosynthesis during 
peptide cross-linking. Glycopeptides (such as vancomycin) act on a different stage of 
the cell wall synthesis; they inhibit the peptidoglycan precursors from inserting into 
the cell wall by the transglycosylase enzyme through binding to the D-alanyl-D-
alanine residue on the precursor (Denyer et al., 2004). It is conceivable that the lack 
of differences in sensitivity with vancomycin could be related to the differences in 
mode of action of these antibiotics, but further testing is required to investigate this. 
The role of Esp in this is unclear at present. As it is a large cell-wall protein it was 
thought that the lack of Esp could cause instability in the cell wall and, if that is the 
case, it would be expected that cells lacking Esp would be more sensitive to SDS 
(which disrupts the cell membrane), however, as previously noted, this was not 
observed. Esp has been connected to several different processes in enterococci, 
including initial adherence, colonisation (Shankar et al., 2001) and biofilm formation 
(Tendolkar et al., 2004, Heikens et al., 2007). Our findings suggest that Esp could 
also have a role in ampicillin sensitivity, but in view of the many potential roles that 
Esp may have, it is conceivable that the effects we observe are indirect. More 
generally, we showed that isothermal calorimetry is a method far more sensitive than 
traditional methods for analysing susceptibility to antibiotics. The method is also 
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5.1. Background and objectives 
 
Enterococci are commonly found in the intestine, which is a hostile environment 
with varying conditions (pH, oxygen levels), bile acids, digestive enzymes, or toxins 
from other bacteria (Wilson et al., 2002).  
 
Bile is produced in the body to help metabolise lipids found in food in the 
gastrointestinal tract (GI tract), by emulsifying and solubilising them. There are 
several components in bile which include: sodium, potassium, chloride, cholesterol, 
phospholipids and bile acids. Bile acids are one of the main constituents providing 
50% of the organic compounds of bile (Begley et al., 2005). They are a water-
soluble group of steroids that can be strongly cytotoxic, as they are able to 
permeabilise membranes (Jenkins, 2008). Therefore bile is considered to also help 
the body by being a bactericidal agent (Merritt and Donaldson, 2009). Bile acids are 
usually present at physiological concentrations of between 0.2-2% in the small 
intestine (Hofmann, 1998).  
 
The enterohepatic circulation is the means by which cholesterol in the liver is 
converted to bile acids for the use in the body and is summarised in Figure 5.1 
(Begley et al., 2005). Cholic acid and chenodeoxycholic acid (primary bile acids) 
made from cholesterol in the liver are usually conjugated with taurine (sodium 
taurocholate) or glycine (sodium glycocholate), which makes these compounds more 
soluble in aqueous solutions. This conjugation allows the bile acids to increase in 
concentration in the lumen of the small intestine, as it reduces their membrane 
permeability and helps the formation of micelles, which allows the emulsification 
and absorption of lipids. In the lower intestine (caecum and colon) these conjugated 
bile acids can be cleaved by bacterial enzymes into free bile acids (secondary bile 
acids) such as deoxycholic acids (Jenkins, 2008) these are then readily reabsorbed 
and transported to the liver for recycling, where they are reconjugated and stored in 
the gallbladder until required for the next meal. This cycle can occur 10 times a day 
and is 95% efficient at recycling the bile acids (Begley et al., 2005, Jenkins, 2008).  
 
 




Figure 5.1. Simplified version of the enterohepatic circulation. (Jenkins, 2008, 
Begley et al., 2005) 
 
Some bacteria have become well adapted to survive in the presence of bile salts. 
Several factors involved in bile resistance have been identified. These include, in the 
case of Gram negative bacteria, the lipopolysaccharide (LPS) which has been shown 
to aid resistance by merely providing an extra barrier, and Tol proteins, which are 
outer membrane pore proteins that are important for membrane integrity and stop 
bile access (Begley et al., 2005, Gunn, 2000). Furthermore, both Gram negative and 
Gram positive bacteria contain efflux pumps, which are the best characterized 
method of removing bile from the cytoplasm (Thanassi et al., 1997, Pumbwe et al., 
2007). Finally, several bacteria contain bile salt hydrolases, which are generally 
intracellular enzymes used by the intestinal microflora (including enterococci) to 
deconjugate the bile salts; they are not normally found in pathogenic species, with 
the exception of L. monocytogenes (Dussurget et al., 2002). Their significance is not 
fully understood, but there are three main theories: (i) deconjugation provides 
additional nutrients; (ii) deconjugation adds cholesterol or bile into their cell 
membranes which can then help them evade the host defence; or (iii) deconjugation 
has a role in bile tolerance. The evidence is conflicting, but there are clear examples 
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were deletion of the genes encoding these hydrolases to give rise to bile sensitive 
mutants (Begley et al., 2005).  
 
As well as having mechanisms to cope with the presence of bile, some pathogens 
also use bile as a trigger to activate or suppress virulence factors as a sensor for 
being in the right place for invasion or colonisation of the host. The most widely 
studied are enteric pathogens. For instance, Salmonella typhimurium down-regulates 
its type III secretion system until the bile concentration has decreased, which usually 
occurs when it has passed through the mucus layer and is at the epithelial cell surface 
(Prouty and Gunn, 2000). In Shigella spp. researchers have observed an increase in 
secretion of invasion plasmid antigens (Ipa), proteins that are involved in increased 
attachment to HeLa cells in the presence of bile (Pope et al., 1995).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
 
Here we analysed the effect of bile salts on biofilm formation in E. faecium strains, 
with a particular focus on E. faecium E1162, which is a clinical isolate and CC17 
clonal strain. 
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5.2. Optimising the crystal violet biofilm assay for Enterococci 
 
The assay for biofilm formation of E. faecium isolates was initially tested to optimise 
the procedure and obtain reliable and consistent results. Several factors were tested, 
including the composition of the media, growth of biofilms in the wells of 96-well 
plates or on pegs, the length of incubation, method of shaking (speed and horizontal 
vs. 3D rotator), and the number of washing steps. The optimal method involved 24 
hour biofilm growth in 96 well plates, shaken on a 3D rotator (data not shown), 
using TSB medium containing 0.25% glucose. Details of the method are given in the 
Materials and Methods section.  
 
5.3. Control biofilm assays for the E. faecium isolates 
 
Initial tests were performed using the crystal violet biofilm assay to confirm that, as 
previously noted (Heikens et al., 2007), E. faecium E1162Δesp produces 
approximately 50% less biofilm than the parental strain (Figure 5.1A). The 
difference was shown to be significant using a Student T-test (p<0.0001). As shown 
before (Nallapareddy et al., 2003), E. faecium TX1330 was a relatively poor biofilm 
former; the amount of biofilm formed was similar or slightly less than formed by E. 
faecium E1162Δesp.  
 
5.4. Hydrophobicity testing for the E. faecium isolates 
 
An important factor in biofilm formation on a surface such as polystyrene is 
hydrophobicity of the bacteria, with hydrophobic cells adhering better (Donlan, 
2002). It was tested whether the lack of Esp and the concomitant reduced ability to 
form biofilms was due to reduced hydrophobicity. This appeared to be the case as 
shown in Fig 5.1 B, with E. faecium E1162 being significantly more hydrophobic 
than E1162Δesp (p<0.0001) and TX1330 (p<0.0001). These results corroborate 
similar findings for E. faecalis (Tendolkar et al., 2004), in which mutants lacking 
Esp are also less hydrophobic. 




Figure 5.2. Biofilm assay and hydrophobicity results for the E. faecium isolates. 
(A) Biofilm formation and (B) Hydrophobicity. The error bars represent the 
mean ± the standard error. *** P<0.0001 
 
5.5. The effect of bile salts on E. faecium. 
 
Prior to performing tests with bile salts an MIC test and growth curves were 
performed for each isolate. All strains were shown to be resistant to bile salts when 
grown in concentrations up to 50% (data not shown). Growth curves did show that in 
the presence of bile salts there was an increase in doubling time from approximately 
36 minutes to 60 minutes (Table 5.1). The optical densities taken after overnight 
culture were the same for all E. faecium strains and therefore unaffected by the 
presence of up to 5%.   




Table 5.1. Average growth rates in the presence and absence of bile salts 
 
 
It was observed that chains of cells were, on average, longer in the presence of bile 
salts (Table 5.2). In the absence of bile, E. faecium cells usually appear as pairs, but 
when bile is present this increases to 4-20 cells per chain (Figure 5.3).  
 
Table 5.2. Average chain length in the absence and presence of 0.5% bile salts. 
 
 




Figure 5.3. Light microscopy images of E. faecium isolates: E1162 (A and B), 
E1162∆esp (C and D) and TX1330 (E and F) in the presence and absence of 
0.5% bile salts. 
 
 




5.6. The effect of bile salts on E. faecium biofilm formation. 
 
The effect of the bile salts on 24 hour biofilm formation in E. faecium strains E1162, 
E1162Δesp and TX1330 is shown in Figure 5.4A. Interestingly, at increasing levels 
of bile salts all three strains formed significantly more biofilm, with the best biofilms 
observed at bile concentrations between 0.5 and 1.5% for E1126 and TX1330. 
Strikingly, this concentration is similar to the approximate physiological 
concentration in the small intestine (Hofmann, 1998).  For E1162Δesp the range of 
bile salt concentrations at which it forms better biofilms was more narrow, with 
maximum values observed at 0.5%. Higher concentrations of bile (above 2-3%) were 
detrimental to biofilm formation, with all strains forming biofilms very poorly at 5%. 
For biofilms grown for 48 hours, similar results were observed (Figure 5.4B). 
However, for E1162Δesp and TX1330 the maximum biofilm formation is 
significantly higher than that seen for 24 hours, about 1.3 and 2 fold more at 0.5% 
bile salts, respectively.  




Figure 5.4. Biofilm formation in the presence of bile salts for 24 hours (A) or 48 
hours (B). With the latter fresh media was provided after 24 hours. The error 
bars represent the mean ± the standard error. 
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5.7. Biofilm formation in the presence of other detergents 
 
Bile salts function as detergents, and it was therefore important to test whether other 
detergents had similar effects. To that purpose, biofilm assays were also performed 
in the presence of non-inhibitory concentrations of SDS (0.00975% to 0.03%) and 
Triton X100 (0.01% to 1%). However, neither of these stimulated biofilm formation 
(see appendix A.1), showing that the effects of bile salt are specific and not due to 
their detergent-like nature. 
 
5.8. Biofilm formation in the presence of sodium glycocholate, sodium 
taurocholate and a 1:1 mix of the two. 
 
Bile salts contain mostly sodium taurocholate and sodium glycocholate. To 
investigate whether either of these components is important in the stimulation of 
biofilm formation, assays were performed in the presence sodium taurocholate, 
sodium glycocholate and a 1:1 mixture of the two. Sodium glycocholate did not 
stimulate biofilm formation in the three strains (Figure 5.5A). In contrast, sodium 
taurocholate clearly stimulated biofilm formation in E. faecium E1162, but not in 
E1162Δesp or TX1330 (Figure 5.5B). Maximum biofilm formation by E1162 was 
found at 0.5% sodium taurocholate. The increase was less than with bile salts but 
still approximately 2-fold more than in the absence of sodium taurocholate. 
Interestingly, when a 1:1 mixture of sodium glycocholate and sodium taurocholate 
was used, E. faecium E1162 formed biofilms to a level similar to that observed when 
using crude bile salts (Figure 5.5C). This indicated that a mixture of the two salts is 
necessary for maximum biofilm formation. Surprisingly, the 
taurocholate/glycocholate mixture did not stimulate biofilm formation in either 
E1162Δesp or TX1330, suggesting that the crude bile salts used before still contain 
other components that stimulate biofilm formation in these strains. 
 
 




Figure 5.5. Biofilm assays in the presence of (A) sodium glycocholate, (B) 
sodium taurocholate, and (C) Sodium taurocholate: Sodium glycocholate (1:1). 
The error bars represent the mean ± the standard error.
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5.9. Effect of bile salts on hydrophobicity. 
 
As shown before, hydrophobicity is an important factor in biofilm formation. It was 
therefore tested whether the effects of bile salts on biofilm formation was due to 
increased hydrophobicity. Surprisingly, in the presence of bile salts there was 
actually a slight decrease in hydrophobicity for both E. faecium E1162 and 
E1162Δesp, but this decrease was statistically not significant (p>0.086 and p>0.511 
respectively; Figure 5.6). Thus, the improved biofilm formation in the presence of 
0.5-1.5% bile salts is clearly not caused by an increase in hydrophobicity. Similarly, 
there was also no effect on hydrophobicity of cells when grown in the presence of 
sodium taurocholate or glycocholate (data not shown). 
 
 
Figure 5.6. Hydrophobicity in the presence of bile salts. (A) E. faecium E1162 
and (B) E.  faecium E1162Δesp. The error bars represent the mean ± the 
standard error. 
 
5.10. Effect of bile salts on initial attachment. 
 
The first step in biofilm formation is direct attachment of cells to a surface, and we 
tested whether it was this stage that was stimulated by bile salts. To analyse this, 
attachment of cells was measured after 2, 4 and 6 hours in the presence or absence of 
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bile salts. Initial attachment after 2 and 4 hours showed no significant increase in 
attachment due to the presence of bile salts in E. faecium E1162 (Figure 5.7A). After 
4 hours, a 2-fold increase in attachment could be observed comparing 0% with 1.5% 
bile salts, while after 6 hours (a stage at which microcolonies start to form) that 
difference was 3-fold. These differences were not observed in 0.5% bile salts. 
Similar trends were observed with E1162Δesp (Figure 5.7B) and TX1330 (Figure 
5.6C), although with these strains the effect was the strongest in 0.5% bile salts. 
With E. faecium TX1330 a significant increase in attachment was only observed 
after 6 hours. From the results it is also clear that the lack of Esp affects initial 
attachment, which has been established previously (Heikens et al., 2007).  
 
Figure 5.7. Initial attachment in the presence of bile salts for the E. faecium 
isolates. (A) E. faecium E1162;;  (B)  E1162Δesp; and (C) TX1330. The error bars 
represent the mean ± the standard error. ** P<0.005. 
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5.11. Effects of the pH and bile salts on biofilm formation 
 
In the GI tract it is not only the concentration of bile salts that changes, but also the 
pH. For instance, the pH in the small intestine is about 6, while that gradually 
increases to pH 8.5 in the distal part of the large intestine (Khan et al., 1999). We 
therefore analysed the effects of the pH on biofilm formation and combined this with 
the studies on the effects of bile salts. As shown in Figure 5.8, at pH 6 both E. 
faecium E1162 and E1162Δesp produced slightly more biofilm (but not 
significantly) compared to pH 7. In contrast, there was a significant (p<0.01) 
decrease in biofilm formation when grown at pH 8 or 8.5. With increasing 
concentrations of bile salts, E. faecium E1162 forms similar amounts of biofilm at 
pH 6 or 7. However, with an alkaline pH biofilm formation is largely inhibited, even 
in the presence of bile salts, showing only a slight increase in biofilm formation 
around 0.5% to 1%. Interestingly, in the presence of 0.5% bile salts E. faecium 
E1162Δesp forms significantly (p<0.05) better biofilms at pH 6 compared to pH 7. 
Again, an alkaline pH appears to inhibit biofilm formation. Hydrophobicity was also 
tested for both strains at the different pH values, but no difference was observed 
(data not shown). 
 




Figure 5.8. Biofilm formation at different pH and in the presence of bile salts. 
(A) E. faecium E1162  and  (B)  E1162Δesp. The error bars represent the mean ± 
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5.12. Ebr biofilm assay in the presence of bile salts. 
 
The expression of the esp gene is regulated by the activator ebrB, a enterococcal 
biofilm regulator gene that also controls other genes, including those encoding 
NADH oxidase Nox, a putative muramidase, a hypothetical protein, and a drug 
resistance transporter (EmrB/QacA). The ebrB gene is located adjacent to the esp 
gene in the genome of E. faecium E1162 on ICEEfm1, a integrative conjugative 
element (See figure 5.9; Janetta Top, personal communication). E. faecium 
E1162ΔebrB, as well as E1162ΔebrB containing a vector expressing ebrB (pAT-
ebrB) and E1162ΔebrB containing the empty vector (pAT18) were kindly provided 
by Janetta Top for biofilm testing in the presence and absence of bile salts. 
 
As shown in Figure 5.10, E. faecium E1162 produces significantly more biofilm 
compared to E1162ΔebrB, both with and without bile salts, similar to what has been 
observed with E1162Δesp. In E. faecium E1162ΔebrB (pAT-ebrB) biofilm formation 
was fully restored while, as expected, this was not the case with the strain containing 
the empty control plasmid (pAT18). In E1162ΔebrB (pAT-ebrB) biofilm formation 
even appeared to be higher than the wild-type strain, which was possibly due to 
increased levels of EbrB when its gene is expressed from the plasmid.  
 
Figure 5.9. Schematic of the section of the ICEEfm1 containing the ebrB gene 
and the other genes it controls. h- represents hypothetical protein. drt- drug 
resistance transporter. 




Figure 5.10. Biofilm formation in the presence of bile salts for E. faecium E1162, 
E1162ΔebrB,   E1162ΔebrB (pAT18)   and   E1162ΔebrB (pAT-ebrB). The error 
bars represent the mean ± the standard error. 
 
5.13. Confocal Laser Scanning Microscopy (CLSM) images of biofilms 
in the presence of bile salts for E1162. 
 
To visualise the biofilms formed in the presence or absence of bile salt, biofilms 
were grown on polyvinyl coverslips and analysed with Confocal Laser Scanning 
Microscopy. Polyvinyl coverslips were used as they have no autofluorescence, 
unlike polystyrene coverslips. Importantly, biofilms form equally well on 
polystyrene and polyvinyl (data not shown). Bacteria were stained with BacLight or 
acridine orange. BacLight shows living bacteria as green and dead bacteria as red 
and acridine orange only stains all cells green. 
 
As shown in Figure 5.11, in the presence of 0.5% or 1.5% bile salts there are 
considerably more cells in the biofilms when compared those grown in the absence 
of bile salts, while also the maximum thickness of the biofilms increased in the 
Chapter 5: Results section III 
 
 114 
presence of bile salts. The images also confirmed that in the presence of 5% bile salts 




Figure 5.11. CLSM images of E1162 stained with BacLight. Biofilms were 
grown in TSB-G over 72 hours (with fresh media every 24 hours) containing 











Table 5.3. Maximum thickness and biomass ± standard error for E. faecium 
E1162, defined using COMSTAT2 software (Heydorn et al., 2000). 
E1162 TSB-G only TSB-G containing 
0.5% bile salts 
TSB-G containing 
1.5% bile salts. 
Maximum 
thickness 
6.3µm ±1.3  17.3µm±1.5 **   18µm±1.6 * 
Biomass 
(µm3/µm2) 
0.5 ± 0.2 3.0 ± 0.3 *  3.9 ± 0.1 * 
** P <0.005, * P<0.05. 
 
Frequently observed in biofilms grown in the presence of 0.5% or 1.5% bile salts 
(but not with 5%) were voids in the image (examples are shown in Figure 5.12). 
These were most likely aggregates of bile salt micelles, which have been observed 
previously in many different shapes such as circles, discs, rods, worm-like or even 
irregular. These shapes were shown to depend on the size of the bile salt molecule, 
the mixture of bile involved and the other components in the media (Jenkins, 2008, 
Partay et al., 2007, Fini et al., 2002). 
 




Figure 5.12. Examples of CLSM images showing the different types of bile salt 
aggregates observed during imaging. Cells were stained with Baclight. A. 
Circular shaped, B. Rod shaped. Scale bar represents 20µm. 
 
5.14. Confocal Laser Scanning microscopy images of biofilms in the 
presence of bile salts for E. faecium E1162Δesp and TX1330. 
 
A number of biofilm images were also taken for E. faecium E1162Δesp and TX1330 
(Figure 5.13). In the conditions used (24 hour biofilms), E1162Δesp showed no 
increase in biofilm formation in the presence of 0.5% bile salts, which was in 
contrast to what was observed with the crystal violet assay at this concentration. 
Conversely, E. faecium TX1330 showed a clear increase in biofilm formation in the 
presence of 0.5% bile salts using this method, as evident by the images (compare 
Figure 5.13C and D) and also the maximum thickness, increasing from 4 µm in the 
absence of bile to 26 µm in the presence of bile. Although the maximum thickness is 
larger than seen with the E. faecium E1162 (Section 5.11) under the same condition, 
it is important to note that this is a single data point and not an average form the total 
biofilm in the image. The biofilm for E. faecium E1162 appears denser and of a more 
even thickness compared to the biofilms formed by E. faecium TX1330. 
 




Figure 5.13. CLSM biofilm formation images for E. faecium E1162Δesp: (A) 
TSB-G; and (B) TSB-G containing 0.5% bile salts with side view. Biofilm 
images for E. faecium TX1330: (C) TSB-G and (D) TSB-G containing 0.5% bile 
salts with side view. Cells were stained with BacLight. Scale bar represents 
20µm. 
 
5.15. CLSM images using calcofluor white staining of E1162 biofilms. 
 
Extracellular polymeric substances (EPS) surrounds the bacteria that have attached 
to the surface, aiding stability and structural scaffolding; it usually contains many 
polysaccharides, lipids, nucleic acids and proteins that help in further attachment to 
the surface and cell-cell attachment (Abee et al., 2011). Calcofluor white stain can be 
used detect EPS in biofilms by attaching to the β-1,4   and   β-1,3 polysaccharides 
present (Chen et al., 2007). As shown in Figure 5.14, biofilms of E. faecium E1162 
were stained with both calcofluor white (blue) and acridine orange to stain bacterial 
cells present. Comparing the images it is observed that in the presence of bile salts 
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there is more calcofluor white staining (blue; figure 5.14E) than seen in the absence 
of bile salts (Figure 5.14B), suggesting the presence of bile is stimulating EPS 
production. In the presence of bile salts also some blue-staining patches are observed 
(see e.g. Figure 5.14 E and F). These could be micelle aggregates of bile salts but 
that needs further confirmation. These patches were not observed in the absence of 
biofilm (data not shown). 
 
 
Figure 5.14. Representative CLSM images of E1162 biofilms grown in the 
absence (A, B, C) and presence of bile salts (D, E, F). Acridine orange staining 
of bacteria shown in green (A and D), calcofluor white staining of EPS shown in 
blue (B and E), and an overlay of both (C and F). Scale bar represents 20µm. 
 
5.16. Analysis of microcolony formation 
 
Microcolonies are aggregates of cells that can mature into large biofilms (Davey and 
O'Toole G, 2000). Initial attachment assays (see section 5.8) showed a sharp increase 
in attachment at 6 hours. To analyse whether it was at this stage that microcolonies 
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of E. faecium E1162 were forming,  the initial attachment test was performed on 
vinyl coverslips in order to visualise the attached cells. It can be observed that when 
no bile salts are present (Figure 5.15A), bacteria are attaching to the surface in pairs 
and that these pairs are starting to clump together.  When bile salts are present 
(Figure 5.15B) we can see attachment of chains of bacteria on the surface and, that 
some of these chains are starting to clump.  
 
Figure 5.15. E. faecium E1162 attachment CLSM images after 6 hour 
incubation, stained with acridine orange. (A) Cells grown in TSB-G and (B) 
cells grown in TSB-G containing 0.5% bile salts. Scale bar represents 20µm. 
 
5.17. Effect of iron limitation on biofilm formation 
 
Iron limitation is another stress factor that enterococci will encounter in the GI tract 
and so it was also studied to see if it affected biofilm formation on the E. faecium 
strains. In previous studies on E. coli the iron chelator used was 2,2-dipyridyl (at 
0.5mM) to decrease iron presence in the media, and a positive control restoring iron 
depletion in the media was also tested by adding 40mM ammonium ferric sulphate 
(Alves et al., 2010, Wise et al., 2002). As a control, biofilms of E.coli strains JM109 
and   DH5α   were   grown,   which   showed   the   expected   decrease   observed   in   the 
presence of the iron chelator (Figure 5.16A; Wu and Outten, 2009, Alves et al., 
2010). The E. faecium strains were then tested, and the results are shown in figure 
5.16B E. faecium E1162∆esp and TX1330 a small decrease was observed, but this 
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was statistically not significant (p>0.5 and p>0.1 respectively).  In contrast, biofilms 
of E. faecium E1162 significantly decrease in the presence of the chelator does show 
a significant decrease (p<0.006).  All strains show biofilm restoration when 
ammonium ferric sulphate is added to the media, to restore iron levels. In fact, E. 
faecium E1162∆esp and TX1330 show slightly better biofilm formation, but this 
increase is not significantly.  
 
 
Figure 5.16. Effect of iron limitation on E. coli biofilm formation (A) and E. 
faecium (B). Conditions include: TSB-G, TSB-G containing 0.5mM 2,2-
dipyridyl (Dipyl) and TSB-G containing Dipyl and 40mM ammonium ferric 









In the present study we demonstrate that biofilm formation by E. faecium is induced 
by the presence of bile. Induction of biofilm formation by bile has also been found 
for several other bacteria, such as with the gastrointestinal commensals Bacteroides 
fragilis (Pumbwe et al., 2007) and Lactobacillus rhamnosus (Lebeer et al., 2007), 
and the pathogens Salmonella typhimurium (Prouty et al., 2002) and Listeria 
monocytogenes (Begley et al., 2009). It was interesting to note that induction of 
biofilm formation by E. faecium was optimal at the concentrations of bile that are 
found in the small intestine. This indicates that, similar to other bacteria (Gunn, 
2000), E. faecium may use bile as an environmental trigger to determine the location 
in the body and maximise the ability to colonise the gut. It is important to note that 
this response to bile salts was not due to the detergent nature of bile salts, as neither 
Triton X100 nor SDS had any effect on biofilm formation. This is reminiscent of 
findings that the proteome of E. faecalis was very dissimilar when grown in bile salts 
or SDS, showing that this closely related organism responds differently to these 
detergents (Flahaut et al., 1996).  
 
The range of bile salt concentrations that stimulate biofilm formation was narrower 
for E. faecium E1162Δesp than for its parental strain, suggesting that the presence of 
Esp influences this triggered response. Interestingly, biofilm formation by E. faecium 
E1162 was induced by sodium taurocholate but not by glycocholate, which was also 
observed in Lactococcus lactis (Zaidi et al., 2011). However, both taurocholate and 
glycocholate were required to induce biofilm formation to a level similar to that 
achieved with crude bile salts, indicating that the two salts act synergistically. 
Strikingly, neither taurocholate/glycocholate, nor a mixture of the two, induced 
biofilm formation in strains lacking Esp (E. faecium E1162Δesp and TX1330). This 
indicates firstly that other components than tauro- or glycocholate in the Ox bile 
extract stimulates biofilm formation in these strains. Secondly, it suggests that Esp 
plays a role, either directly or indirectly, in the response to these salts. This role is at 
present not clear and requires further detailed analysis. 
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Our studies excluded a number of potential explanations as to why physiological 
concentrations of bile salts stimulate biofilm formation in E. faecium. The rate of 
growth is unlikely to play a role as we did not observe a significant difference in the 
doubling time when comparing 0.5% and 5% bile salts, whereas the difference in 
biofilm formation at these concentrations was very large.  Cells lacking Esp are 
clearly less hydrophobic, an observation that was also made in E. faecalis (Tendolkar 
et al., 2004), as well as being less efficient in forming biofilms. It could be 
speculated that bile salts, due to their detergent nature, would increase the 
hydrophobicity of cells which, in turn, would increase biofilm formation; however, 
bile salts and its individual components had no or only a minor effect on 
hydrophobicity; with bile salts there was actually a reduction in hydrophobicity, 
albeit insignificantly. It can thus be concluded that, despite their detergent nature, 
bile salts do not stimulate biofilm formation through a change in hydrophobicity of 
E. faecium cells.  
 
Tests were performed to establish whether there were other changes in E. faecium 
caused by the presence of bile salts. For instance, secretory proteins produced by E. 
faecium E1162 and   E1162∆esp were analysed using SDS-PAGE, but no obvious 
differences were observed when the strains were grown with or without bile salts 
(data not shown). Note that this was only tested for planktonic cells and not for 
biofilm cells, and it cannot be excluded that some proteins are only secreted while 
growing in biofilms. 
 
Another reason for induction of biofilm formation might be through morphological 
changes caused by bile salts. Such changes induced by bile have been observed with 
L. monocytogenes, and it was suggested that this change increased initial attachment, 
which in turn enhanced biofilm formation (Begley et al., 2009). Better attachment 
was indeed observed of E. faecium in the presence of bile salts, which was most 
notable after 6 hours of growth, a stage at which microcolonies could already be 
observed. There was also an increase in chain length in the presence of bile salts that 
may have contributed to increased attachment or formation of microcolonies which, 
in turn, stimulated biofilm formation. Notably, for reasons unknown bile salts led to 
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longer chains in E. faecium E1162Δesp compared to its parental strain or E. faecium 
TX1330, but this did not result in a significantly larger increase in biofilm formation. 
Thus, chain length is unlikely to be the only contributing factor to the induction of 
biofilm formation by bile salts, and our future studies will be aimed at analysing this 
process in more detail.   
 
What was clearly observed was that in the presence of bile salts more EPS was 
produced. A similar observation was made in L. lactis, biofilms of which produced 
more EPS in the presence of cholate (Zaidi et al., 2011). This observation links in 
well with the increase attachment observed at 6 hours, a stage at which 
microcolonies start to form and EPS production increases (Hall-Stoodley and 
Stoodley, 2002), in turn EPS then provides key components for maturation of the 
biofilm (Flemming and Wingender, 2010). Therefore, the most likely explanation for 
our observations is that bile salts induce the production of EPS and that that, in turn, 
stimulates biofilm formation. How bile salts stimulate EPS production will be 
investigated by us in more detail in future studies. 
 
Other environmental stresses were also studied to establish their effect on biofilm 
formation. Enterococci have been shown to grow in high alkaline conditions (Flahaut 
et al., 1997), but observed here was that a media change to around pH 8 significantly 
decreased biofilm formation,  both in the presence and absence of bile salts, this 
decrease was not due to reduced growth (data not shown), while at pH 6 E. faecium 
formed similar biofilms as at pH 7. An increase in temperature to 42oC showed no 
effect on biofilm formation in any of the E. faecium strains (data not shown), but in 
E. faecalis it increases collagen attachment, which was also observed for alkaline 
conditions (Kayaoglu et al., 2005). Iron limitation tests were performed on biofilms 
by adding an iron chelator. E. faecium E1162 was the only strain to show a 
significant decrease in biofilm formation, therefore suggesting that in enterococci 
iron limitation is not a biofilm formation trigger. Iron limitation in other bacteria 
have shown to decrease biofilm formation in E. coli (Alves et al., 2010), and increase 
biofilm formation in S. aureus (Johnson et al., 2005).  
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It is important to note that when producing a mutant such as E. faecium E1162∆esp, 
there maybe pleiotropic effects on downstream genes. For instance, it was suggested 
that the muramidase gene in the E. faecium E1162∆esp was upregulated due to the 
insertion of the chloramphenicol gene into the Esp gene (J. Top, personal 
communication). A study by Waters et al suggests that muramidase has a role in 
dechaining of cells in E. faecalis (Waters et al., 2003). Thus, one would expect an 
up-regulation of this gene leading to shorter chains of E. faecium E1162∆esp, 
whereas the opposite is seen here. It is still possible that other unknown effects may 
have occurred due to making the deletion, but it is unlikely that this muramidase up 
regulation has a role in the increased chain length as observed for E. faecium 
E1162∆esp here. There are thus still unanswered questions on the role of Esp, and 
the next logical step is to look at Esp expression under different environmental 
conditions, which leads us on to Chapter 6. 
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6.1. Background and objectives 
 
It has been demonstrated that biofilm formation by E. faecium E1162 is depends on 
the presence of Esp. Also, as shown in previous chapters, it was observed that E. 
faecium E1162 and E. faecium E1162∆esp respond differently to the presence of 
bile. For these reasons it was decided to analyse the expression of the esp gene under 
various growth conditions, including the presence of bile salts.  
 
As previously stated in the introduction, Esp is an approximately 202 kDa large cell 
wall protein found in both E. faecium and E. faecalis strains. The proteins in both 
organisms are very similar and have a sequence identity of around 90% (Heikens et 
al., 2007). The protein contains some key features shown in figure 6.1, which include 
a signal peptide, an N-terminal domain, A, B & C repeats, a cell wall anchor motif 
(FPKTGE). The repeat units mentioned (areas of repeat amino acids) have been 
separated and aligned, and it can be observed that the repeats are highly conserved 
(Figure 6.1).  
 
The signal peptide contains a motif that is similar to the so-called YSIRK signal 
peptides, which are found in many surface proteins of staphylococci, streptococci 
and related organisms. Proteins containing this type of signal peptide have been 
shown in S. aureus to be distributed along the peptidoglycan cross wall that is 
formed when cells are dividing, while proteins without the YSIRK motif are 
predominately found at the poles (DeDent et al., 2008). It suggests that the motif has 
a role in trafficking the surface proteins to the correct destination on the cell wall.  It 
has been shown that it is required for efficient secretion (Bae and Schneewind, 
2003), switching signal peptides i.e. YSIRK present and absent signal peptides did 
cause the S. aureus surface proteins to switch locations, but that mutations in the 
motif did not cause the surface proteins to reach an incorrect location, they were still 
attached to the cell wall in the required destination (DeDent et al., 2008).  
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Previous studies on E. faecalis Esp had shown similarity with S. aureus Bap protein 
(Biofilm associated protein), the N-terminal domain of which showed a 33% identity 
with the N-terminal domain of Esp, whereas the C repeats of these proteins also have 
a similar level of identity (Toledo-Arana et al., 2001).  As of yet Bap has only been 
isolated from bovine mastitis isolates and when deleted there is a decrease in biofilm 
formation (Valle et al., 2012). There are also similarities in the C repeat region of 
Esp to Rib and C alpha proteins in group B streptococci (GBS), although Esp also 
has additional repeats and an N-terminal region which is unrelated (Shankar et al., 
1999). C alpha protein and Rib in GBS are surface-expressed antigens, which may 
confer resistance against the antibody-mediated immunity (Madoff et al., 1996, 
Wastfelt et al., 1996). Studies on Esp have also shown that the number of repeat 
units varies between isolates as a result of homologous recombination, but a 
complete loss of the repeat units have not been seen, suggesting that they may have 
an important role in stability (Shankar et al., 1999). Variation in the number of A and 
C repeats in Esp have shown no effect on the isolates ability to form biofilms 
(Toledo-Arana et al., 2001). This shuffling of repeat units has been suggested as a 
possible immune evasion technique which has been observed in C alpha proteins 
(Madoff et al., 1991, Madoff et al., 1996). 
 
Tendolakar et al showed by making mutant forms of Esp lacking various domains 
and expressing them in a Esp negative isolate that the N-terminal domain was 
sufficient to mediate biofilm formation in E. faecalis (Tendolkar et al., 2005). Esp 
also consists of a cell wall-anchoring sequence, which for Gram-positive bacteria is 
usually LPXTGX (Schneewind et al., 1993), here E. faecium has the sequence 
FPKTGE, therefore the leucine in position 1 has been replaced with phenylalanine. 
The sortase enzyme cleaves between the threonine and glycine residues in this motif 
and the protein is then covalently immobilized to peptidoglycan in the cell wall 
(Hendrickx et al., 2009b). In spite of the rare residue change Esp is found on the 
surface of the cell wall, which was confirmed experimentally (Shankar et al., 1999, 
Heikens et al., 2007).  
 
 












Figure 6.1. E. faecium E1162 Esp structure. Amino acid sequence for Esp is shown, important sections of the sequence are 
highlighted and repeat sections have been separated out and alignments have been performed. The signal peptide is represented 
by purple and also contains the YSIRK motif. A, B and C repeats are represented by blue, red and green, respectively. Cell 
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6.2. Esp expression analysis using SDS-PAGE 
  
Firstly a fragment of the N-terminal domain of Esp was expressed and purified using 
the pN-tEsp vector, which was supplied by Dr W.J. van Wamel (Van Wamel et al., 
2007). Purified Esp was used to raise polyclonal antibodies in rabbits as outlined in 
the Methods and Material chapter.  
Various conditions were tested to get an understanding of Esp expression. E. faecium 
E1162   and   E1162∆esp were incubated under aerobic or anaerobic conditions in 
either TSA-G-B or TSB-G-B containing various concentrations of bile salts. 
Unfortunately, it was difficult to find the right conditions for western blotting. A 
number of conditions (transfer buffers and blotting time) were tested, but results 
were not consistent; this was likely to be due to the large size of the protein, which 
makes transfer to a membrane inefficient. Nevertheless, the protein was detectable in 
E. faecium E1162 (Figure 6.2), while it was absent in E1162∆esp (compare lanes B 
and F). In the presence of bile, the amount of Esp appears reduced, although this is 
less obvious with 5% bile. In anaerobic conditions there were clearly increased 
levels of Esp, corroborating earlier findings (Van Wamel et al., 2007).  Due to the 
poor quality of the western blots it was decided to analysis Esp expression using 
flow cytometry.  
 
Figure 6.2. Western blot analysis of Esp expression in TSB-G-B: E. faecium 
E1162 under anaerobic (A) aerobic (B) containing no bile salts and aerobically 
containing 0.5% (C), 1.5% (D) and 5% (E) bile salts. As a negative control E. 
faecium E1162∆esp under aerobic conditions with no bile salts (F). 
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6.3. Esp production analysis using flow cytometry. 
 
To test flow cytometry for the cell surface expression of Esp, both exponential 
growing cells and stationary phase cells were examined in the absence of bile salts. 
Interestingly, two peaks were observed in these cells; one peak with low, and one 
peak with high fluorescence intensity. This suggests that only part of the population 
produces the Esp protein on the cell surface. Strikingly, the percentage of cells 
producing Esp was considerable higher, at 40.4%, when in stationary phase (18 
hours of growth; Figure 6.3B), while this was only 21.8% for exponentially growing 
cells (4 hours of growth; Figure 6.3A). This indicates that Esp is mostly produced in 
the stationary phase of growth. In 24-hour biofilm cells, 83.4% of cells produced Esp 
(Figure 6.3C), showing that in biofilms there is a further increase in Esp production. 
Note that in planktonic cells harvested from the wells after biofilm growth the 
production of Esp was significantly lower than in the biofilm cells (33.6%; Figure 
6.5A). 
 
We then tested the effect of bile salts on Esp production, in both stationary phase and 
biofilm cells. Interestingly, in the presence of 0.5% bile salts the percentage of cells 
producing Esp was significantly lower in both conditions: 23.9% for stationary 
grown cells (40.4% without bile, see above), and 31.7% Esp producing cells in 
biofilm grown cells (83.4% without bile; Figure 6.4). Thus, induction of biofilm 
formation by bile salts is not due to an increase in production of Esp.  Planktonic 
cells that were not attached to the surface were also tested in the presence of 0.5% 
bile salts (Figure 6.4B); these cells show similar amounts of Esp production as seen 










Figure 6.3. Flow cytometry histograms, showing cell surface expression of E. 
faecium E1162 cells in the exponential growth phase (A), stationary growth 
phase (B) and biofilm cells (C). E. faecium E1162Δesp grown under stationary 
phase growth was used as a negative control (D). Percentages of cells expressing 
Esp is indicated in each panel and in E. The error bars represent the mean ±the 
standard error. *** p<0.0001 and * p<0.01. 






Figure 6.4 Representative flow cytometry histograms, showing cell surface 
expression of Esp in E. faecium E1162 cells, grown in the presence of 0.5% bile 
salts, in the stationary phase (A) in biofilm cells (B). Percentages of cells 
expressing Esp is indicated in each panel and in C. The error bars represent the 
mean ± the standard error. *** p<0.0001.  
 
 




Figure 6.5. Representative flow cytometry histograms, showing cell surface 
expression of Esp in E. faecium E1162 planktonic cells from biofilm grown 
cultures, in the absence of bile salts (A) and in presence of 0.5% bile salts (B). 
Percentages of cells expressing Esp is indicated in each panel and in C. The 











Flow cytometry experiments did reveal the interesting observation that in E. faecium 
E1162 cultures there are two populations of cells, one population producing Esp on 
the cell surface, and the other without Esp. The ratio between the two populations 
was clearly dependent on growth conditions: ~20% of cells producing Esp on the 
cell surface in exponentially growing cultures, while this increased to about 40% in 
stationary phase and nearly 80% in biofilm cells, reaffirming the clear link of Esp 
with biofilm formation. One previous study (Van Wamel et al., 2007) observed that 
Esp production in E. faecium was higher when grown at 37oC compared to lower 
temperatures, while it also showed (as confirmed here) that there is an increase in 
production during anaerobic growth. This suggested that this increase in production 
of Esp was caused by a switch between environmental reservoirs, going from 21oC 
and an aerobic condition on a hospital surfaces to 37oC and an anaerobic conditions 
once inside the body, which helps E. faecium in early infection. Anaerobic 
conditions have also seen up-regulation in of genes involved in virulence in E. 
faecalis (Day et al., 2003). Glucose concentrations have also been shown to affect 
biofilm formation in Esp-positive strains of E. faecalis, but the actual production of 
Esp was not significantly different (Tendolkar et al., 2004). 
 
It is at present not clear how bile salts induce biofilm formation in E. faecium, in the 
previous chapter (chapter 5) there was an increase in EPS production and initial 
attachment in the presence of bile salts. As shown here, bile salts reduced the cell 
surface expression of Esp in stationary and biofilm grown cells. It is thus clear that 
stimulation of biofilm formation by bile is not caused by an increase in the 
production of Esp. Interestingly, the presence of Esp was shown not to have an effect 
on colonisation of mice intestines (Heikens et al., 2009), and one might speculate 
that this was because of a reduced expression of Esp in the mice colon.  
 
Research on S. aureus Bap protein has shown that the protein promotes adhesion but 
that it also interferes with host cell entry. The interference with host entry is caused 
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by Bap interacting with Gp96, a chaperone protein on the host cell surface. This 
interaction interferes with the fibronectin binding pathway that the bacteria would 
use to invade the cells (Valle et al., 2012). The authors also tested other Bap 
homologues to see if Gp96 interact with these: Esp from E. faecalis and BapA from 
Salmonella enderitidis, using the pull down and ligand overlay assays, they came up 
negative (Valle et al., 2012). Nevertheless, showing that S. aureus Bap can interact 
with proteins on the surface of the cell suggests that homologues of this protein, 
including Esp, may interact with host cell surface proteins. It would thus be 
interesting to test this. In addition, it needs to be tested whether the presence of bile 
may lead to, for instance, increased expression of other cell surface proteins in E. 
faecium that in turn leads improved biofilm formation and stimulation of 
colonisation in the GI tract. 
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The effect of bile salts on biofilm 
formation in E. faecalis 
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7.1. Background and objectives 
 
As previously mentioned in Chapter 5, bile salts are toxic and enterococci have to 
cope with these conditions in order to survive and/or colonise the gut. Here we use 
isolates of E. faecalis that have been isolated form biliary stents and a faecal isolate 
(E. faecalis ATCC19433 (Jones and Shattock, 1960) and analyse their biofilm 
formation in the presence of bile salts. Biliary stents are used to alleviate 
obstructions caused by malignant or benign conditions in the biliary tract. Often 
blockages occur due to the build up of biliary sludge which consists of bacteria, 
protein and bile salt constituents 3 months after placement (Di Rosa et al., 1999). 
Bacteria infect this area via the Oddi sphincters (Sung et al., 1992) or via the portal 
venous system (Sung et al., 1991). The bile concentration in biliary stents is high 
(9±4%) (Donelli et al., 2007) and, if infected, E. faecalis is one of the more 
prominent bacteria present (Di Rosa et al., 1999, Dowidar et al., 1991). 
The isolates used in this chapter, and some of the virulence genes they contain, are 
listed in Table 7.1.  
 
Table 7.1. E. faecalis isolate virulence factorsa
 
aData from E. faecalis BS12297, BS11297, and BS385 from van Merode, van der 
Mei et al, (2006a, 2006b).  In E. faecalis ATCC19433 the presence of esp confirmed 
by PCR, and the presence of GelE was confirmed on milk-agar plates (data not 
shown). 
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As mentioned previously in the introduction, for bacteria to attach to a surface they 
must overcome repulsive forces. There have been a number of studies on cell surface 
heterogeneity in E. faecalis and its influence on biofilm formation (van Merode et 
al., 2006a, van Merode et al., 2006b). When studying bacterial hydrophobicity and 
cell-surface charge, usually a pure culture is used. Within this culture it is presumed 
that the cells are the same, but in fact there may be subpopulations that differ in 
certain factors such as their production of flagella or cell-surface charge, and so 
calculations of cell-surface properties are usually an average. In these studies 
microelectrophoresis were used which can analyse cell surface charge for individual 
cells that is expressed as a zeta potential (charge on the cell surface taking into 
account ionizable groups exposed on the surface, pH and ionic strength).  Using this 
method cultures of bacteria could be identified as heterogeneous (with many 
subpopulations, therefore more than one zeta potential) or homogeneous (no 
subpopulation, one zeta potential). It was found that strains that were heterogeneous 
were better at adhering to polystyrene and producing biofilms than homogeneous 
strains, and it was concluded that heterogeneity in cell surface charge gives bacteria 
an advantage. Interestingly, subculturing one of the subpopulations of a 
heterogeneous strain showed that this subpopulation alone was less efficient at 
biofilm formation (van Merode et al., 2006b).  The cells from the biofilms were also 
compared to planktonic cells and it was found that E. faecalis strains that were 
heterogeneous when planktonic became homogeneous when in biofilm formation. 
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7.2. Biofilm assays for the E. faecalis isolates 
 
Firstly, biofilm assays were performed under standard conditions for all the E. 
faecalis isolates. It was observed that E. faecalis ATCC19433 and BS12297 are the 
best biofilm formers, followed by E. faecalis BS385. E. faecalis BS11297 appears to 
be a poor biofilm former (Figure 7.1A). 
 
Figure 7.1. Biofilm assay and hydrophobicity results for the E. faecalis isolates. 
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7.3. Hydrophobicity testing for the E. faecalis isolates 
 
Hydrophobicity tests were also performed (Figure 7.1B) on the E. faecalis isolates. 
As shown before for E. faecium (chapter 5), the trend in hydrophobicity followed the 
trend in biofilm formation, with the strains forming the best biofilms, E. faecalis 
ATCC19433 and BS12297, also having the highest hydrophobicity. These were then 
followed again by E. faecalis BS385 and E. faecalis BS11297, the latter of which 
had the lowest hydrophobicity. 
 
7.4. CLSM images of E. faecalis biofilms. 
 
CLSM imaging was also performed (Figure 7.2) to visualise the structure of the 
biofilms present. All E. faecalis isolates were tested except for the poor biofilm-
former E. faecalis BS11297. It can be observed that all the isolates produce good 
biofilm; this is also obvious from their maximum thickness and biomass (Table 7.2). 
E. faecalis BS12297 (Figure 7.2A) has a more uniform biofilm formation across the 
surface, were as the biofilm structures formed by E. faecalis ATTC19433 (Figure 
7.2B) and BS385 (Figure 7.2C) appear to be more uneven (Figure 7.2C). 
 
Table 7.2. Maximum thickness and biomass for E. faecalis isolates ± standard 
error, defined using COMSTAT2 software (Heydorn et al., 2000).  
E. faecalis BS12297 ATCC19433 BS385 
Maximum thickness 12.6µm ± 1.9  15.2µm± 1.0   9.29µm± 1.7 
Biomass (µm3/µm2) 2.25 ± 0.5 1.98 ± 0.48  0.84 ± 0.2  
 





Figure 7.2. Representative CLSM biofilm formation images and side views of E. 
faecalis isolates: (A) BS12297 (B) ATCC19433 and (C) BS385. Biofilms were 
grown in TSB-G over 72 hours (with fresh media every 24 hours); cells were 
stained with Acridine orange. Scale bar represents 20 µm. 
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7.5. The effect of bile salts on E. faecalis biofilm formation. 
 
Biofilm formation was studied from the range of 0-5% bile salts for each of the E. 
faecalis isolates (Figure 7.3). When biofilms were grown in the absence of bile salts 
it can be observed that there is more biofilm growth after 48 hours growth compared 
to 24 hours growth (approx. 2 fold). All the isolates except for E. faecalis BS11297 
showed an increase (approx. 2 fold) in biofilm formation in the presence of bile salts 
for 24 hour, and maximum biofilm formation is observed at 1.5% bile salts (Figure 
7.3A). At 48 hours biofilm formation is similar in the presence or absence of bile 
salts (Figure 7.3B) for the isolates, E. faecalis ATCC19433 48h-biofilms have 
irregular dips and peaks in biofilm formation over the concentrations of bile salts 
that were not seen at 24 hours. The main observation is that E. faecalis ATCC19433 
and BS12297 produced the most biofilm over the range of bile salts concentrations 
tested for 24 hours They show a consistent reduction in biofilm formation at low 
concentrations, followed by an increase and this increase is then followed by a 
reduction at the higher concentrations (3-4%) of bile salts, but this reduction is not as 
strong as observed with E. faecium (Chapter 5).  
 
Interestingly unlike E. faecium, the E. faecalis strains have increased biofilm 
formation at concentrations above the usual physiological concentrations found in 
the small intestine. Bile salt concentrations are likely to be higher in bile stents, as 
concentration of bile occurs here prior to release into the small intestine and this 
therefore could explain this occurrence. This is also surprisingly true for E. faecalis 
ATCC19433, a faecal isolate, but interestingly biofilm formation is effected at 48 
hours growth, when concentrations of bile salt are above physiological 
concentrations found in the small intestine. 
 
 






Figure 7.3. Biofilm formation in the presence of bile salts for 24 hours (A) or 48 
hours (B). With the latter fresh media was provided after 24 hours. The error 
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7.6. Biofilm formation in the presence of sodium glycocholate, sodium 
taurocholate and a 1:1 mix of the two. 
 
The two main components of bile salts are sodium taurocholate and sodium 
glycocholate. To investigate whether either of these components is important in the 
stimulation of biofilm formation, assays were performed in the presence sodium 
taurocholate, sodium glycocholate and a 1:1 mixture of the two; concentrations 
tested were between 0-2 percent.  
 
Sodium glycocholate stimulated more biofilm formation in E. faecalis isolates 
ATCC19433, BS12297 and BS385. The first two strains were the best biofilm 
formers when in the presence of sodium taurocholate also, while E. faecalis BS385 
remained the same in this condition. E. faecalis BS11297 showed no increase in 
biofilm formation in any of the conditions tested (Figure 7.4 & Table 7.2). The 
maximum biofilm observed for the other three isolates is at 0.5% sodium 
glycocholate or sodium taurocholate, with approximately a 2-fold increase compared 
to biofilm formation in the absence of bile salts (Figure 7.4A and B). When using a 
1:1 mix of sodium taurocholate and glycocholate, again E. faecalis ATCC19433 and 
BS12297 showed an increase in biofilm formation, which is in this case was 
observed at a higher concentration of approximately 1-1.5% (Figure 7.4C). For E 
faecalis BS385 there was no obvious stimulation of biofilm formation in the 
presence of a mix of sodium glycocholate and taurocholate, suggesting other 











Figure 7.4. Biofilm assays in the presence of (A) sodium glycocholate, (B) 
sodium taurocholate, and (C) Sodium taurocholate: Sodium glycocholate (1:1). 
The error bars represent the mean ± the standard error.  








↑ - increase biofilm formation when the bile component is present at some 
concentration 
↔ - remains unaffected by the presence of the bile component. 
 
7.7. Hydrophobicity in the presence of bile salts. 
 
It was decided to test hydrophobicity when cells were grown in the presence of bile 
salts (Fig 7.5). In the presence of bile salts, hydrophobicity E. faecalis BS12297, 
BS11292 or BS385 did not change significantly. The only strain that in which the 
hydrophobicity altered significantly due to bile salts was E. faecalis ATCC19433. 
 
Figure 7.5. Hydrophobicity in the presence of 1.5% bile salts for the E. faecalis 
isolates. 
  Chapter 7: Results Section V 
149 
 
7.8. Effect of bile salts on initial attachment. 
 
 
Initial attachment to a surface is important step in the formation of biofilms, and here 
we study if bile salts have an effect on this process. Usually, initial attachment is 
determined during the first four hours, while microcolonies start to form at longer 
time-periods (~6 hours (Mohamed et al., 2006). E.faecalis BS11297 is clearly 
extremely poor in initial attachment compared to the other E. faecalis isolates tested 
(Figure 7.6D). For the other three isolates, initial attachment after 4 hours is either 
decreased (ATCC19433 and BS12297) or unchanged (BS385) in the presence of bile 
salts (Fig 7.6 A-C). In contrast, when measuring the number of attached cells after 6 
hours (when microcolonies are formed), an increase is seen for E. faecalis 
ATCC19433 and BS385, while no difference was observed for E. faecalis BS12297. 

















Figure 7.6. Initial attachment assays in the presence of bile salts for E. faecalis 
isolates (A) ATTC19433, (B) BS12297, (C) BS385 and (D) BS11297. The error 
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7.9. Analysis using flow cytometry of Esp production. 
 
Esp from E. faecalis and E. faecium are very similar proteins with approximately 
90% sequence identity. We therefore tested whether the antibodies raised against E. 
faecium Esp would also recognise Esp on the cell surface of E. faecalis cells. All 
isolates were grown to log phase and were then tested for Esp production using flow 
cytometry (Figure 7.7). It can be observed that E. faecalis BS12297 and 
ATCC19733 produce Esp, and indeed both strains also contain the esp gene. As 
expected, E. faecalis BS385, which does not contain the esp gene, shows no Esp 
production. Interestingly, BS11297 does not show any production of Esp, while it 
does carry the gene. However, it should be noted that this strain is a very poor 
biofilm former and is relatively low in hydrophobicity; this could suggest that the 
esp gene is expressed either at a very low level or not at all in this strain. Very 
similar results were obtained when the isolates were grown to stationary phase 
(Figure 7.8). 
 
We also analysed the effect of bile salts on the production of Esp of two of the E. 
faecalis isolate which contain the esp gene: BS12297 and BS11297 (which 
previously showed no Esp production). It was observed in E. faecalis BS12297 
(Figure 7.9) that in log phase cells, in the presence of bile salts, production of Esp is 
significantly decrease (p=0.03), while in stationary phase cells there appeared to be 
an increase in Esp production, although this was not significant (p=0.15). 
Interestingly, a statistically significant increase in Esp production was observed in 
the presence of bile when comparing stationary phase to exponential phase cells, a 
difference not observed in the absence of bile salts (Figure 7.9).  E. faecalis 
BS11297 shows no differences in Esp production when bile is present in either 










Figure 7.7. Flow cytometry histograms, showing cell surface expression of E. 
faecalis isolates.   Representative histograms are shown for: (A) negative control 
(pre-immune sera tested on the isolates), (B) BS385, (C) BS11297, (D) BS12297 
and (E) ATCC19433. All the isolates were grown to log phase. Percentages of 
cells expressing Esp is indicated in F. The error bars represent the mean ±the 
standard error.  






Figure 7.8. Flow cytometry histograms, showing cell surface expression of E. 
faecalis isolates. Representative histograms for (A) negative control (pre-
immune sera tested on the isolates),  (B) BS385, (C) BS11297, (D) BS12297  and 
(E) ATCC19433. All the isolates were grown to stationary phase. Percentages of 
cells expressing Esp is indicated in F. The error bars represent the mean ±the 
standard error.  
 
 





Figure 7.9. Flow cytometry histograms, showing cell surface expression of E. 
faecalis isolate BS12297 grown in log (A) and stationary (B) phase in the 
presence of 1.5 % bile salts. Negative controls using pre-immune sera are shown 
for log phase in the presence of bile (C) and stationary phase grown cells in the 
presence of bile (D). Percentages of cells expressing Esp is indicated in (E) 
alongside data when no bile salts were present in the media when grown. The 
error bars represent the mean ±the standard error. 
 






Variations in biofilm formation between isolates are obvious in the E. faecalis 
isolates tested. As mentioned in chapter 1 and this chapter, more virulence factors 
have been identified in E. faecalis than E. faecium, and several have shown a role in 
biofilm formation. Furthermore, research has shown conflicting evidence on the role 
of Esp in  biofilm formation, which can be Esp dependent (Tendolkar et al., 2004) or 
independent (Kristich et al., 2004) in various E. faecalis isolates. Other factors 
important in biofilm formation include the protease GelE (Hancock and Perego, 
2004) and the aggregation substance Agg, both of which also have a role in 
attachment and conjugation between cells (Olmsted et al., 1991).  
 
A previous study also performed biofilm assays on the bile stents isolates used here 
and we both obtain similar biofilm formation results, with isolates showing the same 
trends in biofilm formation (van Merode et al., 2006a). This chapter also confirms 
results in other papers that have shown that there can be biofilm production 
independent of the presence of Esp, suggesting that there are other factors in biofilm 
formation involved here that are yet to be identified (Kristich et al., 2004, Di Rosa et 
al., 2006). The trend in hydrophobicity is also observed, isolates better at biofilm 
formation are also more hydrophobic.  
 
A surprising result was observed for E. faecalis BS11297. This strain contains both 
Esp and GelE, but biofilm formation was consistently poor in any condition tested. 
This could be explained in part by the low hydrophobicity of this isolate and its poor 
initial attachment. In chapter 5 we have shown that hydrophobicity is in part 
determined by the presence of Esp, and together with the flow cytometry data it 
seems likely that the esp gene is actually not expressed. This is not very unusual; for 
example, the gelE gene has also been found to be present in some isolates while not 
being expressed (Biavasco et al., 2007), and perhaps this is also occurring here with 
esp.  However, this still does not fully explain the poor biofilm formation, as for 
instance E. faecalis BS385 (which lacks both Esp and GelE) still forms reasonable 
biofilms. A previous study on heterogeneity of surface charge in cell cultures 
showed that E. faecalis BS11297 is significantly more homogeneous (the same 
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surface charge on all cells) compared to E. faecalis BS385, and it was suggested that 
this cell surface heterogeneity is important in surface attachment and biofilm 
formation (van Merode et al., 2006a).  
 
In the E. faecalis strains, stimulation of biofilm formation by bile salts was seen in 
all strains except E. faecalis BS11297. Different responses were observed when 
assays were performed in the presence of sodium taurocholate or glycocholate; E. 
faecalis BS835 increased in the presence of sodium glycocholate but not with 
sodium taurocholate and the opposite was seen with E. faecalis ATCC14933. These 
strains vary in their genetic virulence determinants and therefore this variation is 
probably due to genetic differences causing biofilm formation to be effected by 
different bile components. This was also seen in Chapter 5, were E. faecium TX1330 
was shown to have stimulated biofilm formation from different bile components than 
E. faecium E1162.  
 
A previous study by van Merode et al also studied the effect of ox-bile on biofilm 
formation and cell heterogeneity in E. faecalis strains. They found E. faecalis 
BS12297 and BS385 decreased in biofilm formation, but they only tested 5% bile 
salts (van Merode et al., 2006a). Our tests ranged from 0% to 5% and we observed 
that at lower concentrations biofilm formation increased, while at a high 
concentration (5%), biofilm formation remained the same or decreased (compared to 
conditions without bile). With this in mind the paper suggests that high levels of bile 
may stop adherence and therefore biofilm formation, they suggest this is probably 
due to surface charge. Initial adherence tests in this chapter confirm this suggestion 
as all isolates show a decrease in initial attachment and microcolony formation at 5% 
bile salts, but whether this is due to surface charge would need further study. 
 
Hydrophobicity testing was also performed in the presence of bile salts (1.5%); 
varying results were obtained with all but one isolate (E. faecalis BS385) decreasing 
in hydrophobicity. This variation in results is also observed in other research testing 
at 5% ox-bile on these E. faecalis isolates (van Merode et al., 2006b).  
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In E. faecium, Esp production is clearly dependent on the growth phase (chapter 6). 
Similar to E. faecium, cultures of E. faecalis BS12297 and ATCC19433 contained 
mixed populations, with approximately 50-60% of cells expressing Esp on the cell 
surface. In contrast to what was found for E. faecium, no clear differences between 
log phase and stationary phase cells were found.  
 
There have been a few studies on how stress effects gene expression in E. faecalis, in 
particular with concerns to virulence. One study observed that there are many sub-
lethal environments, including the presence of bile salts that cause an increase in 
gene expression of virulence associated genes, including ace (collagen binding 
MSCRAMM, involved in adhesion to host cells), efaA (endocardial adherence factor 
antigen, involved in adhesion to host cells) and cylB (cytolysin, lyses of cells). 
Unfortunately Esp was not included in that study (Lenz et al., 2010). However, it 
was noted that the gene expression response to general stresses, such as salt and 
temperature, had a different pattern of gene expression than observed with bile salts, 
suggesting that bile leads to regulation of different networks as compared to the 
general stress response (Lenz et al., 2010). This is also observed when the proteome 
in the presence of bile was compared to the proteome of different detergents (Flahaut 
et al., 1996). This would be expected as E. faecalis is a GI tract commensal and is 
therefore more likely to encounter bile than other stress factors, such as increased 
temperature. E. faecalis ATCC19433 was analysed in a different study in which it 
was observed that different proteins were produced with differing lengths of 
exposure to bile (Rince et al., 2003). There has also been a study on bile salts-
sensitive mutants; genes inactivated included homologues to genes involved in: fatty 
acid biosynthesis, a transcription regulator, an exonuclease, DNA mismatch repair, 
cell wall synthesis and some with unknown function. In this study a mutation in a E. 
faecium SagA homologue was also identified as a bile-sensitive mutant; this protein 
is a major secreted antigen with a role in physiochemical stresses, cell wall 
metabolism and extracellular matrix (ECM) binding (Breton et al., 2002). We found 
that the production of Esp in E. faecalis BS12297 was induced in cells in the 
stationary phase compared to log phase cells, but only in the presence of bile. The 
above illustrates that when put under stress E. faecalis does increase its expression of 
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virulence factors, some of which are involved in initial adherence step in biofilm 
formation.   
The presence of bile has shown varying effects on different strains, microcolony 
formation and therefore biofilm formation. Esp expression is shown to be consistent 
during growth stages without bile, but there was an increase in expression in the 
presence of bile in stationary phase. Taken together that data shown in this chapter 
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8.1. Background and objectives 
 
C. elegans is a nematode found in soil that is approximately 1 mm in length when 
adult (Figure 8.1). It has a simple structure but also shares some features with higher 
animals, features include the gut, epidermis, neurons, muscles and the innate 
immune system. The nematodes basically are comprised of two tubes: firstly, the 
outer tube containing the hypodermis, cuticle, excretory system, neurons and 
muscles; and secondly, the inner tube that contains the pharynx, intestine and if the 
worm is adult the gonad (Altun and Hall, 2009, Sifri et al., 2005).  
 
Figure 8.1. Adult C. elegans. (Sifri et al., 2005) 
 
C. elegans became an experimental genetic model in the 1960s (Sifri et al., 2005) 
and the interest in this organism increased in 1998 when it was the first multicellular 
organism with a completed genome sequence (Hodgkin, 2005). It has been the 
genetic model for studies in aging, development and neurobiology (Sifri et al., 
2005), but in this chapter we are more interested in C. elegans as a microbial 
virulence model. C. elegans is a good model organism for several reasons: it has a 
quick generation time, it can self fertilise, making genetic tractability easier, it is 
simple to maintain and is inexpensive, has a defined cell lineage map and most 
importantly, as mentioned above a fully sequenced genome which has revealed a 
large number of genes that are vertebrate orthologues (Alegado et al., 2003, Gravato-
Nobre and Hodgkin, 2005).  
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C. elegans is a bacterivore that in the lab is maintained on agar plates and feeds on 
lawns of non-pathogenic E. coli. However, when its supply of food is switched to a 
human pathogen its lifespan is often drastically reduced. Research has revealed that 
mammalian pathogens can infect and kill C. elegans in one of five methods: 
invasion, persistent infection, intestinal infection with colonisation, toxins and 
biofilm formation (Gravato-Nobre and Hodgkin, 2005, Sifri et al., 2005). These 
occurrences have encouraged more detailed studies of how the pathogens infect C. 
elegans. Initially bacteria encounter the physical barriers and need to get past the 
cuticle, which is usually achieved via the mouth and anus. Once in the mouth the 
microbes reach the pharynx (which contains the grinder), which breaks up the 
microbes preventing them getting any further alive (Gravato-Nobre and Hodgkin, 
2005, Alegado et al., 2003). If microbes do pass the pharynx they are able to enter 
the intestine, where they can proliferate, cause cell damage and even death.  
 
C. elegans also has an innate immune responses controlled by signalling pathways 
that include Transforming growth factor (TGF-β),  insulin-like growth factor (IFG)-1, 
p38 MAP kinase pathway, programmed cell death and the Toll pathway (Gravato-
Nobre and Hodgkin, 2005). The mammalian immune responses are more 
complicated than that of C. elegans, as they also have an adaptive immune response, 
while there are also aspects of the innate response that are absent or not used in the 
same way as in C. elegans. For instance, C. elegans does not have phagocytes like 
mammalians. However, they do contain a type of scavenger cell, coelomocytes, but 
there is no evidence as yet that they phagocytise bacteria or have any role in 
immunity (Sifri et al., 2005). Interestingly, C. elegans does contain the Toll 
signalling pathway orthologues, but they do not play the same innate immune system 
role as in mammalians as they are more involved in development and avoidance of 
pathogens. This avoidance mechanism allows C. elegans to recognise the difference 
between a good food source and a bad one (made of pathogens) and therefore move 
from the bad food source to the good (Pujol et al., 2001). This mechanism is 
probably very important due to the lack of adaptive immunity.   
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Studies using various pathogens against C. elegans have shown that virulence factors 
involved in mammalian pathogenicity are also important in C. elegans infection and 
the level of virulence in C. elegans is predictive for the virulence in a mouse model 
(Styer et al., 2005). There are several advantages of this method over rodent 
infection model as it is cheaper, less laborious, far easier to scale up, and it does not 
suffer from an ethical burden (and therefore follows the 3Rs rules). Furthermore, it 
has also proven useful in antimicrobial drug discovery (Moy et al., 2006). This has 
allowed for high throughput studies of various pathogens and their virulence by, for 
instance, screening of libraries of mutant pathogens.  There are various examples of 
virulence factors known to be important in human infection that are also involved in 
nematode infections, including genes in cell wall structures (S. marcescens, wzm 
(Kurz et al., 2003)), biofilms (Y. pseudotuberculosis, hmsHFRS (Darby et al., 
2002)), extoxin (E. faecalis, cyl (Garsin et al., 2001), exoenzymes (E. faecalis, gelE 
(Sifri et al., 2002)), two component regulators (P. aeruginosa, gacAS (Tan et al. 
1999)) and quorum-sensing systems (S. aureus (agr) and E. faecalis (fsr) (Sifri et al., 
2005, Garsin et al., 2001)). 
 
Several studies using C. elegans to study virulence in enterococci have already been 
performed and have shown that E. faecalis is one of the bacteria that are not only 
able to kill C. elegans but also colonize and persist in the intestine of C. elegans 
(Garsin et al., 2001). As mentioned above cytolysin (cyl), sucrose-6-phosphate 
hydrolase (scrB), gelatinase (gelE), fsr quorum-sensing system, and serine protease 
(sprR; (Sifri et al., 2002)) are involved in this infection. Interestingly, the closely 
related E. faecium is also able to persist in the gut of C. elegans, but appears not to 
kill C. elegans when grown aerobically (Garsin et al., 2001). Surprisingly, however, 
E. faecium does  has  a  “fast  killing  mode”  (i.e.  within  a  few  hours  rather  than  days  for  
E. faecalis) when, before infection, the cells are grown anaerobically; this effect was 
shown to be due to the production hydrogen peroxide (Moy et al., 2004). 
 
Published research has shown E. faecium to lack pathogenicity in C. elegans, with 
the occurrence of colonisation but no death, but this has only been shown for a few 
strains (Moy et al., 2006, Moy et al., 2004, Garsin et al., 2001), and for that reason 
  Chapter 8: Results Section VI 
163 
 
we tested several clinical isolates to test whether the lack of pathogenicity applies to 
all E. faecium strains. In addition, we tested whether there was any influence of the 
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8.2. C. elegans killing assay. 
 
The E. faecium strains tested included strains mentioned in the previous chapters (E. 
faecium E1162, E1162∆esp, and TX1330) and the clinical vancomycin-resistant E. 
faecium isolates 1-5 (Figure 8.3A & B) received from the University of 
Southampton, details of which are in the Methods and Material chapter. They were 
tested alongside a negative control (E. coli HB101) and a positive control (E. 
faecalis BS11297). In brief, the C. elegans worms were age-synchronized and grown 
to the young adult stage on E. coli, and then transferred to agar plates with a lawn of 
the particular pathogen or the E. coli control. Over several days the plates were 
examined to establish the number of alive (moving) and dead nematodes (non-
moving, straight and not responsive to gentle touch). 
 
Results for E. faecium E1162, E1162∆esp, and TX1330 are shown in figure 8.2. It 
can be observed that with E. coli HB101, the percentage survival does not go under 
94% even after 10 days; therefore the longevity of C. elegans worms is good when 
fed with this. When C. elegans were fed on the E. faecium strains as sole source of 
food, the longevity of the worms was unaffected, while there was also no difference 
between E. faecium E1162 and E. faecium E1162∆esp. E. faecalis BS11297 is 
shown to be pathogenic to the worms as it has killed all worms by day 10. 
 
The E. faecium isolates provided by the University of Southampton were obtained 
from a range of wards and source samples (See Methods and Materials), with all the 
isolates being resistant to vancomycin as well as other antibiotics. As only a few E. 
faecium strains were tested with C. elegans, it was speculated that perhaps some 
other isolates might be pathogenic due to, for instance, virulence factors found in 
only some E. faecium isolates. However, as before it can be observed that there are 
no significant differences in the levels of virulence of the isolates (Fig 8.3) with, in 
all cases, survival of 80% or more after 10 days.  
 
 




Figure 8.2. C. elegans killing assay results for: E. faecium E1162,   E1162∆esp  
and TX1330. E. faecalis BS11297 as positive control. E. coli HB101 as negative 




Figure 8.3. C. elegans killing assay results for E. faecium hospital clinical 
isolates 1-5. E. coli HB101 as negative control. The error bars represent the 
mean ± the standard error. 
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The C. elegans killing assay was also performed on E. faecalis isolates previously 
used in this thesis (Figure 8.4; data was kindly provided by Sarah Bukhari, a fellow 
PhD student in the Department of Pharmacy and Pharmacology at the University of 
Bath). All the E. faecalis strains showed significant pathogenicity to C. elegans as 
they all decreased survival below 80%. E. faecalis BS11297 showed the highest 
level of virulence against C. elegans, with 16% survival at day 7, and E. faecalis 
ATCC19433 shows the lowest level of virulence of the E. faecalis strains tested, 
with 51% survival at day 7. Interestingly, E. faecalis BS11297 and E. faecalis 
ATCC19433 both contain Esp and GelE virulence factors. However, it should be 
noted that E. faecalis ATCC19433 is a reference strain that was isolated in the 1940s 
(Shattock, 1949), which may have lost other virulence factors, whereas the E. 




Figure 8.4. C. elegans killing assay results for E. faecalis isolates. E. coli HB101 
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8.3. C. elegans anaerobic killing assay 
 
As previously mentioned in the introduction, E. faecium has   a   ‘fast   killing  mode’  
against C. elegans which takes only hours and is caused by the production of 
hydrogen peroxide (Moy et al., 2004). Here it was decided to test if E. faecium 
E1162 too can kill C. elegans in this manner. Bacteria were grown anaerobically on 
plates to form a lawn, after which C. elegans was deposited and then survival counts 
for the worms are performed (data kindly provided by undergraduate project students 
Patrick Siu and Doris Ng). It can be seen from the results (Figure 8.5) that when 
grown anaerobically E. faecium E1162   also   has   a   ‘fast   killing   mode’   against   C. 
elegans, which is not seen when E. faecium E1162 is grown aerobically.  
 
 
Figure 8.5. C. elegans killing assay results for E. faecium E1162 when grown 










In this chapter we have confirmed that E. faecium isolates, including highly-resistant 
clinical strains, are non-pathogenic to C. elegans when grown aerobically. Other 
pathogens that do not kill C. elegans are not widely known. One such pathogen is 
Streptococcus pyogenes which also shows no significantly killing of C. elegans 
under aerobic conditions on BHI (Garsin et al., 2001); the author suggests that this is 
likely to be due to the media it has been grown on. Studies have shown the effect of 
media on C. elegans killing assays as the level of virulence does depend to some 
extend on the composition of the growth medium (Alegado et al., 2003). Even E. 
coli OP50, the usual source of food for C. elegans in the laboratory, becomes 
somewhat virulent to C. elegans if it is grown on BHI (a rich media) (Garsin et al., 
2001). Another example is S. pyogenes, mentioned above, which is pathogenic to C. 
elegans when grown on THB, but not when its grown BHI (Jansen et al., 2002). 
Thus, it is feasible that pathogenicity of E. faecium is also dependent on the medium, 
but due to time constraints that has not been tested further.  
 
Interestingly, other research into streptococci have shown that their killing is due to 
hydrogen peroxide killing, which can occur under aerobic conditions (Bolm et al., 
2004), E. faecium too is able to kill C. elegans using this method, but only under 
anaerobic conditions (Moy et al., 2004), and we have observed this also here with E. 
faecium E1162. As streptococci are close relatives of enterococci, they may have 
unspecialised evolutionarily conserved mechanisms of virulence, and perhaps it is 
therefore not surprising that they have a similar mode of killing in C. elegans.  
 
It is also important to ask the question of why there is a difference between E. 
faecalis and E. faecium as they are very similar species. As mentioned in the 
introduction to this chapter there have been several virulence factors identified in E. 
faecalis that are involved in C. elegans infection (cyl, scrB, gelE, fsr, and sprR; (Sifri 
et al., 2002)) and this chapter has also observed the difference in virulence that can 
occur between the E. faecalis isolates which is probably due to the presence and 
absence of specific virulence factors. E. faecium has none of the above factors, 
except for scrB, and this may well be the reason for its apparent reduced level of 
virulence. E. faecalis also contains Esp, and it was observed that E. faecalis BS385, 
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the only isolate without Esp, showed similar levels of virulence to E. faecalis 
BS12297, which does contain Esp, suggesting that Esp does not play a part in 
virulence in C. elegans. However, it is important to note that these strains come from 
different backgrounds and other factors may play a role here. Here using the C. 
elegans killing assay no difference between E. faecium E1162 and E. faecium 
E1162∆esp was shown, suggesting that Esp alone is not a determining factor in 
virulence. It is also interesting that virulence factors identified involved in C. elegans 
infections in bacteria do not currently include surface proteins involved in adhesion 
(Sifri et al., 2005, Alegado et al., 2003).  
 
Here we have further established that E. faecium does not cause C. elegans killing 
under aerobic conditions, but in the case of E. faecium E1162 does under anaerobic 
conditions and that the lack of Esp does not allow increase survival. Future tests 
would include testing the pathogenicity of E. faecium on different media, such as 
THB, to see if virulence differs. It would also be interesting to analyse whether 
biofilm-associated surface proteins in enterococci to test if any are involved in 
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9.1. Final discussion 
 
Initially, as described in chapter 3, three SPases were identified in E. faecium. Only a 
few other Gram-positive bacteria have more than one SPase, which includes B. 
subtilis, C. perfringens, S. aureus and S.  epidermidis (van Roosmalen et al., 2004). 
Many proteins are secreted via the Sec-dependent pathway of which SPases are an 
important component. For this reason a bioinformatic analysis was performed to 
identify secretory proteins in E. faecium E1162.  In E. faecium E1162 2.3% of 
proteins contained a Sec-type signal peptide, which is relatively low compared to 
other Gram-positive bacteria that contain approximately 4% secretory proteins 
(Tjalsma et al., 2000a), and 1.8% contained a lipoprotein signal peptide. The amount 
of lipoproteins identified here is also low, especially if compared to E. faecalis V385 
genome which has 2.7% lipoproteins (Reffuveille et al., 2011). It is possible that it is 
these extra lipoproteins that make E. faecalis more prevalent in hospitals. The 
secreted proteins identified included many virulence factors, such as Esp, autolysins, 
PilB subunit protein, two Bee3 proteins and collagen adhesion proteins. It was 
speculated that some SPases may be important either in specific conditions or in the 
processing of a specific subset of secretory proteins. The aim was to delete the 
individual SPases in E. faecium and then to study the phenotypic effects (e.g. on 
virulence) and analyse whether SPases would be suitable antimicrobial targets in 
enterococci. Inhibitors of SPases have already been identified (Harris et al., 2009) 
and so further research on SPases could encouraged additional research into 
inhibitors.  
 
Unfortunately, deletion mutants of the SPases in E. faecium were not obtained 
inferring the genes could be essential. However, there are only a small number of 
genetic manipulation tools available for enterococci, and in order to investigate if the 
genes were essential, an inducible integration vector was constructed. The vector 
was constructed, but not tested due to time constraints. 
 
  Chapter 9: Final discussion 
172 
 
Virulence in enterococci was then studied investigating antibiotic resistance and 
biofilm formation in enterococci and the role of Esp. Firstly antimicrobial resistance 
was investigated using calorimetry. Calorimetry has been used previously to 
differentiate between growing cultures of meticillin-susceptible and meticillin-
resistant S. aureus; it was able to do this in 4-5 hours (von Ah et al., 2008). Here in 
chapter 4 it was also shown to be a rapid and sensitive method when investigating 
antimicrobial resistance in bacteria. This was particularly shown when a difference 
in ampicillin resistance was observed between E. faecium E1162 and E. faecium 
E1162∆esp, whereas this difference was not observed with classical antibiotic-
sensitivity tests.  The esp mutant was shown to be more sensitive to ampicillin and 
this  was  the  first  evidence  of  Esp’s  role  in  antibiotic  resistance. 
 
Biofilm formation was tested for all the isolates studied. In E. faecium the presence 
of Esp enabled higher levels of biofilm formation, which was shown by comparing 
E. faecium E1162 to E. faecium E1162∆esp and E. faecium TX1330. The presence 
of Esp in E. faecium was also demonstrated to increase hydrophobicity, which is 
very clearly linked to the levels of biofilm formation and this has also been shown to 
be the case in E. faecalis (Tendolkar et al., 2004). Indeed, E. faecalis isolates also 
demonstrated that good biofilm formers were more hydrophobic in nature. Esp 
expression in E. faecium was also studied under different growth conditions (Chapter 
6). The results indicated that Esp expression in E. faecium E1162 and E. faecalis 
cultures contained two populations, only one of which was expressing Esp. It was 
also observed that Esp expression in E. faecium E1162 was growth-dependent 
illustrated by low Esp expression at exponential growth phase with increasing 
amounts in stationary phase, and then as many as 80% of cells expressing Esp during 
biofilm formation. Interestingly, this growth-dependent expression was not observed 
in E. faecalis BS12297, as no difference was seen for Esp expression between cells 
in exponential and stationary phase. Expression of Esp in E. faecalis BS12297 cells 
in biofilm cells was not tested. 
 
The effect of bile salts on biofilm formation was studied in both E. faecium (Chapter 
5) and E. faecalis (Chapter 7) as enterococci have to withstand bile salts in the GI 
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tract, which is their natural habitat. Bile salts appeared to increase biofilm formation 
for both E. faecium and E. faecalis, especially around the physiological 
concentration (0.2-2%) of the small intestine in humans (Hofmann, 1998). E. 
faecalis not only showed an increase in biofilm formation at the physiological 
concentration, but also at somewhat higher concentrations of bile salts. This is not 
surprising as some of these isolates came from bile stents were bile concentrations 
are around 9±4% (Donelli et al., 2007). Increases in biofilm formation when bile 
salts are present have also been observed in other bacteria such as with the 
gastrointestinal commensals B. fragilis (Pumbwe et al., 2007) and L. rhamnosus 
(Lebeer et al., 2007), and the pathogens S. typhimurium (Prouty et al., 2002) and L. 
monocytogenes (Begley et al., 2009). It is also important to note that the increase in 
biofilm formation observed here was not due to the detergent nature of bile salts, as 
other detergents did not influence biofilm formation. Biofilm formation was also 
shown to vary in the presence of individual components of bile salts, E. faecium 
E1162 was induced by sodium taurocholate but not by sodium glycocholate, which 
was also observed in Lactococcus lactis (Zaidi et al., 2011). In E. faecium the 
presence of bile salts caused an increase in initial attachment, microcolony formation 
and EPS production. These increases were not due to hydrophobicity, cell growth or 
cell morphology. In the case of E. faecalis, isolates varied in the biofilm formation 
when bile salts were present; where there was an increase there was also an increase 
microcolony formation.  
 
Interestingly E. faecium E1162  and  E1162∆esp showed differing biofilm formation 
when bile salts were present in the media, suggesting a possible role in sensing bile 
salts. E. faecium E1162∆esp showed increased biofilm formation only at 0.5% bile 
salts, were as E. faecium E1162 showed increase of biofilm formation over a range 
of concentrations. It was also observed that when separate components of bile salts 
were tested, it was found that the stimulation in biofilm formation found in E. 
faecium E1162∆esp was not caused by sodium glycocholate or taurocholate. The 
next step was to study Esp expression in the presence of bile salts for E. faecium 
E1162 biofilm cells, surprisingly tests indicated there was a decrease in expression 
(Chapter 6). Further research is require to understand this occurrence, perhaps the 
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lack of Esp causes other interactions to occur allowing more biofilm under 
conditions when bile is present. 
 
Virulence in enterococci was also investigated using C. elegans infection models 
(Chapter 8). Various highly antibiotic-resistant E. faecium isolates were not 
pathogenic to C. elegans. However, E. faecium E1162 demonstrated pathogenicity 
within hours when grown anaerobically, which has also been shown in other E. 
faecium isolates (Moy et al., 2004). Interestingly E. faecalis does not have this fast 
killing mode, as for this organism it can take up to 5 days  to kill C. elegans under 
anaerobic conditions (Moy et al., 2004), illustrating again the differences seen 
between E. faecium and E. faecalis. E. faecalis isolates showed varying 
pathogenicity to C. elegans depending on the virulence factors they contained.  
 
One of the main aims of this thesis was to further understand the role of the Esp 
protein, as its role is still unclear. These tests were able to confirm its role in biofilm 
formation, its possible role in ampicillin resistance and bile salts response, and that it 
also does not appear to affect virulence in C. elegans. It was also observed that 
different growth phases effected the expression of Esp, but there still remains a lot to 
understand. Below are some ideas for future work. 
 
9.2. Future work 
 
Future work on SPases is to continue searching for mutants and test the integration 
vector. This vector will not only be useful here for the study of SPases but also for 
other genes and, more importantly, essential genes that if deleted are lethal to 
enterococci. This extends the number of genetic tools that are available for further 
enterococcal research, which currently are quite limited (Kristich et al., 2007).  It 
would also be interesting to further characterise some of the hypothetical secreted 
proteins identified in E. faecium E1162. All the factors involved in biofilm formation 
are not fully understood and additional factors involved in biofilm formation are 
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being identified every day with new genetic tools. With the use of genetic tools more 
proteins are being identified as virulence factors; this was the case when pili in E. 
faecalis were discovered (Sillanpaa et al., 2004), these were all originally 
hypothetical proteins. Much is to be discovered about the functions of existing 
proteins (e. g. Esp) and hypothetical proteins must also have roles to be discovered, 
they could interact with or be themselves virulence factors. It was also surprising to 
observe that E. faecalis V385 (Reffuveille et al., 2011) has more lipoproteins than E. 
faecium E1162; it would therefore be interesting to analyse more E. faecium 
genomes to see whether the percentages for lipoproteins and secreted proteins seen 
here are true for all the genomes. 
 
As mentioned in the introduction, biofilm formation can increase antibiotic 
resistance in bacteria from 10-1000 fold (Hoiby et al., 2010). In this thesis 
calorimetry was demonstrated to be a sensitive method for studying antibiotic 
resistance therefore future research with the use of calorimetry could help in the 
discovery of effective drugs against enterococcal biofilms. Research has also been 
performed into adapting this method for biofilm analysis and this method has shown 
promising results when studying bactericidal and bacteriostatic treatments of 
biofilms (Buchholz et al., 2010a).  
 
We and others have observed that E. faecalis appears to produce more biofilm than 
E. faecium. Many more virulence factors have been studied in detail in E. faecalis 
than in E. faecium and this includes the frs-system and GelE production which have 
a role in eDNA production in E. faecalis. This system has not yet been identified in 
E. faecium and the production of gelatinase is sporadic (Biavasco et al., 2007, 
Vankerckhoven et al., 2004, Billstrom et al., 2008). It would be interesting to 
establish if eDNA is important to E. faecium biofilm formation and, if so, what are 
the mechanisms of its release if GelE is not present. 
 
Further understanding of Esp is still required; a study into S. aureus Bap protein, 
which has similarities to Esp, observed that the protein attaches to Gp96, a 
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chaperone protein on the host cell surface (Valle et al., 2012). That study also 
showed that Esp did not interact with Gp96 (Valle et al., 2012), but Esp may interact 
with other host cells surface proteins and therefore this would be interesting to 
establish this. To further extend information on Esp, crystallisation trials using 
purified N-terminal domain were performed (Bukhari and Bolhuis, unpublished 
data), but unfortunately no crystals were obtained. Further trials with the full protein 
are unlikely due to the size of the protein, but sections of the protein can be further 
studied and may give more information on the function of this protein. Currently 
analysis of the A repeat units with nuclear magnetic resonance (NMR) are being 
performed. Infecting C. elegans with E. faecalis suggested that Esp does not play a 
role in virulence. It would be interesting to establish if this is true for other surface 
proteins in other bacteria and so further testing is required.  
 
The increase in biofilm formation due to bile salts also requires further studies. In the 
case of E. faecium there was a distinct difference in biofilm formation in the 
presence of bile between E. faecium E1162 and E. faecium E1162∆esp, suggesting 
Esp had role in bile response. However, in the presence of bile the expression of Esp 
decreases, which seems counterintuitive. EPS production was shown to increase in 
biofilm formation when bile salts were present in E. faecium. This was not tested in 
E. faecalis therefore this requires confirmation, but also it would be interesting to 
study the composition of the EPS. Are there differences between E. faecium and E. 
faecalis? Does the presence of bile salts also effect composition? Enterococci have 
bile salt hydrolases and one theory is that these deconjugate the bile salts and that 
leads to insertion of the resulting components into cell membrane (Begley et al., 
2005). It is conceivable that would result in increased amounts of EPS, either 
through direct flux of bile or the glycine/taurine amino acids into the EPS, or 
indirectly through increased expression of enzymes involved in EPS production. 
Studying how bile increases EPS would also be required, perhaps using proteomics 
or transcriptomic studies.  Proteomics studies have been used to study mixed-species 
biofilms, biofilm-related proteins produced under stress (Klein et al., 2012) and for 
the analysis of the differences in secreted proteins in the planktonic and biofilm cells 
(Muthukrishnan et al., 2011). However, proteomics as of yet has not been fully used 
to study EPS (Seneviratne et al., 2012), and it would be therefore interesting to 
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utilise this more and test if regulatory proteins and/or other factors involved can be 
identified. Such studies do not need to be limited to EPS production only, but can be 
extended to include other factors involved in biofilm formation. For instance, in B. 
fragilis it was observed that fimbriae are overproduced in the presence of bile salts 
(Pumbwe et al., 2007), which could also be the case for enterococci.  
 
In B. fragilis (Pumbwe et al., 2007) and Bifidobacterium animalis subsp. lactis 
(Ruas-Madiedo et al., 2009) observed the production of vesicles in the presence of 
bile salts was observed. Ruas-Madiedo et al (2009) suggest this is a method of 
detoxification, but other studies have shown that vesicles can carry factors involved 
in attachment (Grenier and Mayrand, 1987) and the release of quorum sensing 
signalling molecules (Mashburn and Whiteley, 2005), all of which are important for 
colonisation and virulence. Vesicle release has also been linked with the release of 
eDNA (Kadurugamuwa and Beveridge, 1995), which links well with other future 
research on the study of eDNA production in E. faecium. Therefore it would be 
interesting to examine by transmission electron microscopy (TEM) to see if vesicles 
are also observed in on enterococcal cells in the presence of bile salts for. As shown 
here there are many ideas to investigate why biofilm formation is increased in the 
presence of bile salt. 
 
9.3. Summary of the main results from this thesis. 
 
 The E. faecium genome contains three SPases one of which is an ER-type 
SPase. This is unusual as they are usually found in sporulating bacteria which 
E. faecium is not. 
 2.3% of the secreted proteins have a Sec-type signal peptide and 1.8% have a 
Lipo-type signal peptide. 
 Esp was shown to have a possible role in ampicillin resistance using 
calorimetry. This technique was also demonstrated to be a sensitive and rapid 
method to study antimicrobial resistance 
 Esp in E. faecium increases hydrophobicity and thereby biofilm formation. 
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 E. faecium Esp is expressed in a growth-dependent manner, with most Esp 
expression occurring in biofilm cells. This growth-dependent manner was not 
observed in E. faecalis BS12297. 
 In both E. faecium and E. faecalis the presence of physiological 
concentrations of bile salts induced biofilm formation. It was also observed 
that individual components of bile salts differed in their effect on biofilm 
formation depending on the isolate. 
 Induction of biofilm due to bile salts was shown to occur independently of 
the presence of Esp, however the presence of Esp in E. faecium E1162 did 
allow for increased biofilm formation in a wider variety of concentrations 
than seen in E. faecium E1162Δesp,   suggesting   Esp’s involvement in the 
increased biofilm formation under this growth condition. 
 In E. faecium the presence of bile salts caused an increase in initial 
attachment, microcolony formation and EPS production. 
 This increase in biofilm formation was not caused by an increase in Esp 
expression. 
 Multi-drug resistant clinical isolates of E. faecium where shown not to kill C. 
elegans. E. faecium E1162 did kill C. elegans when grown anaerobically 
using   the   ‘fast   killing   mode’   and   E. faecalis Esp was shown not to be a 



































Figure A.1. Biofilm formation for E. faecium isolates in the presence of 























ABEE, T., KOVACS, A. T., KUIPERS, O. P. & VAN DER VEEN, S. 2011. Biofilm 
formation and dispersal in Gram-positive bacteria. Curr Opin Biotechnol, 22, 
172-9. 
ALEGADO, R. A., CAMPBELL, M. C., CHEN, W. C., SLUTZ, S. S. & TAN, M. 
W. 2003. Characterization of mediators of microbial virulence and innate 
immunity using the Caenorhabditis elegans host-pathogen model. Cell 
Microbiol, 5, 435-44. 
ALLISON, D. G. 2003. The biofilm matrix. Biofouling, 19, 139-50. 
ALTUN, Z. F. & HALL, D. H. 2009. Introduction. [Online]. Available: 
doi:10.3908/wormatlas.1.1 [Accessed]. 
ALVES, J. R., PEREIRA, A. C., SOUZA, M. C., COSTA, S. B., PINTO, A. S., 
MATTOS-GUARALDI, A. L., HIRATA-JUNIOR, R., ROSA, A. C. & 
ASAD, L. M. 2010. Iron-limited condition modulates biofilm formation and 
interaction with human epithelial cells of enteroaggregative Escherichia coli 
(EAEC). J Appl Microbiol, 108, 246-55. 
ANDREWS, J. M. 2001. Determination of minimum inhibitory concentrations. J 
Antimicrob Chemother, 48 Suppl 1, 5-16. 
ARIAS, C. A. & MURRAY, B. E. 2012. The rise of the Enterococcus: beyond 
vancomycin resistance. Nat Rev Microbiol, 10, 266-78. 
BABU, M. M., PRIYA, M. L., SELVAN, A. T., MADERA, M., GOUGH, J., 
ARAVIND, L. & SANKARAN, K. 2006. A database of bacterial 
lipoproteins (DOLOP) with functional assignments to predicted lipoproteins. 
J Bacteriol, 188, 2761-73. 
BAE, T. & SCHNEEWIND, O. 2003. The YSIRK-G/S motif of staphylococcal 
protein A and its role in efficiency of signal peptide processing. J Bacteriol, 
185, 2910-9. 
BALDASSARRI, L., CECCHINI, R., BERTUCCINI, L., AMMENDOLIA, M. G., 
IOSI, F., ARCIOLA, C. R., MONTANARO, L., DI ROSA, R., GHERARDI, 
G., DICUONZO, G., OREFICI, G. & CRETI, R. 2001. Enterococcus spp. 
produces slime and survives in rat peritoneal macrophages. Med Microbiol 
Immunol, 190, 113-20. 
BALDONI, D., HERMANN, H., FREI, R., TRAMPUZ, A. & STEINHUBER, A. 
2009. Performance of microcalorimetry for early detection of methicillin 
resistance in clinical isolates of Staphylococcus aureus. J Clin Microbiol, 47, 
774-6. 
BARNES, A. M., BALLERING, K. S., LEIBMAN, R. S., WELLS, C. L. & 
DUNNY, G. M. 2012. Enterococcus faecalis produces abundant extracellular 
structures containing DNA in the absence of cell lysis during early biofilm 
formation. MBio, 3, e00193-12. 
BEEZER, A. E. 1980. Biological Microcalorimetry, Academic press. 
BEGLEY, M., GAHAN, C. G. & HILL, C. 2005. The interaction between bacteria 
and bile. FEMS Microbiol Rev, 29, 625-51. 
BEGLEY, M., KERR, C. & HILL, C. 2009. Exposure to bile influences biofilm 
formation by Listeria monocytogenes. Gut Pathog, 1, 11. 
  References 
184 
 
BELOIN, C. & GHIGO, J. M. 2005. Finding gene-expression patterns in bacterial 
biofilms. Trends Microbiol, 13, 16-9. 
BIAVASCO, F., FOGLIA, G., PAOLETTI, C., ZANDRI, G., MAGI, G., 
GUAGLIANONE, E., SUNDSFJORD, A., PRUZZO, C., DONELLI, G. & 
FACINELLI, B. 2007. VanA-type enterococci from humans, animals, and 
food: species distribution, population structure, Tn1546 typing and location, 
and virulence determinants. Appl Environ Microbiol, 73, 3307-19. 
BILLSTROM, H., LUND, B., SULLIVAN, A. & NORD, C. E. 2008. Virulence and 
antimicrobial resistance in clinical Enterococcus faecium. Int J Antimicrob 
Agents, 32, 374-7. 
BIXLER, G. D. & BHUSHAN, B. 2012. Biofouling: lessons from nature. Philos 
Transact A Math Phys Eng Sci, 370, 2381-417. 
BIYIKOGLU, B., RICKER, A. & DIAZ, P. I. 2012. Strain-specific colonization 
patterns and serum modulation of multi-species oral biofilm development. 
Anaerobe, 18, 459-70. 
BOLM, M., JANSEN, W. T., SCHNABEL, R. & CHHATWAL, G. S. 2004. 
Hydrogen peroxide-mediated killing of Caenorhabditis elegans: a common 
feature of different streptococcal species. Infect Immun, 72, 1192-4. 
BOURGOGNE, A., HILSENBECK, S. G., DUNNY, G. M. & MURRAY, B. E. 
2006. Comparison of OG1RF and an isogenic fsrB deletion mutant by 
transcriptional analysis: the Fsr system of Enterococcus faecalis is more than 
the activator of gelatinase and serine protease. J Bacteriol, 188, 2875-84. 
BOURGOGNE, A., SINGH, K. V., FOX, K. A., PFLUGHOEFT, K. J., MURRAY, 
B. E. & GARSIN, D. A. 2007. EbpR is important for biofilm formation by 
activating expression of the endocarditis and biofilm-associated pilus operon 
(ebpABC) of Enterococcus faecalis OG1RF. J Bacteriol, 189, 6490-3. 
BOURGOGNE, A., THOMSON, L. C. & MURRAY, B. E. 2010. Bicarbonate 
enhances expression of the endocarditis and biofilm associated pilus locus, 
ebpR-ebpABC, in Enterococcus faecalis. BMC Microbiol, 10, 17. 
BRAISSANT, O., WIRZ, D., GOPFERT, B. & DANIELS, A. U. 2010. Biomedical 
use of isothermal microcalorimeters. Sensors (Basel), 10, 9369-83. 
BRANDL, K., PLITAS, G., MIHU, C. N., UBEDA, C., JIA, T., FLEISHER, M., 
SCHNABL, B., DEMATTEO, R. P. & PAMER, E. G. 2008. Vancomycin-
resistant enterococci exploit antibiotic-induced innate immune deficits. 
Nature, 455, 804-7. 
BRENNER, S. 1974. The genetics of Caenorhabditis elegans. Genetics, 77, 71-94. 
BRETON, Y. L., MAZE, A., HARTKE, A., LEMARINIER, S., AUFFRAY, Y. & 
RINCE, A. 2002. Isolation and characterization of bile salts-sensitive 
mutants of Enterococcus faecalis. Curr Microbiol, 45, 434-9. 
BRYAN, E. M., BAE, T., KLEEREBEZEM, M. & DUNNY, G. M. 2000. Improved 
vectors for nisin-controlled expression in gram-positive bacteria. Plasmid, 
44, 183-90. 
BUCHHOLZ, F., HARMS, H. & MASKOW, T. 2010a. Biofilm research using 
calorimetry--a marriage made in heaven? Biotechnol J, 5, 1339-50. 
BUCHHOLZ, F., WOLF, A., LERCHNER, J., MERTENS, F., HARMS, H. & 
MASKOW, T. 2010b. Chip calorimetry for fast and reliable evaluation of 
bactericidal and bacteriostatic treatments of biofilms. Antimicrob Agents 
Chemother, 54, 312-9. 
BURNS, A. R., KWOK, T. C., HOWARD, A., HOUSTON, E., JOHANSON, K., 
CHAN, A., CUTLER, S. R., MCCOURT, P. & ROY, P. J. 2006. High-
  References 
185 
 
throughput screening of small molecules for bioactivity and target 
identification in Caenorhabditis elegans. Nat Protoc, 1, 1906-14. 
CARNIOL, K. & GILMORE, M. S. 2004. Signal transduction, quorum-sensing, and 
extracellular protease activity in Enterococcus faecalis biofilm formation. J 
Bacteriol, 186, 8161-3. 
CETINKAYA, Y., FALK, P. & MAYHALL, C. G. 2000. Vancomycin-resistant 
enterococci. Clin Microbiol Rev, 13, 686-707. 
CHEN, M. Y., LEE, D. J., TAY, J. H. & SHOW, K. Y. 2007. Staining of 
extracellular polymeric substances and cells in bioaggregates. Appl Microbiol 
Biotechnol, 75, 467-74. 
CHMIELEWSKI, R. A. N. & FRANK, J. F. 2003. Biofilm Formation and Control in 
Food Processing Facilities. COMPREHENSIVE REVIEWS IN FOOD 
SCIENCE AND FOOD SAFETY, 2, 22-32. 
CHOW, J. W. 2000. Aminoglycoside resistance in enterococci. Clin Infect Dis, 31, 
586-9. 
CHUANG-SMITH, O. N., WELLS, C. L., HENRY-STANLEY, M. J. & DUNNY, 
G. M. 2010. Acceleration of Enterococcus faecalis biofilm formation by 
aggregation substance expression in an ex vivo model of cardiac valve 
colonization. PLoS One, 5, e15798. 
COBO MOLINOS, A., ABRIOUEL, H., OMAR, N. B., LOPEZ, R. L. & GALVEZ, 
A. 2008. Detection of ebp (endocarditis- and biofilm-associated pilus) genes 
in enterococcal isolates from clinical and non-clinical origin. Int J Food 
Microbiol, 126, 123-6. 
COETSER, S. E. & CLOETE, T. E. 2005. Biofouling and biocorrosion in industrial 
water systems. Crit Rev Microbiol, 31, 213-32. 
COSTERTON, J. W. 1995. Overview of microbial biofilms. J Ind Microbiol, 15, 
137-40. 
CRETI, R., FABRETTI, F., KOCH, S., HUEBNER, J., GARSIN, D. A., 
BALDASSARRI, L., MONTANARO, L. & ARCIOLA, C. R. 2009. Surface 
protein EF3314 contributes to virulence properties of Enterococcus faecalis. 
Int J Artif Organs, 32, 611-20. 
CRETI, R., KOCH, S., FABRETTI, F., BALDASSARRI, L. & HUEBNER, J. 2006. 
Enterococcal colonization of the gastro-intestinal tract: role of biofilm and 
environmental oligosaccharides. BMC Microbiol, 6, 60. 
DALBEY, R. E. & WICKNER, W. 1985. Leader peptidase catalyzes the release of 
exported proteins from the outer surface of the Escherichia coli plasma 
membrane. J Biol Chem, 260, 15925-31. 
DARBY, C., HSU, J. W., GHORI, N. & FALKOW, S. 2002. Caenorhabditis 
elegans: plague bacteria biofilm blocks food intake. Nature, 417, 243-4. 
DAVEY, M. E. & O'TOOLE G, A. 2000. Microbial biofilms: from ecology to 
molecular genetics. Microbiol Mol Biol Rev, 64, 847-67. 
DAY, A. M., COVE, J. H. & PHILLIPS-JONES, M. K. 2003. Cytolysin gene 
expression in Enterococcus faecalis is regulated in response to aerobiosis 
conditions. Mol Genet Genomics, 269, 31-9. 
DEDENT, A., BAE, T., MISSIAKAS, D. M. & SCHNEEWIND, O. 2008. Signal 
peptides direct surface proteins to two distinct envelope locations of 
Staphylococcus aureus. EMBO J, 27, 2656-68. 
DENYER, S. P., HODGES, N. A. & GORMAN, S. P. 2004. Hugo and Russell's 
Pharmaceutical Microbiology, Blackwell Publishing. 
  References 
186 
 
DERLON, N., MASSE, A., ESCUDIE, R., BERNET, N. & PAUL, E. 2008. 
Stratification in the cohesion of biofilms grown under various environmental 
conditions. Water Res, 42, 2102-10. 
DI ROSA, R., BASOLI, A., DONELLI, G., PENNI, A., STAVATORI, F. M., 
FIOCCA, F. & BALDASSARRI, L. 1999. A microbiological and 
morphological study of blocked biliary stents. Microbial Ecology in Health 
and Disease, 11, 84-88. 
DI ROSA, R., CRETI, R., VENDITTI, M., D'AMELIO, R., ARCIOLA, C. R., 
MONTANARO, L. & BALDASSARRI, L. 2006. Relationship between 
biofilm formation, the enterococcal surface protein (Esp) and gelatinase in 
clinical isolates of Enterococcus faecalis and Enterococcus faecium. FEMS 
Microbiol Lett, 256, 145-50. 
DONELLI, G., GUAGLIANONE, E., DI ROSA, R., FIOCCA, F. & BASOLI, A. 
2007. Plastic biliary stent occlusion: factors involved and possible preventive 
approaches. Clin Med Res, 5, 53-60. 
DONLAN, R. M. 2002. Biofilms: microbial life on surfaces. Emerg Infect Dis, 8, 
881-90. 
DONSKEY, C. J., CHOWDHRY, T. K., HECKER, M. T., HOYEN, C. K., 
HANRAHAN, J. A., HUJER, A. M., HUTTON-THOMAS, R. A., 
WHALEN, C. C., BONOMO, R. A. & RICE, L. B. 2000. Effect of antibiotic 
therapy on the density of vancomycin-resistant enterococci in the stool of 
colonized patients. N Engl J Med, 343, 1925-32. 
DOWIDAR, N., KOLMOS, H. J., LYON, H. & MATZEN, P. 1991. Clogging of 
biliary endoprostheses. A morphologic and bacteriologic study. Scand J 
Gastroenterol, 26, 1137-44. 
DUSSURGET, O., CABANES, D., DEHOUX, P., LECUIT, M., BUCHRIESER, C., 
GLASER, P. & COSSART, P. 2002. Listeria monocytogenes bile salt 
hydrolase is a PrfA-regulated virulence factor involved in the intestinal and 
hepatic phases of listeriosis. Mol Microbiol, 45, 1095-106. 
EARRS 2010. EARRS annual report 2010. 
ECKERT, C., LECERF, M., DUBOST, L., ARTHUR, M. & MESNAGE, S. 2006. 
Functional analysis of AtlA, the major N-acetylglucosaminidase of 
Enterococcus faecalis. J Bacteriol, 188, 8513-9. 
EICHENBAUM, Z., FEDERLE, M. J., MARRA, D., DE VOS, W. M., KUIPERS, 
O. P., KLEEREBEZEM, M. & SCOTT, J. R. 1998. Use of the lactococcal 
nisA promoter to regulate gene expression in gram-positive bacteria: 
comparison of induction level and promoter strength. Appl Environ 
Microbiol, 64, 2763-9. 
ENGELBERT, M., MYLONAKIS, E., AUSUBEL, F. M., CALDERWOOD, S. B. 
& GILMORE, M. S. 2004. Contribution of gelatinase, serine protease, and 
fsr to the pathogenesis of Enterococcus faecalis endophthalmitis. Infect 
Immun, 72, 3628-33. 
FINI, A., FOEROCI, G. & RODA, A. 2002. Acidity in bile acid systems. 
Polyhedron, 21, 1421-1427. 
FLAHAUT, S., FRERE, J., BOUTIBONNES, P. & AUFFRAY, Y. 1996. 
Comparison of the bile salts and sodium dodecyl sulfate stress responses in 
Enterococcus faecalis. Appl Environ Microbiol, 62, 2416-20. 
FLAHAUT, S., HARTKE, A., GIARD, J. C. & AUFFRAY, Y. 1997. Alkaline stress 
response in Enterococcus faecalis: adaptation, cross-protection, and changes 
in protein synthesis. Appl Environ Microbiol, 63, 812-4. 
  References 
187 
 
FLEMMING, H. C. & WINGENDER, J. 2010. The biofilm matrix. Nat Rev 
Microbiol, 8, 623-33. 
FLUIT, A. C., VISSER, M. R. & SCHMITZ, F. J. 2001. Molecular detection of 
antimicrobial resistance. Clin Microbiol Rev, 14, 836-71, table of contents. 
FRANZ, C. M., HOLZAPFEL, W. H. & STILES, M. E. 1999. Enterococci at the 
crossroads of food safety? Int J Food Microbiol, 47, 1-24. 
FREUDL, R. 2013. Leaving home ain't easy: protein export systems in Gram-
positive bacteria. Res Microbiol. 
FUX, C. A., COSTERTON, J. W., STEWART, P. S. & STOODLEY, P. 2005. 
Survival strategies of infectious biofilms. Trends Microbiol, 13, 34-40. 
GALLARDO-MORENO, A. M., GONZALEZ-MARTIN, M. L., PEREZ-
GIRALDO, C., BRUQUE, J. M. & GOMEZ-GARCIA, A. C. 2002. Serum as 
a factor influencing adhesion of Enterococcus faecalis to glass and silicone. 
Appl Environ Microbiol, 68, 5784-7. 
GARSIN, D. A., SIFRI, C. D., MYLONAKIS, E., QIN, X., SINGH, K. V., 
MURRAY, B. E., CALDERWOOD, S. B. & AUSUBEL, F. M. 2001. A 
simple model host for identifying Gram-positive virulence factors. Proc Natl 
Acad Sci U S A, 98, 10892-7. 
GELSOMINO, R., VANCANNEYT, M., COGAN, T. M., CONDON, S. & 
SWINGS, J. 2002. Source of enterococci in a farmhouse raw-milk cheese. 
Appl Environ Microbiol, 68, 3560-5. 
GHOLIZADEH, Y. & COURVALIN, P. 2000. Acquired and intrinsic glycopeptide 
resistance in enterococci. Int J Antimicrob Agents, 16 Suppl 1, S11-7. 
GIRON, D. 1986. Applications of thermal analysis in the pharmaceutical and 
biomedical analysis. Journal of Pharmaceutica and biomedical analysis, 4, 
755-770. 
GRAVATO-NOBRE, M. J. & HODGKIN, J. 2005. Caenorhabditis elegans as a 
model for innate immunity to pathogens. Cell Microbiol, 7, 741-51. 
GRENIER, D. & MAYRAND, D. 1987. Functional characterization of extracellular 
vesicles produced by Bacteroides gingivalis. Infect Immun, 55, 111-7. 
GUITON, P. S., HUNG, C. S., KLINE, K. A., ROTH, R., KAU, A. L., HAYES, E., 
HEUSER, J., DODSON, K. W., CAPARON, M. G. & HULTGREN, S. J. 
2009. Contribution of autolysin and Sortase a during Enterococcus faecalis 
DNA-dependent biofilm development. Infect Immun, 77, 3626-38. 
GUNN, J. S. 2000. Mechanisms of bacterial resistance and response to bile. 
Microbes Infect, 2, 907-13. 
HABASH, M. & REID, G. 1999. Microbial biofilms: their development and 
significance for medical device-related infections. J Clin Pharmacol, 39, 
887-98. 
HALL-STOODLEY, L., COSTERTON, J. W. & STOODLEY, P. 2004. Bacterial 
biofilms: from the natural environment to infectious diseases. Nat Rev 
Microbiol, 2, 95-108. 
HALL-STOODLEY, L. & STOODLEY, P. 2002. Developmental regulation of 
microbial biofilms. Curr Opin Biotechnol, 13, 228-33. 
HALL-STOODLEY, L. & STOODLEY, P. 2009. Evolving concepts in biofilm 
infections. Cell Microbiol, 11, 1034-43. 
HALLGREN, A., CLAESSON, C., SAEEDI, B., MONSTEIN, H. J., 
HANBERGER, H. & NILSSON, L. E. 2009. Molecular detection of 
aggregation substance, enterococcal surface protein, and cytolysin genes and 
  References 
188 
 
in vitro adhesion to urinary catheters of Enterococcus faecalis and E. faecium 
of clinical origin. Int J Med Microbiol, 299, 323-32. 
HAMON, M. A., STANLEY, N. R., BRITTON, R. A., GROSSMAN, A. D. & 
LAZAZZERA, B. A. 2004. Identification of AbrB-regulated genes involved 
in biofilm formation by Bacillus subtilis. Mol Microbiol, 52, 847-60. 
HANCOCK, L. E. & GILMORE, M. S. 2002. The capsular polysaccharide of 
Enterococcus faecalis and its relationship to other polysaccharides in the cell 
wall. Proc Natl Acad Sci U S A, 99, 1574-9. 
HANCOCK, L. E. & PEREGO, M. 2004. The Enterococcus faecalis fsr two-
component system controls biofilm development through production of 
gelatinase. J Bacteriol, 186, 5629-39. 
HARRIS, D. A., POWERS, M. E. & ROMESBERG, F. E. 2009. Synthesis and 
biological evaluation of penem inhibitors of bacterial signal peptidase. 
Bioorg Med Chem Lett, 19, 3787-90. 
HEIKENS, E., BONTEN, M. J. & WILLEMS, R. J. 2007. Enterococcal surface 
protein Esp is important for biofilm formation of Enterococcus faecium 
E1162. J Bacteriol, 189, 8233-40. 
HEIKENS, E., LEENDERTSE, M., WIJNANDS, L. M., VAN LUIT-ASBROEK, 
M., BONTEN, M. J., VAN DER POLL, T. & WILLEMS, R. J. 2009. 
Enterococcal surface protein Esp is not essential for cell adhesion and 
intestinal colonization of Enterococcus faecium in mice. BMC Microbiol, 9, 
19. 
HEIKENS, E., SINGH, K. V., JACQUES-PALAZ, K. D., VAN LUIT-ASBROEK, 
M., OOSTDIJK, E. A., BONTEN, M. J., MURRAY, B. E. & WILLEMS, R. 
J. 2011. Contribution of the enterococcal surface protein Esp to pathogenesis 
of Enterococcus faecium endocarditis. Microbes Infect, 13, 1185-90. 
HENDRICKX, A. P., BONTEN, M. J., VAN LUIT-ASBROEK, M., 
SCHAPENDONK, C. M., KRAGTEN, A. H. & WILLEMS, R. J. 2008. 
Expression of two distinct types of pili by a hospital-acquired Enterococcus 
faecium isolate. Microbiology, 154, 3212-23. 
HENDRICKX, A. P., SCHAPENDONK, C. M., VAN LUIT-ASBROEK, M., 
BONTEN, M. J., VAN SCHAIK, W. & WILLEMS, R. J. 2010. Differential 
PilA pilus assembly by a hospital-acquired and a community-derived 
Enterococcus faecium isolate. Microbiology, 156, 2649-59. 
HENDRICKX, A. P., VAN LUIT-ASBROEK, M., SCHAPENDONK, C. M., VAN 
WAMEL, W. J., BRAAT, J. C., WIJNANDS, L. M., BONTEN, M. J. & 
WILLEMS, R. J. 2009a. SgrA, a nidogen-binding LPXTG surface adhesin 
implicated in biofilm formation, and EcbA, a collagen binding MSCRAMM, 
are two novel adhesins of hospital-acquired Enterococcus faecium. Infect 
Immun, 77, 5097-106. 
HENDRICKX, A. P., VAN WAMEL, W. J., POSTHUMA, G., BONTEN, M. J. & 
WILLEMS, R. J. 2007. Five genes encoding surface-exposed LPXTG 
proteins are enriched in hospital-adapted Enterococcus faecium clonal 
complex 17 isolates. J Bacteriol, 189, 8321-32. 
HENDRICKX, A. P., WILLEMS, R. J., BONTEN, M. J. & VAN SCHAIK, W. 
2009b. LPxTG surface proteins of enterococci. Trends Microbiol, 17, 423-
30. 
HEYDORN, A., NIELSEN, A. T., HENTZER, M., STERNBERG, C., GIVSKOV, 
M., ERSBOLL, B. K. & MOLIN, S. 2000. Quantification of biofilm 
  References 
189 
 
structures by the novel computer program COMSTAT. Microbiology, 146 ( 
Pt 10), 2395-407. 
HODGKIN, J. 2005. Introduction to genetics and genomics. In: COMMUNITY, T. 
C. E. R. (ed.) WormBook. WormBook. 
HOFMANN, A. F. 1998. Bile secreation and the enterohepatic circulation of bile 
acids. In: FLEDMAN, M., SCHARSCHMIDT, B. F. & M.H., S. (eds.) 
Gastrointestinal Disease. 6 ed.: Philadelphia, PA: Saunders. 
HOIBY, N., BJARNSHOLT, T., GIVSKOV, M., MOLIN, S. & CIOFU, O. 2010. 
Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents, 35, 322-
32. 
HUFNAGEL, M., KOCH, S., CRETI, R., BALDASSARRI, L. & HUEBNER, J. 
2004. A putative sugar-binding transcriptional regulator in a novel gene locus 
in Enterococcus faecalis contributes to production of biofilm and prolonged 
bacteremia in mice. J Infect Dis, 189, 420-30. 
HUTCHINGS, M. I., PALMER, T., HARRINGTON, D. J. & SUTCLIFFE, I. C. 
2009. Lipoprotein biogenesis in Gram-positive bacteria: knowing when to 
hold 'em, knowing when to fold 'em. Trends Microbiol, 17, 13-21. 
HWANG, G., KANG, S., EL-DIN, M. G. & LIU, Y. 2012. Impact of conditioning 
films on the initial adhesion of Burkholderia cepacia. Colloids Surf B 
Biointerfaces, 91, 181-8. 
JANSEN, W. T., BOLM, M., BALLING, R., CHHATWAL, G. S. & SCHNABEL, 
R. 2002. Hydrogen peroxide-mediated killing of Caenorhabditis elegans by 
Streptococcus pyogenes. Infect Immun, 70, 5202-7. 
JENKINS, G. 2008. Bile acids: Toxicology and bioactivity, Cambridge: Royal 
society of Chemistry. 
JETT, B. D., HUYCKE, M. M. & GILMORE, M. S. 1994. Virulence of enterococci. 
Clin Microbiol Rev, 7, 462-78. 
JOHNSON, M., COCKAYNE, A., WILLIAMS, P. H. & MORRISSEY, J. A. 2005. 
Iron-responsive regulation of biofilm formation in staphylococcus aureus 
involves fur-dependent and fur-independent mechanisms. J Bacteriol, 187, 
8211-5. 
JONES, D. & SHATTOCK, P. M. 1960. The location of the group antigen of group 
D Streptococcus. J Gen Microbiol, 23, 335-43. 
JUNCKER, A. S., WILLENBROCK, H., VON HEIJNE, G., BRUNAK, S., 
NIELSEN, H. & KROGH, A. 2003. Prediction of lipoprotein signal peptides 
in Gram-negative bacteria. Protein Sci, 12, 1652-62. 
JUREEN, R., HARTHUG, S., SORNES, S., DIGRANES, A., WILLEMS, R. J. & 
LANGELAND, N. 2004. Comparative analysis of amplified fragment length 
polymorphism and pulsed field gel electrophoresis in a hospital outbreak and 
subsequent endemicity of ampicillin-resistant Enterococcus faecium. FEMS 
Immunol Med Microbiol, 40, 33-9. 
KADURUGAMUWA, J. L. & BEVERIDGE, T. J. 1995. Virulence factors are 
released from Pseudomonas aeruginosa in association with membrane 
vesicles during normal growth and exposure to gentamicin: a novel 
mechanism of enzyme secretion. J Bacteriol, 177, 3998-4008. 
KAU, A. L., MARTIN, S. M., LYON, W., HAYES, E., CAPARON, M. G. & 
HULTGREN, S. J. 2005. Enterococcus faecalis tropism for the kidneys in the 
urinary tract of C57BL/6J mice. Infect Immun, 73, 2461-8. 
  References 
190 
 
KAYAOGLU, G., ERTEN, H. & ORSTAVIK, D. 2005. Growth at high pH 
increases Enterococcus faecalis adhesion to collagen. Int Endod J, 38, 389-
96. 
KHAN, M. Z., PREBEG, Z. & KURJAKOVIC, N. 1999. A pH-dependent colon 
targeted oral drug delivery system using methacrylic acid copolymers. I. 
Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 
combinations. J Control Release, 58, 215-22. 
KINNEBREW, M. A., UBEDA, C., ZENEWICZ, L. A., SMITH, N., FLAVELL, R. 
A. & PAMER, E. G. 2010. Bacterial flagellin stimulates Toll-like receptor 5-
dependent defense against vancomycin-resistant Enterococcus infection. J 
Infect Dis, 201, 534-43. 
KLEIN, M. I., XIAO, J., LU, B., DELAHUNTY, C. M., YATES, J. R., 3RD & 
KOO, H. 2012. Streptococcus mutans protein synthesis during mixed-species 
biofilm development by high-throughput quantitative proteomics. PLoS One, 
7, e45795. 
KOBAYASHI, S. D., MUSSER, J. M. & DELEO, F. R. 2012. Genomic analysis of 
the emergence of vancomycin-resistant Staphylococcus aureus. MBio, 3. 
KOVACS-SIMON, A., TITBALL, R. W. & MICHELL, S. L. 2011. Lipoproteins of 
bacterial pathogens. Infect Immun, 79, 548-61. 
KRISTICH, C. J., CHANDLER, J. R. & DUNNY, G. M. 2007. Development of a 
host-genotype-independent counterselectable marker and a high-frequency 
conjugative delivery system and their use in genetic analysis of Enterococcus 
faecalis. Plasmid, 57, 131-44. 
KRISTICH, C. J., LI, Y. H., CVITKOVITCH, D. G. & DUNNY, G. M. 2004. Esp-
independent biofilm formation by Enterococcus faecalis. J Bacteriol, 186, 
154-63. 
KRISTICH, C. J., NGUYEN, V. T., LE, T., BARNES, A. M., GRINDLE, S. & 
DUNNY, G. M. 2008. Development and use of an efficient system for 
random mariner transposon mutagenesis to identify novel genetic 
determinants of biofilm formation in the core Enterococcus faecalis genome. 
Appl Environ Microbiol, 74, 3377-86. 
KROGH, A., LARSSON, B., VON HEIJNE, G. & SONNHAMMER, E. L. 2001. 
Predicting transmembrane protein topology with a hidden Markov model: 
application to complete genomes. J Mol Biol, 305, 567-80. 
KUIPERS, O. P., DE RUYTER, P. G. G. A., KLEEREBEZEN, M. & VOS, W. M. 
1998. Quorum sensing-controlled gene expression in lactic acid bacteria. 
Journal of Biotechnology, 64, 15-21. 
KUMAR, C. G. & ANAND, S. K. 1998. Significance of microbial biofilms in food 
industry: a review. Int J Food Microbiol, 42, 9-27. 
KURZ, C. L., CHAUVET, S., ANDRES, E., AUROUZE, M., VALLET, I., 
MICHEL, G. P., UH, M., CELLI, J., FILLOUX, A., DE BENTZMANN, S., 
STEINMETZ, I., HOFFMANN, J. A., FINLAY, B. B., GORVEL, J. P., 
FERRANDON, D. & EWBANK, J. J. 2003. Virulence factors of the human 
opportunistic pathogen Serratia marcescens identified by in vivo screening. 
EMBO J, 22, 1451-60. 
LACKS, S. & GREENBERG, B. 1977. Complementary specificity of restriction 
endonucleases of Diplococcus pneumoniae with respect to DNA methylation. 
J Mol Biol, 114, 153-68. 
LAEMMLI, U. K. 1970. Cleavage of structural proteins during the assembly of the 
head of bacteriophage T4. Nature, 227, 680-5. 
  References 
191 
 
LASA, I. & PENADES, J. R. 2006. Bap: a family of surface proteins involved in 
biofilm formation. Res Microbiol, 157, 99-107. 
LATASA, C., SOLANO, C., PENADES, J. R. & LASA, I. 2006. Biofilm-associated 
proteins. C R Biol, 329, 849-57. 
LAVERDE GOMEZ, J. A., HENDRICKX, A. P., WILLEMS, R. J., TOP, J., SAVA, 
I., HUEBNER, J., WITTE, W. & WERNER, G. 2011. Intra- and interspecies 
genomic transfer of the Enterococcus faecalis pathogenicity island. PLoS 
One, 6, e16720. 
LEAVIS, H. L., WILLEMS, R. J., VAN WAMEL, W. J., SCHUREN, F. H., 
CASPERS, M. P. & BONTEN, M. J. 2007. Insertion sequence-driven 
diversification creates a globally dispersed emerging multiresistant 
subspecies of E. faecium. PLoS Pathog, 3, e7. 
LEBEER, S., VERHOEVEN, T. L., PEREA VELEZ, M., VANDERLEYDEN, J. & 
DE KEERSMAECKER, S. C. 2007. Impact of environmental and genetic 
factors on biofilm formation by the probiotic strain Lactobacillus rhamnosus 
GG. Appl Environ Microbiol, 73, 6768-75. 
LEENDERTSE, M., HEIKENS, E., WIJNANDS, L. M., VAN LUIT-ASBROEK, 
M., TESKE, G. J., ROELOFS, J. J., BONTEN, M. J., VAN DER POLL, T. 
& WILLEMS, R. J. 2009. Enterococcal surface protein transiently aggravates 
Enterococcus faecium-induced urinary tract infection in mice. J Infect Dis, 
200, 1162-5. 
LEENHOUTS, K. J., KOK, J. & VENEMA, G. 1990. Stability of Integrated 
Plasmids in the Chromosome of Lactococcus lactis. Appl Environ Microbiol, 
56, 2726-2735. 
LEJEUNE, P. 2003. Contamination of abiotic surfaces: what a colonizing bacterium 
sees and how to blur it. Trends Microbiol, 11, 179-84. 
LENZ, C. A., HEW FERSTL, C. M. & VOGEL, R. F. 2010. Sub-lethal stress effects 
on virulence gene expression in Enterococcus faecalis. Food Microbiol, 27, 
317-26. 
LEWIS, K. 2001. Riddle of biofilm resistance. Antimicrob Agents Chemother, 45, 
999-1007. 
LI, Y. H. & TIAN, X. 2012. Quorum sensing and bacterial social interactions in 
biofilms. Sensors (Basel), 12, 2519-38. 
LOO, C. Y., CORLISS, D. A. & GANESHKUMAR, N. 2000. Streptococcus 
gordonii biofilm formation: identification of genes that code for biofilm 
phenotypes. J Bacteriol, 182, 1374-82. 
MADOFF, L. C., HORI, S., MICHEL, J. L., BAKER, C. J. & KASPER, D. L. 1991. 
Phenotypic diversity in the alpha C protein of group B streptococci. Infect 
Immun, 59, 2638-44. 
MADOFF, L. C., MICHEL, J. L., GONG, E. W., KLING, D. E. & KASPER, D. L. 
1996. Group B streptococci escape host immunity by deletion of tandem 
repeat elements of the alpha C protein. Proc Natl Acad Sci U S A, 93, 4131-6. 
MARRAFFINI, L. A. & SONTHEIMER, E. J. 2010. CRISPR interference: RNA-
directed adaptive immunity in bacteria and archaea. Nat Rev Genet, 11, 181-
90. 
MASHBURN, L. M. & WHITELEY, M. 2005. Membrane vesicles traffic signals 
and facilitate group activities in a prokaryote. Nature, 437, 422-5. 
MCDOUGALD, D., RICE, S. A., BARRAUD, N., STEINBERG, P. D. & 
KJELLEBERG, S. 2012. Should we stay or should we go: mechanisms and 
ecological consequences for biofilm dispersal. Nat Rev Microbiol, 10, 39-50. 
  References 
192 
 
MERRITT, M. E. & DONALDSON, J. R. 2009. Effect of bile salts on the DNA and 
membrane integrity of enteric bacteria. J Med Microbiol, 58, 1533-41. 
MIERAU, I. & KLEEREBEZEM, M. 2005. 10 years of the nisin-controlled gene 
expression system (NICE) in Lactococcus lactis. Appl Microbiol Biotechnol, 
68, 705-17. 
MILLER, M. B. & BASSLER, B. L. 2001. Quorum sensing in bacteria. Annu Rev 
Microbiol, 55, 165-99. 
MIROUX, B. & WALKER, J. E. 1996. Over-production of proteins in Escherichia 
coli: mutant hosts that allow synthesis of some membrane proteins and 
globular proteins at high levels. J Mol Biol, 260, 289-98. 
MOHAMED, J. A. & HUANG, D. B. 2007. Biofilm formation by enterococci. J 
Med Microbiol, 56, 1581-8. 
MOHAMED, J. A., HUANG, W., NALLAPAREDDY, S. R., TENG, F. & 
MURRAY, B. E. 2004. Influence of origin of isolates, especially endocarditis 
isolates, and various genes on biofilm formation by Enterococcus faecalis. 
Infect Immun, 72, 3658-63. 
MOHAMED, J. A., TENG, F., NALLAPAREDDY, S. R. & MURRAY, B. E. 2006. 
Pleiotrophic effects of 2 Enterococcus faecalis sagA-like genes, salA and 
salB, which encode proteins that are antigenic during human infection, on 
biofilm formation and binding to collagen type i and fibronectin. J Infect Dis, 
193, 231-40. 
MONDS, R. D. & O'TOOLE, G. A. 2009. The developmental model of microbial 
biofilms: ten years of a paradigm up for review. Trends Microbiol, 17, 73-87. 
MONTANARO, L., POGGI, A., VISAI, L., RAVAIOLI, S., CAMPOCCIA, D., 
SPEZIALE, P. & ARCIOLA, C. R. 2011. Extracellular DNA in biofilms. Int 
J Artif Organs, 34, 824-31. 
MOONS, P., MICHIELS, C. W. & AERTSEN, A. 2009. Bacterial interactions in 
biofilms. Crit Rev Microbiol, 35, 157-68. 
MORGANROTH, E. & WILDERER, P. A. 2000. Influence of detachment 
mechanisms on competition in biofilms. Water research, 34, 417-426. 
MORI, H. & ITO, K. 2001. The Sec protein-translocation pathway. Trends 
Microbiol, 9, 494-500. 
MORRISON, D., WOODFORD, N., BARRETT, S. P., SISSON, P. & COOKSON, 
B. D. 1999. DNA banding pattern polymorphism in vancomycin-resistant 
Enterococcus faecium and criteria for defining strains. J Clin Microbiol, 37, 
1084-91. 
MOY, T. I., BALL, A. R., ANKLESARIA, Z., CASADEI, G., LEWIS, K. & 
AUSUBEL, F. M. 2006. Identification of novel antimicrobials using a live-
animal infection model. Proc Natl Acad Sci U S A, 103, 10414-9. 
MOY, T. I., MYLONAKIS, E., CALDERWOOD, S. B. & AUSUBEL, F. M. 2004. 
Cytotoxicity of hydrogen peroxide produced by Enterococcus faecium. Infect 
Immun, 72, 4512-20. 
MURRAY, B. E. 1992. Beta-lactamase-producing enterococci. Antimicrob Agents 
Chemother, 36, 2355-9. 
MUTHUKRISHNAN, G., QUINN, G. A., LAMERS, R. P., DIAZ, C., COLE, A. L., 
CHEN, S. & COLE, A. M. 2011. Exoproteome of Staphylococcus aureus 
reveals putative determinants of nasal carriage. J Proteome Res, 10, 2064-78. 
NAKAYAMA, J., CHEN, S., OYAMA, N., NISHIGUCHI, K., AZAB, E. A., 
TANAKA, E., KARIYAMA, R. & SONOMOTO, K. 2006. Revised model 
for Enterococcus faecalis fsr quorum-sensing system: the small open reading 
  References 
193 
 
frame fsrD encodes the gelatinase biosynthesis-activating pheromone 
propeptide corresponding to staphylococcal agrd. J Bacteriol, 188, 8321-6. 
NALLAPAREDDY, S. R., QIN, X., WEINSTOCK, G. M., HOOK, M. & 
MURRAY, B. E. 2000a. Enterococcus faecalis adhesin, ace, mediates 
attachment to extracellular matrix proteins collagen type IV and laminin as 
well as collagen type I. Infect Immun, 68, 5218-24. 
NALLAPAREDDY, S. R., SILLANPAA, J., MITCHELL, J., SINGH, K. V., 
CHOWDHURY, S. A., WEINSTOCK, G. M., SULLAM, P. M. & 
MURRAY, B. E. 2011a. Conservation of Ebp-type pilus genes among 
Enterococci and demonstration of their role in adherence of Enterococcus 
faecalis to human platelets. Infect Immun, 79, 2911-20. 
NALLAPAREDDY, S. R., SINGH, K. V., DUH, R. W., WEINSTOCK, G. M. & 
MURRAY, B. E. 2000b. Diversity of ace, a gene encoding a microbial 
surface component recognizing adhesive matrix molecules, from different 
strains of Enterococcus faecalis and evidence for production of ace during 
human infections. Infect Immun, 68, 5210-7. 
NALLAPAREDDY, S. R., SINGH, K. V. & MURRAY, B. E. 2006a. Construction 
of improved temperature-sensitive and mobilizable vectors and their use for 
constructing mutations in the adhesin-encoding acm gene of poorly 
transformable clinical Enterococcus faecium strains. Appl Environ Microbiol, 
72, 334-45. 
NALLAPAREDDY, S. R., SINGH, K. V. & MURRAY, B. E. 2008a. Contribution 
of the collagen adhesin Acm to pathogenesis of Enterococcus faecium in 
experimental endocarditis. Infect Immun, 76, 4120-8. 
NALLAPAREDDY, S. R., SINGH, K. V., OKHUYSEN, P. C. & MURRAY, B. E. 
2008b. A functional collagen adhesin gene, acm, in clinical isolates of 
Enterococcus faecium correlates with the recent success of this emerging 
nosocomial pathogen. Infect Immun, 76, 4110-9. 
NALLAPAREDDY, S. R., SINGH, K. V., SILLANPAA, J., GARSIN, D. A., 
HOOK, M., ERLANDSEN, S. L. & MURRAY, B. E. 2006b. Endocarditis 
and biofilm-associated pili of Enterococcus faecalis. J Clin Invest, 116, 2799-
807. 
NALLAPAREDDY, S. R., SINGH, K. V., SILLANPAA, J., ZHAO, M. & 
MURRAY, B. E. 2011b. Relative contributions of Ebp Pili and the collagen 
adhesin ace to host extracellular matrix protein adherence and experimental 
urinary tract infection by Enterococcus faecalis OG1RF. Infect Immun, 79, 
2901-10. 
NALLAPAREDDY, S. R., WEINSTOCK, G. M. & MURRAY, B. E. 2003. Clinical 
isolates of Enterococcus faecium exhibit strain-specific collagen binding 
mediated by Acm, a new member of the MSCRAMM family. Mol Microbiol, 
47, 1733-47. 
NOBLE, W. C., VIRANI, Z. & CREE, R. G. 1992. Co-transfer of vancomycin and 
other resistance genes from Enterococcus faecalis NCTC 12201 to 
Staphylococcus aureus. FEMS Microbiol Lett, 72, 195-8. 
O'NEILL, M. A., VINE, G. J., BEEZER, A. E., BISHOP, A. H., HADGRAFT, J., 
LABETOULLE, C., WALKER, M. & BOWLER, P. G. 2003. Antimicrobial 
properties of silver-containing wound dressings: a microcalorimetric study. 
Int J Pharm, 263, 61-8. 
O'TOOLE, G., KAPLAN, H. B. & KOLTER, R. 2000. Biofilm formation as 
microbial development. Annu Rev Microbiol, 54, 49-79. 
  References 
194 
 
OLMSTED, S. B., KAO, S. M., VAN PUTTE, L. J., GALLO, J. C. & DUNNY, G. 
M. 1991. Role of the pheromone-inducible surface protein Asc10 in mating 
aggregate formation and conjugal transfer of the Enterococcus faecalis 
plasmid pCF10. J Bacteriol, 173, 7665-72. 
PAETZEL, M., KARLA, A., STRYNADKA, N. C. & DALBEY, R. E. 2002. Signal 
peptidases. Chem Rev, 102, 4549-80. 
PALMER, J., FLINT, S. & BROOKS, J. 2007. Bacterial cell attachment, the 
beginning of a biofilm. J Ind Microbiol Biotechnol, 34, 577-88. 
PALMER, K. L. & GILMORE, M. S. 2010. Multidrug-resistant enterococci lack 
CRISPR-cas. MBio, 1. 
PALMER, T. & BERKS, B. C. 2012. The twin-arginine translocation (Tat) protein 
export pathway. Nat Rev Microbiol, 10, 483-96. 
PARTAY, L. B., SEGA, M. & JEDLOVSZKY, P. 2007. Morphology of bile salt 
micelles as studied by computer simulation methods. Langmuir, 23, 12322-8. 
PAULSEN, I. T., BANERJEI, L., MYERS, G. S., NELSON, K. E., SESHADRI, R., 
READ, T. D., FOUTS, D. E., EISEN, J. A., GILL, S. R., HEIDELBERG, J. 
F., TETTELIN, H., DODSON, R. J., UMAYAM, L., BRINKAC, L., 
BEANAN, M., DAUGHERTY, S., DEBOY, R. T., DURKIN, S., 
KOLONAY, J., MADUPU, R., NELSON, W., VAMATHEVAN, J., TRAN, 
B., UPTON, J., HANSEN, T., SHETTY, J., KHOURI, H., UTTERBACK, 
T., RADUNE, D., KETCHUM, K. A., DOUGHERTY, B. A. & FRASER, C. 
M. 2003. Role of mobile DNA in the evolution of vancomycin-resistant 
Enterococcus faecalis. Science, 299, 2071-4. 
PETERSEN, T. N., BRUNAK, S., VON HEIJNE, G. & NIELSEN, H. 2011. SignalP 
4.0: discriminating signal peptides from transmembrane regions. Nat 
Methods, 8, 785-6. 
PINKSTON, K. L., GAO, P., DIAZ-GARCIA, D., SILLANPAA, J., 
NALLAPAREDDY, S. R., MURRAY, B. E. & HARVEY, B. R. 2011. The 
Fsr quorum-sensing system of Enterococcus faecalis modulates surface 
display of the collagen-binding MSCRAMM Ace through regulation of gelE. 
J Bacteriol, 193, 4317-25. 
POPE, L. M., REED, K. E. & PAYNE, S. M. 1995. Increased protein secretion and 
adherence to HeLa cells by Shigella spp. following growth in the presence of 
bile salts. Infect Immun, 63, 3642-8. 
PRAGAI, Z., TJALSMA, H., BOLHUIS, A., VAN DIJL, J. M., VENEMA, G. & 
BRON, S. 1997. The signal peptidase II (Isp) gene of Bacillus subtilis. 
Microbiology, 143 ( Pt 4), 1327-33. 
PROUTY, A. M. & GUNN, J. S. 2000. Salmonella enterica serovar typhimurium 
invasion is repressed in the presence of bile. Infect Immun, 68, 6763-9. 
PROUTY, A. M., SCHWESINGER, W. H. & GUNN, J. S. 2002. Biofilm formation 
and interaction with the surfaces of gallstones by Salmonella spp. Infect 
Immun, 70, 2640-9. 
PUJOL, N., LINK, E. M., LIU, L. X., KURZ, C. L., ALLOING, G., TAN, M. W., 
RAY, K. P., SOLARI, R., JOHNSON, C. D. & EWBANK, J. J. 2001. A 
reverse genetic analysis of components of the Toll signaling pathway in 
Caenorhabditis elegans. Curr Biol, 11, 809-21. 
PUMBWE, L., SKILBECK, C. A., NAKANO, V., AVILA-CAMPOS, M. J., 
PIAZZA, R. M. & WEXLER, H. M. 2007. Bile salts enhance bacterial co-
aggregation, bacterial-intestinal epithelial cell adhesion, biofilm formation 
  References 
195 
 
and antimicrobial resistance of Bacteroides fragilis. Microb Pathog, 43, 78-
87. 
QIN, X., BACHMAN, B., BATTLES, P., BELL, A., BESS, C. & BICKHAM, C. 
2009. E. faecium TX1330 genome. Submitted directly [Online]. Available: 
http://www.ncbi.nlm.nih.gov/nuccore/ACHL00000000.1 [Accessed]. 
QIN, X., GALLOWAY-PENA, J. R., SILLANPAA, J., HYEOB ROH, J., 
NALLAPAREDDY, S. R., CHOWDHURY, S., BOURGOGNE, A., 
CHOUDHURY, T., MUNZY, D. M., BUHAY, C. J., DING, Y., DUGAN-
ROCHA, S., LIU, W., KOVAR, C., SODERGREN, E., HIGHLANDER, S., 
PETROSINO, J. F., WORLEY, K. C., GIBBS, R. A., WEINSTOCK, G. M. 
& MURRAY, B. E. 2012. Complete genome sequence of Enterococcus 
faecium strain TX16 and comparative genomic analysis of Enterococcus 
faecium genomes. BMC Microbiol, 12, 135. 
QIN, X., SINGH, K. V., WEINSTOCK, G. M. & MURRAY, B. E. 2000. Effects of 
Enterococcus faecalis fsr genes on production of gelatinase and a serine 
protease and virulence. Infect Immun, 68, 2579-86. 
QIN, X., SINGH, K. V., WEINSTOCK, G. M. & MURRAY, B. E. 2001. 
Characterization of fsr, a regulator controlling expression of gelatinase and 
serine protease in Enterococcus faecalis OG1RF. J Bacteriol, 183, 3372-82. 
QIN, X., SINGH, K. V., XU, Y., WEINSTOCK, G. M. & MURRAY, B. E. 1998. 
Effect of disruption of a gene encoding an autolysin of Enterococcus faecalis 
OG1RF. Antimicrob Agents Chemother, 42, 2883-8. 
REFFUVEILLE, F., LENEVEU, C., CHEVALIER, S., AUFFRAY, Y. & RINCE, 
A. 2011. Lipoproteins of Enterococcus faecalis: bioinformatic identification, 
expression analysis and relation to virulence. Microbiology, 157, 3001-13. 
REN, D., BEDZYK, L. A., THOMAS, S. M., YE, R. W. & WOOD, T. K. 2004. 
Gene expression in Escherichia coli biofilms. Appl Microbiol Biotechnol, 64, 
515-24. 
RICE, L. B. 2006. Antimicrobial resistance in gram-positive bacteria. Am J Med, 
119, S11-9; discussion S62-70. 
RICH, R. L., KREIKEMEYER, B., OWENS, R. T., LABRENZ, S., NARAYANA, 
S. V., WEINSTOCK, G. M., MURRAY, B. E. & HOOK, M. 1999. Ace is a 
collagen-binding MSCRAMM from Enterococcus faecalis. J Biol Chem, 274, 
26939-45. 
RINCE, A., LE BRETON, Y., VERNEUIL, N., GIARD, J. C., HARTKE, A. & 
AUFFRAY, Y. 2003. Physiological and molecular aspects of bile salt 
response in Enterococcus faecalis. Int J Food Microbiol, 88, 207-13. 
ROSENBERG, M., PERRY, A., BAYER, E. A., GUTNICK, D. L., ROSENBERG, 
E. & OFEK, I. 1981. Adherence of Acinetobacter calcoaceticus RAG-1 to 
human epithelial cells and to hexadecane. Infect Immun, 33, 29-33. 
ROZDZINSKI, E., MARRE, R., SUSA, M., WIRTH, R. & MUSCHOLL-
SILBERHORN, A. 2001. Aggregation substance-mediated adherence of 
Enterococcus faecalis to immobilized extracellular matrix proteins. Microb 
Pathog, 30, 211-20. 
RUAS-MADIEDO, P., GUEIMONDE, M., ARIGONI, F., DE LOS REYES-
GAVILAN, C. G. & MARGOLLES, A. 2009. Bile affects the synthesis of 
exopolysaccharides by Bifidobacterium animalis. Appl Environ Microbiol, 
75, 1204-7. 
SAMBROOK, J. & RUSSEL, D. W. 2001. Molecular Cloning, A laboratory 
manual, CSHL Press. 
  References 
196 
 
SARTINGEN, S., ROZDZINSKI, E., MUSCHOLL-SILBERHORN, A. & MARRE, 
R. 2000. Aggregation substance increases adherence and internalization, but 
not translocation, of Enterococcus faecalis through different intestinal 
epithelial cells in vitro. Infect Immun, 68, 6044-7. 
SAVA, I. G., HEIKENS, E., KROPEC, A., THEILACKER, C., WILLEMS, R. & 
HUEBNER, J. 2010. Enterococcal surface protein contributes to persistence 
in the host but is not a target of opsonic and protective antibodies in 
Enterococcus faecium infection. J Med Microbiol, 59, 1001-4. 
SCHNEEWIND, O., MIHAYLOVA-PETKOV, D. & MODEL, P. 1993. Cell wall 
sorting signals in surface proteins of gram-positive bacteria. EMBO J, 12, 
4803-11. 
SELLENRIEK, P., HOLMES, J., FERRETT, H., DRURY, R. & STORCH, G. A. 
2005. Comparison of MicroScan Walk-Away®,   Phoenix™   and   VITEK-
TWO®Microbiology Systems Used in the Identification 
and Susceptibility Testing of Bacteria. 105th General Meeting of the American 
Society for Microbiology. 
SENEVIRATNE, C. J., WANG, Y., JIN, L., WONG, S. S., HERATH, T. D. & 
SAMARANAYAKE, L. P. 2012. Unraveling the resistance of microbial 
biofilms: has proteomics been helpful? Proteomics, 12, 651-65. 
SHANKAR, N., BAGHDAYAN, A. S. & GILMORE, M. S. 2002. Modulation of 
virulence within a pathogenicity island in vancomycin-resistant Enterococcus 
faecalis. Nature, 417, 746-50. 
SHANKAR, N., LOCKATELL, C. V., BAGHDAYAN, A. S., DRACHENBERG, 
C., GILMORE, M. S. & JOHNSON, D. E. 2001. Role of Enterococcus 
faecalis surface protein Esp in the pathogenesis of ascending urinary tract 
infection. Infect Immun, 69, 4366-72. 
SHANKAR, V., BAGHDAYAN, A. S., HUYCKE, M. M., LINDAHL, G. & 
GILMORE, M. S. 1999. Infection-derived Enterococcus faecalis strains are 
enriched in esp, a gene encoding a novel surface protein. Infect Immun, 67, 
193-200. 
SHATTOCK, P. M. 1949. The streptococci of group D; the serological grouping of 
Streptococcus bovis and observations on serologically refractory group D 
strains. J Gen Microbiol, 3, 80-92. 
SIFRI, C. D., BEGUN, J. & AUSUBEL, F. M. 2005. The worm has turned--
microbial virulence modeled in Caenorhabditis elegans. Trends Microbiol, 
13, 119-27. 
SIFRI, C. D., MYLONAKIS, E., SINGH, K. V., QIN, X., GARSIN, D. A., 
MURRAY, B. E., AUSUBEL, F. M. & CALDERWOOD, S. B. 2002. 
Virulence effect of Enterococcus faecalis protease genes and the quorum-
sensing locus fsr in Caenorhabditis elegans and mice. Infect Immun, 70, 
5647-50. 
SILLANPAA, J., NALLAPAREDDY, S. R., PRAKASH, V. P., QIN, X., HOOK, 
M., WEINSTOCK, G. M. & MURRAY, B. E. 2008. Identification and 
phenotypic characterization of a second collagen adhesin, Scm, and genome-
based identification and analysis of 13 other predicted MSCRAMMs, 
including four distinct pilus loci, in Enterococcus faecium. Microbiology, 
154, 3199-211. 
SILLANPAA, J., NALLAPAREDDY, S. R., SINGH, K. V., PRAKASH, V. P., 
FOTHERGILL, T., TON-THAT, H. & MURRAY, B. E. 2010. 
Characterization of the ebp(fm) pilus-encoding operon of Enterococcus 
  References 
197 
 
faecium and its role in biofilm formation and virulence in a murine model of 
urinary tract infection. Virulence, 1, 236-46. 
SILLANPAA, J., XU, Y., NALLAPAREDDY, S. R., MURRAY, B. E. & HOOK, 
M. 2004. A family of putative MSCRAMMs from Enterococcus faecalis. 
Microbiology, 150, 2069-78. 
SINGH, K. V., LEWIS, R. J. & MURRAY, B. E. 2009. Importance of the epa locus 
of Enterococcus faecalis OG1RF in a mouse model of ascending urinary tract 
infection. J Infect Dis, 200, 417-20. 
SINGH, K. V., NALLAPAREDDY, S. R., NANNINI, E. C. & MURRAY, B. E. 
2005. Fsr-independent production of protease(s) may explain the lack of 
attenuation of an Enterococcus faecalis fsr mutant versus a gelE-sprE mutant 
in induction of endocarditis. Infect Immun, 73, 4888-94. 
SINGH, K. V., NALLAPAREDDY, S. R., SILLANPAA, J. & MURRAY, B. E. 
2010a. Importance of the collagen adhesin ace in pathogenesis and protection 
against Enterococcus faecalis experimental endocarditis. PLoS Pathog, 6, 
e1000716. 
SINGH, K. V., QIN, X., WEINSTOCK, G. M. & MURRAY, B. E. 1998. Generation 
and testing of mutants of Enterococcus faecalis in a mouse peritonitis model. 
J Infect Dis, 178, 1416-20. 
SINGH, R., RAY, P., DAS, A. & SHARMA, M. 2010b. Penetration of antibiotics 
through Staphylococcus aureus and Staphylococcus epidermidis biofilms. J 
Antimicrob Chemother, 65, 1955-8. 
SOOD, S., MALHOTRA, M., DAS, B. K. & KAPIL, A. 2008. Enterococcal 
infections & antimicrobial resistance. Indian J Med Res, 128, 111-21. 
STYER, K. L., HOPKINS, G. W., BARTRA, S. S., PLANO, G. V., 
FROTHINGHAM, R. & ABALLAY, A. 2005. Yersinia pestis kills 
Caenorhabditis elegans by a biofilm-independent process that involves novel 
virulence factors. EMBO Rep, 6, 992-7. 
SUNG, J. Y., LEUNG, J. W., SHAFFER, E. A., LAM, K., OLSON, M. E. & 
COSTERTON, J. W. 1992. Ascending infection of the biliary tract after 
surgical sphincterotomy and biliary stenting. J Gastroenterol Hepatol, 7, 
240-5. 
SUNG, J. Y., SHAFFER, E. A., OLSON, M. E., LEUNG, J. W., LAM, K. & 
COSTERTON, J. W. 1991. Bacterial invasion of the biliary system by way 
of the portal-venous system. Hepatology, 14, 313-7. 
SUTHERLAND, I. W. 2001. The biofilm matrix--an immobilized but dynamic 
microbial environment. Trends Microbiol, 9, 222-7. 
TAMURA, K., PETERSON, D., PETERSON, N., STECHER, G., NEI, M. & 
KUMAR, S. 2011. MEGA5: molecular evolutionary genetics analysis using 
maximum likelihood, evolutionary distance, and maximum parsimony 
methods. Mol Biol Evol, 28, 2731-9. 
TENDOLKAR, P. M., BAGHDAYAN, A. S., GILMORE, M. S. & SHANKAR, N. 
2004. Enterococcal surface protein, Esp, enhances biofilm formation by 
Enterococcus faecalis. Infect Immun, 72, 6032-9. 
TENDOLKAR, P. M., BAGHDAYAN, A. S. & SHANKAR, N. 2005. The N-
terminal domain of enterococcal surface protein, Esp, is sufficient for Esp-
mediated biofilm enhancement in Enterococcus faecalis. J Bacteriol, 187, 
6213-22. 
  References 
198 
 
TENDOLKAR, P. M., BAGHDAYAN, A. S. & SHANKAR, N. 2006. Putative 
surface proteins encoded within a novel transferable locus confer a high-
biofilm phenotype to Enterococcus faecalis. J Bacteriol, 188, 2063-72. 
TENG, F., KAWALEC, M., WEINSTOCK, G. M., HRYNIEWICZ, W. & 
MURRAY, B. E. 2003. An Enterococcus faecium secreted antigen, SagA, 
exhibits broad-spectrum binding to extracellular matrix proteins and appears 
essential for E. faecium growth. Infect Immun, 71, 5033-41. 
TENG, F., SINGH, K. V., BOURGOGNE, A., ZENG, J. & MURRAY, B. E. 2009. 
Further characterization of the epa gene cluster and Epa polysaccharides of 
Enterococcus faecalis. Infect Immun, 77, 3759-67. 
TERRA, R., STANLEY-WALL, N. R., CAO, G. & LAZAZZERA, B. A. 2012. 
Identification of Bacillus subtilis SipW as a bifunctional signal peptidase that 
controls surface-adhered biofilm formation. J Bacteriol, 194, 2781-90. 
THANASSI, D. G., CHENG, L. W. & NIKAIDO, H. 1997. Active efflux of bile 
salts by Escherichia coli. J Bacteriol, 179, 2512-8. 
THOMAS, V. C., HIROMASA, Y., HARMS, N., THURLOW, L., TOMICH, J. & 
HANCOCK, L. E. 2009. A fratricidal mechanism is responsible for eDNA 
release and contributes to biofilm development of Enterococcus faecalis. Mol 
Microbiol, 72, 1022-36. 
THOMAS, V. C., THURLOW, L. R., BOYLE, D. & HANCOCK, L. E. 2008. 
Regulation of autolysis-dependent extracellular DNA release by 
Enterococcus faecalis extracellular proteases influences biofilm development. 
J Bacteriol, 190, 5690-8. 
TJALSMA, H., BOLHUIS, A., JONGBLOED, J. D., BRON, S. & VAN DIJL, J. M. 
2000a. Signal peptide-dependent protein transport in Bacillus subtilis: a 
genome-based survey of the secretome. Microbiol Mol Biol Rev, 64, 515-47. 
TJALSMA, H., NOBACK, M. A., BRON, S., VENEMA, G., YAMANE, K. & 
VAN DIJL, J. M. 1997. Bacillus subtilis contains four closely related type I 
signal peptidases with overlapping substrate specificities. Constitutive and 
temporally controlled expression of different sip genes. J Biol Chem, 272, 
25983-92. 
TJALSMA, H., STOVER, A. G., DRIKS, A., VENEMA, G., BRON, S. & VAN 
DIJL, J. M. 2000b. Conserved serine and histidine residues are critical for 
activity of the ER-type signal peptidase SipW of Bacillus subtilis. J Biol 
Chem, 275, 25102-8. 
TOLEDO-ARANA, A., VALLE, J., SOLANO, C., ARRIZUBIETA, M. J., 
CUCARELLA, C., LAMATA, M., AMORENA, B., LEIVA, J., PENADES, 
J. R. & LASA, I. 2001. The enterococcal surface protein, Esp, is involved in 
Enterococcus faecalis biofilm formation. Appl Environ Microbiol, 67, 4538-
45. 
TOP, J., SINNIGE, J. C., MAJOOR, E. A., BONTEN, M. J., WILLEMS, R. J. & 
VAN SCHAIK, W. 2011. The recombinase IntA is required for excision of 
esp-containing ICEEfm1 in Enterococcus faecium. J Bacteriol, 193, 1003-6. 
TOP, J., WILLEMS, R. & BONTEN, M. 2008. Emergence of CC17 Enterococcus 
faecium: from commensal to hospital-adapted pathogen. FEMS Immunol 
Med Microbiol, 52, 297-308. 
UBEDA, C., TAUR, Y., JENQ, R. R., EQUINDA, M. J., SON, T., SAMSTEIN, M., 
VIALE, A., SOCCI, N. D., VAN DEN BRINK, M. R., KAMBOJ, M. & 
PAMER, E. G. 2010. Vancomycin-resistant Enterococcus domination of 
  References 
199 
 
intestinal microbiota is enabled by antibiotic treatment in mice and precedes 
bloodstream invasion in humans. J Clin Invest, 120, 4332-41. 
VAGNER, V., DERVYN, E. & EHRLICH, S. D. 1998. A vector for systematic gene 
inactivation in Bacillus subtilis. Microbiology, 144 ( Pt 11), 3097-104. 
VALLE, J., LATASA, C., GIL, C., TOLEDO-ARANA, A., SOLANO, C., 
PENADES, J. R. & LASA, I. 2012. Bap, a Biofilm Matrix Protein of 
Staphylococcus aureus Prevents Cellular Internalization through Binding to 
GP96 Host Receptor. PLoS Pathog, 8, e1002843. 
VAN DIJL, J. M., DE JONG, A., VENEMA, G. & BRON, S. 1995. Identification of 
the potential active site of the signal peptidase SipS of Bacillus subtilis. 
Structural and functional similarities with LexA-like proteases. J Biol Chem, 
270, 3611-8. 
VAN MERODE, A. E., VAN DER MEI, H. C., BUSSCHER, H. J. & KROM, B. P. 
2006a. Influence of culture heterogeneity in cell surface charge on adhesion 
and biofilm formation by Enterococcus faecalis. J Bacteriol, 188, 2421-6. 
VAN MERODE, A. E., VAN DER MEI, H. C., BUSSCHER, H. J., WAAR, K. & 
KROM, B. P. 2006b. Enterococcus faecalis strains show culture 
heterogeneity in cell surface charge. Microbiology, 152, 807-14. 
VAN ROOSMALEN, M. L., GEUKENS, N., JONGBLOED, J. D., TJALSMA, H., 
DUBOIS, J. Y., BRON, S., VAN DIJL, J. M. & ANNE, J. 2004. Type I 
signal peptidases of Gram-positive bacteria. Biochim Biophys Acta, 1694, 
279-97. 
VAN SCHAIK, W., TOP, J., RILEY, D. R., BOEKHORST, J., VRIJENHOEK, J. 
E., SCHAPENDONK, C. M., HENDRICKX, A. P., NIJMAN, I. J., 
BONTEN, M. J., TETTELIN, H. & WILLEMS, R. J. 2010. Pyrosequencing-
based comparative genome analysis of the nosocomial pathogen 
Enterococcus faecium and identification of a large transferable pathogenicity 
island. BMC Genomics, 11, 239. 
VAN WAMEL, W. J., HENDRICKX, A. P., BONTEN, M. J., TOP, J., 
POSTHUMA, G. & WILLEMS, R. J. 2007. Growth condition-dependent Esp 
expression by Enterococcus faecium affects initial adherence and biofilm 
formation. Infect Immun, 75, 924-31. 
VAN WELY, K. H., SWAVING, J., FREUDL, R. & DRIESSEN, A. J. 2001. 
Translocation of proteins across the cell envelope of Gram-positive bacteria. 
FEMS Microbiol Rev, 25, 437-54. 
VANKERCKHOVEN, V., VAN AUTGAERDEN, T., VAEL, C., LAMMENS, C., 
CHAPELLE, S., ROSSI, R., JABES, D. & GOOSSENS, H. 2004. 
Development of a multiplex PCR for the detection of asa1, gelE, cylA, esp, 
and hyl genes in enterococci and survey for virulence determinants among 
European hospital isolates of Enterococcus faecium. J Clin Microbiol, 42, 
4473-9. 
VENGADESAN, K. & NARAYANA, S. V. 2011. Structural biology of Gram-
positive bacterial adhesins. Protein Sci, 20, 759-72. 
VINE, G. J. & BISHOP, A. H. 2005. The analysis of microorganisms by 
microcalorimetry in the pharmaceutical industry. Curr Pharm Biotechnol, 6, 
223-38. 
VON AH, U., WIRZ, D. & DANIELS, A. U. 2008. Rapid differentiation of 
methicillin-susceptible Staphylococcus aureus from methicillin-resistant S. 
aureus and MIC determinations by isothermal microcalorimetry. J Clin 
Microbiol, 46, 2083-7. 
  References 
200 
 
VON REGE, H. & SAND, W. 1998. Evaluation of biocide effecacy by 
microcalorimetric determination of microbial activity in biofilms. Journal of 
Microbiological Methods, 33, 227-235. 
WASTFELT, M., STALHAMMAR-CARLEMALM, M., DELISSE, A. M., 
CABEZON, T. & LINDAHL, G. 1996. Identification of a family of 
streptococcal surface proteins with extremely repetitive structure. J Biol 
Chem, 271, 18892-7. 
WATERS, C. M., ANTIPORTA, M. H., MURRAY, B. E. & DUNNY, G. M. 2003. 
Role of the Enterococcus faecalis GelE protease in determination of cellular 
chain length, supernatant pheromone levels, and degradation of fibrin and 
misfolded surface proteins. J Bacteriol, 185, 3613-23. 
WATERS, C. M., HIRT, H., MCCORMICK, J. K., SCHLIEVERT, P. M., WELLS, 
C. L. & DUNNY, G. M. 2004. An amino-terminal domain of Enterococcus 
faecalis aggregation substance is required for aggregation, bacterial 
internalization by epithelial cells and binding to lipoteichoic acid. Mol 
Microbiol, 52, 1159-71. 
WERNER, G., STROMMENGER, B. & WITTE, W. 2008. Acquired vancomycin 
resistance in clinically relevant pathogens. Future Microbiol, 3, 547-62. 
WILLEMS, R. J., HANAGE, W. P., BESSEN, D. E. & FEIL, E. J. 2011. Population 
biology of Gram-positive pathogens: high-risk clones for dissemination of 
antibiotic resistance. FEMS Microbiol Rev, 35, 872-900. 
WILLIAMSON, R., GUTMANN, L., HORAUD, T., DELBOS, F. & ACAR, J. F. 
1986. Use of penicillin-binding proteins for the identification of enterococci. 
J Gen Microbiol, 132, 1929-37. 
WILSON, M., MCNAB, R. & HENDERSON, B. 2002. Bacteria diseases 
mechanisms and introduction to cellular microbiology, Cambridge 
University press. 
WISE, A. J., HOGAN, J. S., CANNON, V. B. & SMITH, K. L. 2002. Phagocytosis 
and serum susceptibility of Escherichia coil cultured in iron-deplete and iron-
replete media. J Dairy Sci, 85, 1454-9. 
WU, Y. & OUTTEN, F. W. 2009. IscR controls iron-dependent biofilm formation in 
Escherichia coli by regulating type I fimbria expression. J Bacteriol, 191, 
1248-57. 
YANISCH-PERRON, C., VIEIRA, J. & MESSING, J. 1985. Improved M13 phage 
cloning vectors and host strains: nucleotide sequences of the M13mp18 and 
pUC19 vectors. Gene, 33, 103-19. 
ZAHLLER, J. & STEWART, P. S. 2002. Transmission electron microscopic study 
of antibiotic action on Klebsiella pneumoniae biofilm. Antimicrob Agents 
Chemother, 46, 2679-83. 
ZAIDI, A. H., BAKKES, P. J., KROM, B. P., VAN DER MEI, H. C. & DRIESSEN, 
A. J. 2011. Cholate-stimulated biofilm formation by Lactococcus lactis cells. 
Appl Environ Microbiol, 77, 2602-10. 
ZHOU, X. X., LI, W. F., MA, G. X. & PAN, Y. J. 2006. The nisin-controlled gene 
expression system: construction, application and improvements. Biotechnol 
Adv, 24, 285-95. 
 
 
 
